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ABSTRACT
MODERN OPTIMIZATION IN OBSERVATIONAL STUDIES
Colin B. Fogarty
Dylan S. Small
Perhaps the best known use of modern techniques for optimization in observational studies
is within matching algorithms, wherein treated units are placed into matched sets with similar control units to adjust for overt biases. While the intuitive appeal of matching has been
long understood, its ascent in popularity can be attributed in large part to computational
advances in network flow optimization. This dissertation explores how modern optimization
can be leveraged to address other problems in observational studies. First, we demonstrate
how, in the absence of covariate overlap, the maximal box problem can be used to define an
interpretable study population wherein inference can be conducted without extrapolating
on important variables. Next, we discuss how integer programming can be used to perform
inference, construct confidence intervals, and provide sensitivity analyses for meaningful
causal estimands in matched observational studies when the outcomes of interest are binary.
Third, we present a method utilizing convex optimization for conducting a sensitivity analysis when there are multiple outcome variables of interest which, we show, can help attenuate
the loss in power from accounting for multiple comparisons when assessing the robustness of
a study’s findings to unmeasured confounding. Finally, we present methods for conducting a
sensitivity analysis for the average treatment effect with continuous outcome variables with
and without assuming a known direction of effect.
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CHAPTER 1 : Introduction
In an ideal world there would be no need for observational studies; any hypothesized causal
relationship would be tested through controlled randomized experiments, with randomization conferring both a “reasoned basis for inference” (Fisher, 1935) and protection against
unmeasured confounding. While ethical and logistical constraints make this experimental
ideal impossible to attain, researchers should not be deterred from striving towards it when
seeking answers to questions that can only be assessed through observational data.
H.F. Dorn advised that the planner of an observational study should always ask himself
the question, “how would the study be conducted if it were possible to do it by controlled
experimentation?”(Dorn, 1953, p. 680). The idea that the analysis of observational studies
should be made experiment-like was strongly advocated by William Cochran, and has proven
profoundly influential not only in how observational studies are planned, but also in how they
are analyzed. Matching is one strategy which can be viewed in this light. In an observational
study employing matching, treated individuals are placed into matched sets with similar
control individuals in an attempt to replicate a block randomized experiment. With the
advent of the propensity score (Rosenbaum and Rubin, 1983) and advances in optimization
routines for matching (Rosenbaum, 1991; Hansen and Klopfer, 2012), matching has entered
mainstream usage. In my research, I have demonstrated that advances in optimization
that aided matching’s ascent can also be leveraged to address a host of seemingly unrelated
issues commonly encountered in the design and analysis of observational studies. Through
developing methods for estimation and inference in matched observational studies, I hope
to further promote the usefulness of matching in the analysis of non-randomized studies.
Not only does matching facilitate estimation of and inference for causal effects assuming no
unmeasured confounding, but it also provides a framework for assessing the robustness of a
study’s conclusions to unmeasured confounding through a sensitivity analysis (Rosenbaum,
2002a, Section 4).
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Each of the four chapters within the body of the chapter contains a single, self-contained,
paper. In the first paper, we investigate the causal effect of admission to an ICU versus to
a hospital ward on 60 day mortality rates for sepsis patients. In conducting this analysis,
we encountered a problem common in observational studies: a lack of overlap with respect
to important covariates. In this application, a lack of overlap arises because many ICU
patients are more severely ill than any hospital ward patient. We cannot possibly infer
the effect of the admission decision on mortality for the these patients, as we lack patients
admitted to hospital wards with whom their outcomes can be fairly compared. Assessment of
causal effects for those individuals would represent an analysis of “extreme counterfactuals,”
resulting in an extrapolation to which the data cannot honestly attest (King and Zeng, 2006).
Rather, inference must be restricted to the area of common support (i.e., those patients
who were less gravely ill at presentation). Through the maximal box problem (Eckstein
et al., 2002), we define a study population by incorporating existing methods for identifying
individuals outside the area of common support with respect to important covariates while
yielding inclusion criteria which are readily interpretable as intervals of values for these
variables. By limiting ourselves to important covariates, we are able to verify the efficacy
of our method through the use of visual aids such as scatterplots. We then use matching
within this study population to adjust for overt biases for all covariates, and we only proceed
with inference if the balance between the two groups is deemed acceptable. In this way,
practitioners can transparently describe the individuals remaining in the study population,
and hence the individuals to whom the resulting statistical analysis applies. This paper is
joint work with Mark Mikkelsen, David Gaieski, and Dylan Small, and will appear in the
Journal of the American Statistical Association: Applications and Case Studies.
The second paper discusses difficulties encountered when using randomization inference
and the potential outcomes framework in the analysis of observational studies with binary
outcomes. Unlike with continuous outcomes, the only natural causal estimands have corresponding hypothesis tests that are composite in nature when the outcome variable of interest
is binary. This means that there are many allocations of potential outcomes which yield the
2

same hypothesized value of the causal estimand. Examples of such estimands are the risk
difference, risk ratio, and the effect ratio. To reject a null hypothesis for a causal parameter
of this sort, we must reject the null for all allocations of the potential outcomes which satisfy the null. The situation is further complicated when conducting a sensitivity analysis,
as inference must also account for the potential existence of unmeasured confounding with
a range of impacts on the assignment of interventions. We show that hypothesis testing
for a composite null with binary outcomes can be performed by solving an integer linear
program under the assumption of no unmeasured confounding. When conducting a sensitivity analysis, an integer quadratic program is required. Under mild assumptions, these
optimization problems yield the worst-case p-value within the composite null. We show that
our formulation is strong, in that the optimal objective value for our integer program closely
approximates that of the corresponding continuous relaxation. This allows hypothesis testing and sensitivity analyses to be conducted efficiently even with large sample sizes and
large matched sets. We further demonstrate through a simulation study the importance of a
thoughtful formulation in solving large-scale discrete optimization problems. This paper is
joint work with Pixu Shi, Mark Mikkelsen, and Dylan Small, and will appear in the Journal
of the American Statistical Association: Theory and Methods.
In the third paper, we discuss how modern optimization lends support towards demonstrating “multiple operationalism" (Campbell, 1988) in an observational study, wherein one
predicts a particular direction of effect for multiple outcome variables under the causal theory in question. This strategy is in line with Fisher’s advocating of “elaborate theories”
as a means to help bridge the gap between association and causation in an observational
study; however, when testing hypotheses on multiple outcomes multiple comparisons must
be taken into account. This is true not only when assuming no unmeasured confounding,
but also when assessing how robust a study’s findings are to unmeasured confounding in
the subsequent sensitivity analysis. Concerns over a loss in power may lead practitioners
to instead investigate the outcome variable they believe a priori will be most affected by
the intervention, thus reducing the extent to which Fisher’s advice is followed in practice.
3

We demonstrate that when performing multiple comparisons in a sensitivity analysis, the
loss in power from controlling the familywise error rate can be attenuated. This is because
unmeasured confounding cannot have a different impact on the probability of assignment to
treatment for a given individual depending on the outcome being analyzed. Existing methods for testing the overall truth of multiple hypotheses allow this to occur by combining the
results of sensitivity analyses performed on individual outcomes. By solving a quadratically
constrained linear program, we are able to perform a sensitivity analysis while avoiding this
logical inconsistency. We show that this allows for uniform improvements in the power of a
sensitivity analysis when compared to combining individual sensitivity analyses. This is true
not only for testing the overall null across outcomes, but also for testing null hypotheses on
specific outcome variables when using certain sequential rejection procedures. We illustrate
our method through an example examining the impact of smoking on naphthalene levels in
the body. This paper is joint work with Dylan Small, and will appear in the Journal of the
American Statistical Association: Theory and Methods.
In the fourth paper, we present methods for conducting a sensitivity analysis for perhaps the
most common summary measure of a treatment’s effect, the average treatment effect, with
continuous outcome variables, Our analysis follows the standard approach for inference on
the average treatment effect in randomized experiments by restricting the set of potential
outcomes under consideration to those which satisfy an estimated bound on the variance of
the average treatment effect. We show that while the problem could be formulated as a large
integer program, a solution can be attained to the problem in its greatest generality in linear
time. We further discuss the incorporation of an assumption of a known direction of effect,
and how integer programming can be used to conduct a sensitivity analysis in this case.
We then compare the sensitivity of inferences to unmeasured confounding under a host of
assumptions on the potential outcomes, including the assumption of an additive treatment
effect. This work remains in progress and is inspired by recent work of Paul Rosenbaum.
As an aside, it goes without saying that “inspired by the work of Paul Rosenbaum" is an
accurate descriptor of this dissertation in its entirety.
4

CHAPTER 2 : Discrete Optimization for Interpretable Study Populations and
Randomization Inference in an Observational Study of Severe Sepsis
Mortality
Joint work with Mark Mikkelsen, David Gaieski, and Dylan Small

2.1. Introduction
2.1.1. Severe Sepsis Incidence and Mortality
Severe sepsis is a leading cause of morbidity and mortality worldwide. It is defined as a
systematic inflammatory response to infection that is accompanied by acute organ dysfunction. Angus et al. (2001) estimate that severe sepsis afflicts roughly 750,000 individuals in
the United States per year, of whom an estimated 215,000 perish. Gaieski et al. (2013) note
that cases of severe sepsis appear to be on the rise. In a recent study, Liu et al. (2014)
found that sepsis contributed to one in every two to three deaths in two complementary
hospital cohorts, and suggest that “improved treatment of sepsis (potentially a final hospital
pathway for multiple other underlying conditions) could offer meaningful improvements in
population mortality.”
A critical decision along this pathway is whether to admit a patient to an intensive care
unit (ICU), or rather to an appropriate hospital ward. It is estimated that approximately
50 percent of severe sepsis patients in the United States are admitted to an ICU after
presentation to an emergency department, with the rest being admitted to a hospital ward
(Angus and van der Poll, 2013). Recent evidence suggests that admission to a non-ICU
setting may be increasing (Whittaker et al., 2015). Severe sepsis varies in degree of gravity
at time of presentation to the emergency department. In general, sicker patients tend to
be placed in the ICU, and those exhibiting less severe symptoms are often admitted to the
hospital ward. Furthermore, Brun-Buisson et al. (1996) and Rohde et al. (2013) note that
there are systematic ways in which the epidemiology, site of infection, and organ dysfunctions
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appear to vary between ICU and hospital ward patients.
The existing literature offers contrasting opinions on the optimal process of care for severe
sepsis patients. Esteban et al. (2007) argue that there is a large population of patients not
admitted to the ICU who could “potentially benefit from more aggressive resuscitation and
innovative therapies” that are available in the ICU. They found that severe sepsis patients
in hospital wards had a higher estimated mortality rate than those who were admitted to
the ICU, although their result was not statistically significant. On the other hand, Levy
et al. (2008) found that admission to an ICU covered by intensivists may result in worse
health outcomes, in part because patients may receive unnecessary (but potentially harmful)
therapies or procedures. It is feasible, then, that certain severe sepsis patients may be better
off if they were admitted to the hospital ward, as they would not be subjected to interventions
in the ICU that are not warranted given their condition. In keeping with this hypothesis,
Sundararajan et al. (2005) found that severe sepsis mortality rates among non-ICU patients
were lower than those among ICU patients.
The goal of our analysis is to assess the causal effect of ICU admission versus hospital ward
admission on health outcomes. To be precise, we aim to compare the average health outcomes if all individuals were admitted to the ICU with the average outcomes if all patients
were admitted to the hospital ward. We use data from a retrospective observational cohort
study wherein hospital admissions of individuals with severe sepsis to the Hospital of the
University of Pennsylvania between January 2005 and December 2009 were examined; see
Whittaker et al. (2015) for further details on the data set. We only consider patients without
hemodynamic septic shock (a patient has hemodynamic septic shock if the patient has severe
sepsis coupled with hypotension after initial fluid resuscitation) because patients with hemodynamic septic shock are almost exclusively admitted to the ICU (ProCESS Trial, 2014).
Investigators identified 1507 remaining individuals with severe sepsis but not hemodynamic
septic shock, of whom 695 were admitted to an ICU and 812 were admitted to a hospital ward. Thirty covariates detailing demographic information, comorbidities, emergency
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Table 1: Covariate Means and Standard Deviations, Original Population and Study Population for Tier 1 Covariates. The first two columns are the covariate means (standard deviations) in the initial study population, and the last two columns are the covariate means
(standard deviations) in the study population defined in Section 2.4.3.
Covariate
Age
Charlson comorbity index
Initial serum lactate
APACHE II score

Original Population
ICU
Ward
60.1
55.1
(17.4)
(18.4)
2.52
2.41
(2.81)
(2.64)
4.26
2.56
(2.98)
(1.23)
17.7
13.6
(6.37)
(5.27)

Study Population
ICU
Ward
60.56
55.88
(17.1)
(18.3)
2.43
2.48
(2.70)
(2.65)
3.22
2.61
(1.24)
(0.956)
16.9
13.8
(5.46)
(4.73)

department process of care, and site of infection were identified by expert consultation as
germane to the hospital pathway and to health outcomes. We separated our covariates into
three tiers of importance based on an a priori assessment (i.e. before examining the data
set) of their effect on admission decisions and mortality. Our health outcome is a binary
variable that takes on the value 1 if a patient died any time between the date of hospital
admission and 60 days after hospital admission. The tier 1 covariates are listed in Table
1 along with their means and standard deviations among ICU and hospital ward patients,
while the remaining covariates are summarized in Appendix A.1.
A subgroup of severe sepsis patients who are of particular interest to the critical care community are those with cryptic septic shock. These are severe sepsis patients who have normal
levels of systolic blood pressure (so do not have hemodynamic septic shock) yet exhibit high
levels of initial serum lactate (≥ 4 mmol/L) (Puskarich et al., 2011). Initial serum lactate
levels refer to the amount of lactic acid in the blood upon presentation to an emergency department. Initial serum lactate levels have been associated with mortality for severe sepsis
patients independent of organ dysfunction, and are therefore thought to be a highly useful biomarker for risk-stratifying patients upon presentation to an emergency department
(Mikkelsen et al., 2009). Some believe that cryptic septic shock patients should be classified
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as septic shock patients and admitted to an ICU by default, while others suggest that there
may be no benefit to such a protocol; see Jones (2011) and Rivers et al. (2011) for both
sides of the debate. Hence, in addition to comparing ICU versus hospital ward mortality
among all severe sepsis patients without hemodynamic septic shock, we would further like
to compare mortality within the subgroup of cryptic septic shock patients, as this subgroup
may exhibit mortality outcomes that differ from other severe sepsis patients. While only
10% of patients admitted to the hospital wards had cryptic septic shock in our sample, this
number was 44% for patients admitted to the ICU.
2.1.2. From Observational Study to Idealized Experiment
Randomization inference provides an appealing framework even when the data are not the
result of a randomized experiment. This is in keeping with the advice of H.F. Dorn, as relayed
in Cochran (1965), that “the planner of an observational study should always ask himself
the question, ‘how would the study be conducted if it were possible to do it by controlled
experimentation?’ ” Through matching on observed covariates, we attempt to mimic a wellbalanced randomized experiment. Matching methods encourage researcher blinding, since
matched sets can and should be constructed without looking at the outcome of interest.
Using randomizations within this idealized experiment as the basis for inference also allows us
to assess the robustness of a study’s finding to unmeasured confounding through a sensitivity
analysis. See Rosenbaum (2002a) for a discussion of using randomization inference within
observational studies.
Towards this end, we employ covariate matching to account for measured confounders that
may bias our comparison of 60 day mortality rates if all patients had been admitted to
the ICU versus if all patients had been admitted to the hospital ward, and then conduct
inference with respect to the match that is produced; see Stuart (2010) for a comprehensive
overview of common matching algorithms. Full matching, the algorithm used herein, is
a type of matching algorithm that optimally assigns individuals into strata consisting of
either one treated unit and many control units or one control unit and many treated units,
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and is particularly appealing for studies where the ratio of treated individuals to control
individuals is close to 1:1. See Rosenbaum (1991) and Hansen (2004) for additional details
on full matching.
In Section 2.2, we discuss the randomized experiment that full matching aims to replicate.
We begin our analysis in Section 2.3, where we discuss an issue encountered within our
comparison of hospital wards and ICU that is common to many observational studies: an
inherent lack of covariate overlap. In Section 2.4, we discuss how the maximal box problem
marries together existing methods for addressing lack of covariate overlap with the intuitive
appeal of a study population whose boundaries are clearly defined in terms of important
covariates.
Section 2.5 lays out the necessary framework for conducting inference on the average treatment effect in the idealized experiment we aim to uncover. Difficulties arise due to the
composite nature of a null hypothesis on the average treatment effect, in that different allocations of potential outcomes can yield the same average treatment effect while inducing
different randomization distributions for its estimate. We overcome these difficulties by finding a sharp upper bound on the variance of the estimated average treatment effect over all
elements of the composite null, which under a normal approximation allows us to carry out
inference for the composite null in question. In Section 2.6, we apply our methodology to
our sepsis example.
Though seemingly unrelated, our solutions for defining an interpretable study population
and conducting randomization inference on the average treatment effect with binary outcomes both utilize methods from discrete optimization. Traditionally, discrete optimization
problems were viewed as tractable if the worst-case instance could be solved by an algorithm that grows polynomially in the instance’s size, and statisticians have typically limited
themselves to using algorithms of this type. Both of the problems we pose are N P-hard,
meaning that there is no known polynomial time algorithm for the worst-case instances of
these problems. However, there have been recent advances in solving typical cases of these
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problems such that a typical case of these problems can often be solved in a reasonable
amount of time (Schrijver, 2003). In a recent paper, Zubizarreta (2012) highlighted the
usefulness of mixed integer programming for attaining well balanced matched sets. We illustrate that when applying the methods described in this paper to our data set, solutions
can be attained in a matter of seconds. Through the methods developed in this work, we
hope to further emphasize the usefulness of discrete optimization for observational studies
and statistics in general.

2.2. Review of Causal Inference via Matching
2.2.1. Notation For a Stratified Randomized Experiment
Suppose there are I total strata, the ith of which contains ni ≥ 2 individuals. In each
stratum, mi ≥ 1 individuals receive the treatment, ni − mi individuals receive the control,
and min{mi , ni − mi } = 1. Furthermore, mi is fixed across randomizations, resulting in
ni distinct assignments to treatment and control for the ith stratum. Assignments are
independent between distinct strata. Under the potential outcomes framework with binary
responses, each individual has two potential binary outcomes: one under treatment, rT ij ,
and one under control, rCij , which are 1 if an event would occur and 0 otherwise. The true
treatment effect for individual j in stratum i is δij = rT ij − rCij , and is unobservable as each
individual receives either treatment or control. The observed response for each individual
is Rij = rT ij Zij + rCij (1 − Zij ), where Zij is an indicator variable that takes the value 1 if
individual j in stratum i is assigned to the treatment; see, for example, Neyman (1923) and
Rubin (1974). Each individual has observed covariates xij .
There are N =

PI

i=1 ni

individuals in the study, of whom NT =

PI

i=1 mi

receive the

treatment and NC = N − NT receive the control. Let R = (R11 , R12 , ..., RI,nI )T and
Q
Z = (Z11 , Z12 , ..., ZI,nI )T . Let Ω be the set of Ii=1 ni possible values z of Z under the given
stratification. In a randomized experiment, randomness is modeled through the assignment
vector; each z ∈ Ω has probability 1/|Ω| of being selected. Hence, quantities dependent
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on the assignment vector such as Z and R are random, whereas rT ij , rCij , xij are fixed
quantities. Let F = {rT ij , rCij , xij , i = 1, .., I, j = 1, ..., ni }. For a randomized experiment,
we can then write that P(Zij = 1|F, Z ∈ Ω) = mi /ni , i = 1, .., I; j = 1, ..., ni and that
P(Z = z|F, Z ∈ Ω) = 1/|Ω|.
2.2.2. Matching and Observational Studies
In an observational study, we begin with an unmatched study population of size N . Matching methods aim to create strata where the constituent individuals have similar covariate
values, or at a minimum similar probabilities of assignment to treatment (Rosenbaum and
Rubin, 1983; Stuart, 2010). Once a match is obtained, the acceptability of the resulting stratification is assessed for covariate balance through the use of various diagnostics,
the most common of these being the standardized difference (Rosenbaum, 2010). Let the
notation introduced in Section 2.2.1 now apply to the stratification yielded by the matching algorithm. If the match passes the balance diagnostics, randomization inference then
proceeds under the assumptions of no unmeasured confounding, common support for the
assignment probabilities, and equal probabilities of assignment within a matched set. The
assumption of no unmeasured confounding states that given the observed covariates, the
probabilities of assignment to treatment are independent of the potential outcomes, that
is P(Zij = 1|xij ) = P(Zij = 1|xij , rT ij , rCij ), i = 1, ..., I; j = 1, ..., ni .
bility is known as the propensity score, and we denote it by e(xij ).

This proba-

The assumption

of common support for the assignment probabilities can be written as 0 < e(xij ) < 1,
i = 1, ..., I; j = 1, ..., ni . Finally, the assumption of equal probability of treatment assignment within a matched set can be written as e(xij ) = e(xik ) for all i = 1, ..., I; j, k = 1, ..., ni .
Under these assumptions, we have that P(Zij = 1|F, Z ∈ Ω) = mi /ni , i = 1, .., I; j = 1, ..., ni
and that P(Z = z|F, Z ∈ Ω) = 1/|Ω|, thus recovering the randomized experiment described
in Section 2.2.1.
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2.3. Lack of Common Support
2.3.1. Imbalance Caused by Limited Covariate Overlap
We begin by conducting a full match on our entire study population. As was previously
noted, we have 30 pre-treatment covariates that were deemed important for both the probability of admission to the ICU versus the ward and for the outcome. Of these, 13 contained
missing values; see Appendix A.1 for the percentages of missing observations for these 13
covariates. To account for this, we include 13 new missingness indicators, and fill in the missing values with the mean of the covariates. As is discussed in Rosenbaum and Rubin (1984)
and Rosenbaum (2010, Section 9.4), this facilitates balancing both the observed covariates
and the pattern of missingness between the two groups being compared. We also include an
indicator for whether an individual has cryptic septic shock. We thus have 44 covariates that
could be used in constructing our matched sets. In determining which variables to match
on, the avoidance of various types of “collider-bias” (Greenland, 2003) must be considered.
We first do not control for any post-treatment variables in order to avoid biases that stem
from controlling for the consequence of an exposure. One particular type of collider bias,
M -bias, can be induced even when only controlling for pre-treatment variables. Despite
this, we choose to control for all 44 of these pre-treatment covariates because of the work of
Ding and Miratrix (2014), simulation studies of Liu et al. (2012), and arguments of Rubin
(2009) that suggest that biases stemming from not controlling for a relevant pre-treatment
covariate tend to be more substantial than those that are caused by M -bias.
We use rank-based Mahalanobis distance with a propensity score caliper of 0.2 standard deviations as our distance metric between ICU and hospital ward patients, where the propensity
scores are estimated via a logistic regression of our covariates on the treatment indicator;
for further discussion on the role of propensity score calipers in multivariate matching, see
Rosenbaum (2010, Section 8.3). In addition, we match exactly on the cryptic septic shock
indicator, meaning that each stratum produced by the full match must either contain all
cryptic septic shock patients or none. We use standardized differences, defined as a weighted
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difference in means divided by the pooled standard deviation between groups before matching, to assess balance in our resulting match for the remaining covariates (Stuart and Green,
2008). A common rule of thumb is to deem the balance of a resulting match acceptable if
all absolute standardized differences fall below 0.1 (Rosenbaum, 2010). We modify this rule
slightly based on our covariate importance tiers, using thresholds of 0.05, 0.10, and 0.15 for
the standardized differences of tiers 1, 2, and 3 respectively. Thus, we require more stringent
balance for those covariates that are deemed to be of highest importance for the admission
decision and for mortality.
We first perform an unrestricted full matching. Without any restrictions, full matching can
produce extremely large strata. When applied to our data set, there are strata with ratios
of hospital ward patients to ICU patients of 37:1, 1:21, 1:32, and 1:65. Noting the potential
for outlandishly large strata, Hansen (2004) advocates placing a bound on the maximal
allowable strata size in order to increase the effective sample size (and thus, the power of
the resulting analysis). In keeping with this, we also performed full matches with restricted
ratios of hospital ward patients to ICU patients within each stratum, with ratios ranging
from 2:1, 1:2 to 15:1, 1:15. Neither the unrestricted full match nor any of the restricted
full matches resulted in an adequately balanced matched sample based on our standardized
difference thresholds.
Our failure to attain a suitably balanced stratification does not suggest a deficiency with
full matching; to the contrary, no matching algorithm should be able to produce a suitably
balanced stratification without discarding individuals, as there is a severe lack of covariate
overlap between patients admitted to the ICU and patients admitted to the hospital wards.
Two covariates that were out of balance in all of the restricted ratio matches were initial
serum lactate levels and APACHE II scores. As is described in Section 2.1, initial serum
lactate is believed to be important for both the admission decision and for health outcomes,
while the APACHE II score is a measure of disease severity using physiologic variables and
chronic health conditions (Knaus et al., 1985). As Figure 1 displays, virtually all of the
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Figure 1: Lack of Common Support and the Maximal Box. This figure shows a scatter plot of
initial serum lactate levels and APACHE II scores. The plot also shows the maximal box, which is
the solution to the optimization problem posed in Section 2.4. The rectangular boundaries represent
the study population identified as having a common support, wherein subsequent inference will be
restricted. It was formed by finding the rectangle containing the largest number of filled points,
subject to excluding all hollow points in the plot. The triangles represent ICU patients, and the
circles represent hospital ward patients. Whether a point is filled or hollow is described in Section
2.4.3 in detail, and has to do with whether or not it was determined that a given individual was in
the area of viable common support for his or her observed tier 1 covariates. Points are jittered to
avoid overplotting.

patients admitted to the hospital ward lie in the lower left hand quadrant of the scatterplot
of APACHE II scores versus initial serum lactate levels. Naturally, this lack of overlap arises
because many ICU patients are more severely ill than any hospital ward patient. We cannot
possibly infer the effect of admission to the ICU versus the hospital ward on mortality for
the severely ill ICU patients, as we lack patients admitted to the hospital wards with which
the outcomes of those ICU patients can be fairly compared. Assessment of causal effects
for those individuals would represent an analysis of “extreme counterfactuals,” resulting in
an extrapolation to which the data cannot honestly attest (King and Zeng, 2006). Rather,
inference about the effect of being admitted to an ICU or a hospital ward on mortality must
be restricted to the area of common support (i.e., those patients who were less gravely ill at
14

presentation), a fact to which restricted ratio full matches bear testament in their inability
to attain suitable balance.
2.3.2. Different Types of Overlap
Before proceeding, we discuss a few different notions of covariate overlap. The first notion,
which we call strong overlap, is that for every treated unit in the data, there is a control
unit that has similar or the same covariate values and that for every control unit, there
is a treated unit that has similar or the same covariate values. While strong overlap is
most desirable and can be readily diagnosed in low dimensions through visual tools such as
scatterplots, it is difficult to obtain when there are a moderate or high number of covariates because of the curse of dimensionality. The second notion, which we call interpolation
overlap, is that for any treated unit, an estimate of that treated unit’s counterfactual control potential outcome given the unit’s covariates can be inferred through an interpolation
rather than an extrapolation of the observed control outcomes and that for any control
unit, an estimate of that control’s unit counterfactual potential outcome can also be inferred through interpolation. King and Zeng (2006) present an operational way to check
for interpolation overlap by means of the convex hull of the treated and control covariate
distributions. According to their criterion, one is performing interpolation if a given treated
(control) individual is in the convex hull of the control (treated) covariate distributions, and
is performing extrapolation otherwise. Interpolation overlap then exists if all treated units
are in the convex hull of the control units, and all control units are in the convex hull of the
treated units. Unfortunately, as noted in King and Zeng (2006) their interpolation overlap
criterion is also difficult to satisfy in moderate and high dimensions. In Appendix A.2, we
demonstrate through a simulation study that even when the treated and control covariate
distributions are identical, the number of individuals for which “interpolation” is identified
as being performed by the convex hull diagnostic decreases substantially as the covariate
dimension increases.
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2.3.3. Existing Methods for Achieving Overlap
A lack of overlap is typically addressed by defining a study population restriction wherein
adequate overlap can be attained. Many methods are motivated by the fact that, asymptotically, strong overlap is present if and only if the propensity score at a given covariate
value, e(xj ), is bounded away from 0 and 1 for all individuals j ∈ {1, ...N }. In this sense,
the propensity score provides a scalar indication of both the existence of and the extent
of covariate overlap. Dehejia and Wahba (1999) recommend removing treated units whose
propensity scores are larger than the maximal propensity score among the control units,
and removing control units whose propensity score are smaller than the minimal propensity
score among the treated units. Crump et al. (2009) define a study population by seeking
the subset of the covariate space which minimizes the efficiency bound for the variance of
the study population average treatment effect. Based on this optimality criterion, they find
that for a wide range of distributions a close approximation to the optimal selection rule is
to drop all units with estimated propensity scores outside of [0.1, 0.9]. One concern with
propensity score approaches for attaining overlap for finite sample inference is that while
boundedness away from 0 and 1 implies strong overlap asymptotically, for finite samples
treated (control) individuals with nonzero propensity scores may still lack comparable control (treated) individuals in terms of their observed covariates. Another concern is that these
propensity scores must be estimated, so that individuals with nonzero estimated propensity
scores may nonetheless fall outside the area of overlap.
Other methods directly deal with the covariates themselves when defining a new study
population. King and Zeng (2006) identify a multivariate space wherein one performs interpolation rather than extrapolation by removing treated individuals whose covariates lie
outside of the convex hull of the covariates for the control individuals, and removing control
individuals whose covariates lie outside of the convex hull of the covariates for the treated
individuals. Rosenbaum (2012) describes a method for optimal subsampling wherein one
chooses an upper bound on how many treated units can be removed from the resulting
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matched sample. Hill and Su (2013) employ Bayesian Additive Regression Trees (Chipman
et al., 2010) to identify areas of common support, using the fact that the variability of
individual-level conditional expectations tend to increase drastically in such areas. Individuals are then classified as being inside or outside the area of common support based on
thresholds for these variances.
Though easy to implement and often accompanied by theoretical justifications, the resulting
study population returned by these methods is often unappealing as it may be difficult to
interpret in terms of the covariates themselves. This makes it difficult to succinctly and
transparently describe the individuals to whom the performed inference applies. Furthermore, for study populations defined by propensity scores alone, a researcher’s notion of
which individuals have high or low “propensity” for treatment may be vastly different from
the individuals designated as such through fitting a propensity score model to the data.
A practitioner not participating in the study could then have a misconception of the individuals to whom the inference applies based on his or her preconceived notion of which
individuals are likely to receive treatment or control. In his Design of Observational Studies
book, Rosenbaum advises that when excluding extreme individuals “it is usually better to
go back to the covariates themselves, xj , perhaps redefining the population under study to
be a subpopulation of the original population” (Rosenbaum, 2010, Section 3.3.3). Stuart
(2010) further echoes this sentiment, arguing that “it can help the interpretation of results
if it is possible to define the discard rule using one or two covariates” (Stuart, 2010, page
15).
To illustrate the potential confusion arising from a study population definition in terms of
propensity scores, suppose we decided to apply the suggestion of Crump et al. (2009) to
our tier 1 covariates in order to define our study population. In its most succinct form, the
resulting study population would be defined as {i : logit(3.5 − 0.0049(agei ) + 0.069(CCIi ) −
0.46(init. ser. laci ) − 0.12(APACHE IIi )) ∈ [0.1, 0.9]}. The boundaries of this set would
likely hold little meaning to practitioners, as it is hard to characterize qualitatively the
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individuals who fall within these bounds. Inference performed on this subset would pertain
to a set of individuals who lack a clear characterization on the basis of the covariates of
interest themselves, limiting how actionable the findings may be.
Traskin and Small (2011) suggest a tree based approach for defining an internally valid
study population based on values of covariates alone. In the first step of their method,
the practitioner uses a pre-existing method for study population definition of her choice;
any of those described at the beginning of this section would be valid choices. For each
individual, this outputs an indicator of whether or not that individual belongs to the area
of common support (and hence, should be included in the new study population). The user
next fits a regression tree of a designated depth that aims to minimize the probability of
misclassification, and defines the study population based on the resulting tree (rather than
by the method used in the initial step). While resulting in a markedly more interpretable
study population, by their very nature trees result in interval restrictions that are path
dependent, rather than intervals that are universally applicable for all individuals.
Restrictions to rectangular regions of the covariate space are appealing as they can be explicitly defined in terms of the intersection of a series of intervals, rather than as a complicated
function of the observed covariates. Each interval pertains to a unique covariate, allowing
one to paint a coherent description of the resulting study population through covariatespecific constraints. This allows the practitioner to clearly understand the restriction that
each covariate imposes on the study population. Currently, little guidance exists on how
to define these covariate based inclusion criterion. Ad-hoc choices based on inspection may
discard large proportions of individuals, and further may fail to discard individuals who are
identified as problematic.
2.3.4. An Attainable Objective
As outlined in this section, there are inherent difficulties with attaining strong overlap
in high dimensions. We thus instead seek to define a study population characterized by
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three principles which are both attainable and verifiable. Firstly, we would like the study
population to demonstrate overlap with respect to those covariates deemed most important
for the treatment and the outcome. By focusing on attaining overlap for a small set of
important covariates, both strong and interpolation overlap can be potentially obtained for
a reasonably sized study population. Furthermore, the overlap with respect to these most
important covariates can be verified using visual aids such as scatterplots. Secondly, the
resulting study population should be such that balance can be attained on all covariates. As
balance is a property of the marginal distributions for the treated and control individuals,
standard metrics such as standardized differences can speak to balance being attained for
all covariates. Finally, we would like our study population to have a simple definition in
terms of important covariates while not being overly wasteful in discarding individuals.
Our approach to achieving these goals is two-fold. We begin by constructing, through the
solution to the maximal box problem, a study population that incorporates existing methods
for identifying individuals outside the area of common support with respect to important
covariates, retains as many viable individuals as possible, and is readily interpretable based
on important covariates as it defined through the intersection of interval restrictions. After
this, we use full matching to arrive upon a stratification that mimics a well-balanced randomized experiment within this study population. We then proceed with inference in the
resulting study population only if the balance on all covariates is deemed acceptable.

2.4. Defining a Study Population
2.4.1. The Maximal Box Problem
A box [`, u] is defined to be a closed interval (hyperrectangle) of Rp ,
[`, u] := {x ∈ Rp : `i ≤ xi ≤ ui ∀i ∈ {1, .., p}}

Suppose one has a finite collection of vectors {xj }, j = 1, ..., N, that can be partitioned
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into two disjoint sets of “positive” points, X + and “negative” points, X − . The maximal
box problem aims to find the lower and upper boundaries of a box, [˜`, ũ], such that the
corresponding box contains the maximal number of points in X + while containing none of
the points in X − . Explicitly, [˜`, ũ] is the arg max of the following optimization problem
(MB, for maximal box):

maximize |[`, u] ∩ X + |

(MB)

subject to |[`, u] ∩ X − | = 0,

where the notation |A| denotes the number of elements of set A. Henceforth, we refer to
|[`, u] ∩ X + | as the cardinality of a box [`, u].
Eckstein et al. (2002) describe the problem in detail. They prove that the problem is N Phard in general, but is polynomial time for any fixed dimension p. They provide an efficient
branch and bound algorithm for solving it, which they show to have modest computation
time in practice. They also provide a mixed integer programming formulation of the problem,
which facilitates its use with freely available and commercial solvers.
2.4.2. From Maximal Boxes to Study Populations
Let D(xj , X, Z) be a binary decision rule that determines whether or not a point xj needs
to be excluded from the analysis to ensure covariate overlap (1 if not, 0 if so). For example,
the recommendations of Dehejia and Wahba (1999), DDW (xj , X, Z), and the rule proposed
in Crump et al. (2009) (the simplified version of the rule), DC (xj , X, Z), can be written in
this form as:

DDW (xj , X, Z) =




1 {ê(xj ) ≤ max{ê(xk ) s.t. Zk = 0}} if Zj = 1


1 {ê(xj ) ≥ min{ê(xk ) s.t. Zk = 1}}

DC (xj , X, Z) = 1 {ê(xj ) ∈ [0.1, 0.9]}
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if Zj = 0

Our sets of positive and negative points are then defined based on the selected decision rule,
with X + := {xj : D(xj , X, Z) = 1}, and X − := {xj : D(xj , X, Z) = 0}. We then solve
(MB) using these designations of positive and negative points. The resulting maximal box is
one that contains the largest possible number of observations who could feasibly have been
in the study population, while eliminating all individuals who were designated for exclusion.
The study population defined by the maximal box has a clear interpretation in terms of
the covariates themselves: an individual is in the study population if ˜` ≤ xj ≤ ũ, and is
excluded otherwise.
We note that as p (the number of covariates used to define the maximal box) increases, the
number of positive points in corresponding maximal box is non-decreasing. At the same
time, this increases the potential computational burden, as there are at most |X + |2p possible candidates for the boundaries of the maximal box (Eckstein et al., 2002). Thus, in
practice we recommend forming the boundaries on the maximal box based on values of the
most important covariates. Note that defining a study population on the basis of important covariates can also be justified on the basis of interpretability. If one defined a study
population using a maximal box formed from a large number of covariates, the resulting
study population would likely be just as cryptic as one determined solely by the estimated
propensity scores. Further, Hill and Su (2013) argue that methods for common support restriction should primarily consider those covariates that are most important for the outcome.
As such, we seek to define a study population based on the most important pre-treatment
covariates. We also recommend using covariates that are not binary for constructing the
maximal box as the resulting restriction would either eliminate one of the categories entirely,
or (more commonly) be the whole range [0,1]. If there is a binary covariate of considerable
importance, we recommend accounting for it by either exactly matching or almost exactly
matching on the binary covariate; see Rosenbaum (2010, Sections 9.1 and 9.2) for details.
There is a possibility that the resulting maximal box only contains a small fraction of the
positive points. This means there is no easy way to define a region of good overlap between
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the treated and control individuals without eliminating the vast majority of the data. In
Appendix A.3, we discuss an extension of the maximal box problem posed in Eckstein et al.
(2002) that may be appropriate in this setting. This generalization allows for a small number,
C, of points marked for exclusion (negative points) to be included within the bounds of the
maximal box, which would in turn allow for the incorporation of more positive points; see
Appendix A.3 for more discussion on the ramifications of choosing C > 0. In our example,
we proceed with C = 0, thus requiring the exclusion of all points marked as being outside
the area of viable support.
2.4.3. Application to Our Original Population
As defining a maximal box with all 44 covariates would yield a highly unwieldy 44 dimensional box with limited interpretability, we instead aim to construct a maximal box using
our four tier 1 covariates: age, Charlson comorbidity index, APACHE II scores, and initial
serum lactate levels. Our approach is to fit a propensity score model using a logistic regression on our four tier 1 covariates, and to then employ the simplified criterion of Crump et al.
(2009) with these propensity scores to determine which observations had to be removed.
We use this reduced propensity score model because individuals within the area of common
support on our important variables may be nonetheless extreme with respect to other, less
important, covariates, which may in turn lead to them being marked for removal if we used
the full propensity score model. As our focus is on attaining covariate overlap and balance
for our most important variables while seeking balance on all other variables, we wanted our
exclusion metric to reflect lying in the area of covariate overlap with respect to our most
important variables. See Appendix A.4 for a more detailed discussion of this goal and the
(1)

behavior of alternative strategies. Denoting the tier 1 covariate for individual j as xj , our
n 

o
(1)
decision rule is DC,Tier1 (xj , X, Z) = 1 ê xj
∈ [0.1, 0.9] . This results in 108 individuals being marked for exclusion. We have implemented the branch and bound algorithm of
Eckstein et al. (2002) in the R programming language (R Development Core Team, 2014),
and used it to find our study population; a script for our implementation is provided in the
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supplementary materials. For this data set, our implementation took 2 seconds to run on a
desktop computer with a 3.40 GHz processor and 16.0 GB RAM.
We created a maximal box using all four tier 1 covariates, and also created one using only
initial serum lactate and APACHE II scores. The cardinalities of these boxes were very close
to one another (1214 and 1208 respectively). As such, we use the box defined using only
initial serum lactate and APACHE II scores for enhanced interpretability. The resulting
maximal box is displayed as the rectangle in Figure 1. As can be seen, the study population
under investigation can be explicitly defined as those individuals in our initial study whose
APACHE II scores are between 5 and 29 and whose initial serum lactate levels are between
1.2 and 5.8 mmol/L. Our study population thus restricts analysis to those individuals who
had less severe, but not the least severe, conditions upon presentation to the emergency
department. The study population defined by the maximal box includes 701 out of 812
patients admitted into the wards and 507 out of 695 patients admitted to the ICU, resulting
in 1208 out of the original 1507 individuals being available for further study; furthermore, it
contains 86.3% of all individuals whose estimated propensity scores were deemed acceptable
by our decision rule. Table 1 shows the means and standard deviations of the tier 1 covariates
among this study population; values for the other covariates can be found in Appendix A.1.
As can be seen, restricting ourselves to this study population improved pre-matching balance
for many of the covariates.
We now proceed with a full matching on our study population of 1208 individuals whose
condition upon presentation was less severe. In so doing, we follow a procedure analogous to
the one described in Section 3.1 within our newly defined study population. We first refit our
propensity score model using all 44 covariates for the 1208 individuals in our newly defined
study population to exploit the so-called balancing property of the propensity score within
our population of interest (Rosenbaum and Rubin, 1983). We use rank-based Mahalanobis
distance based on all 44 covariates with a propensity score caliper of 0.2 standard deviations
computed only for patients in our study population to define distance between ICU and
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Balance in Study Population with Full Matching
Tier 1:
●

Age
CCI

●
●

Initial serum lactate

●

APACHE II score
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Max temperature (F)
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GI infection
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●
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●

●
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Urinary infection
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Cellulitis
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Bacteremia
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Resp. infection
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Year
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CAD
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Chronic liver
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Chronic renal
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HIV
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Hypertension
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Figure 2: Covariate Imbalances Before and After Full Matching, Study Population. The dotplot
(a Love plot) shows the absolute standardized differences without matching, and after conducting
a restricted 1:7, 7:1 full matching on our study population. The vertical dotted lines correspond
to the standardized difference tolerances for each of the three covariate tiers. Although not shown
here, all standardized differences corresponding to our 13 missingness indicators had standardized
differences below 0.1, indicating that the pattern of missing data was also balanced between the ICU
and hospital ward groups.

hospital ward patients. Further, we require exact matching for the cryptic septic shock
indicator. Using the resulting distance matrix, we run a series of full matches with ratios
of 1:k, k:1, starting with k = 2 and increasing k until a suitably balanced matched sample
could be attained. We found that a 1:7, 7:1 full match was able to adhere to the standardized
difference tolerances defined in Section 2.3.1, as is displayed in Figure 2.
At this point we have obtained a matched data set that is easy to characterize in terms
of bounds on two important covariates and demonstrates balance on all of our covariates.
Moving forward, we will treat this match as though it were instead a block randomized
experiment with strata of maximal size 8, where in each stratum either one unit is randomly
assigned the treatment and the rest receive the control, or one unit is randomly assigned
the control and the rest receive the treatment. Using randomizations within this idealized
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experiment as the basis for statistical inference, our goal is to assess not only whether there
is a substantial difference in mortality rates depending on admission to the ICU or the
hospital ward, but also to measure the extent of the effect. In order to do so, we now discuss
performing inference and constructing confidence intervals for the average treatment effect
in our idealized experiment.

2.5. Randomization Inference for the Average Treatment Effect with Binary Outcomes
The average treatment effect with binary outcomes (also known as the causal risk difference)
is the difference between the proportion of positive responses among the potential outcomes
P P i
δij . It it
under treatment and the potential outcomes under control, δ := (1/N ) Ii=1 nj=1
identifiable under the assumption of strong ignorability (Rosenbaum and Rubin, 1983), and
an unbiased estimator of the average treatment effect under a stratified design is given by
P i
P
(Zij Rij /mi − (1 − Zij )Rij /(ni − mi )) is the estimated
δ̂ := Ii=1 (ni /N )δ̂i , where δ̂i = nj=1
average treatment effect within stratum i (Rosenbaum, 2002a, Section 2.5).
We consider tests of the null hypothesis that (1/N )

PI

i=1

Pni

j=1 δij

= δ0 , δ0 ∈ {d/N : d ∈

[−N, N ] ∩ Z}, where Z denotes the set of all integers. In reality, a null hypothesis of this
form is a large collection of hypotheses on the set of treatment effects, δ = [δ11 , δ12 , ..., δI,nI ].
P P i
Let Dδ0 be the set of all δ such that (1/N ) Ii=1 nj=1
δij = δ0 and such that the treatment
effects are compatible with the observed data. The latter requirement means that if unit j
in stratum i received the treatment in the observed experiment, the value of rT ij is fixed at
Rij and hence δij can equal either Rij or Rij − 1. If said unit received the control, the value
of rCij is fixed at Rij , and δij can equal either −Rij or 1 − Rij . To reject a null hypothesis
P P i
(1/N ) Ii=1 nj=1
δij = δ0 , we require that we reject the null hypothesis that the allocation
of treatment effects equals δ for all δ ∈ Dδ0 .
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2.5.1. Existing Methods
Inspired by the work of Neyman (1923), randomization inference for the average treatment
effect is typically conducted by finding a consistent estimator of an upper bound on the
variance of the estimated ATE resulting in randomization inference that asymptotically has
the proper Type I error rate; see Ding (2014) among many. Robins (1988) improves upon
the upper bound of Neyman (1923) for binary outcomes under an unstratified design and
uses the resulting upper bound to create confidence intervals that are narrower than those
based on a Wald-type procedure. More recently, Aronow et al. (2014) provide asymptotically
sharp upper bounds on var(δ̂) under general potential outcomes.
For a stratified design, the variance for the estimated ATE is

I
2 
2
X
Sδi
SCi
n2i ST2 i
var(δ̂) =
+
−
N 2 mi
ni − mi
ni

(2.1)

i=1

Pni
Pni
2
2
2
2
where ST2 i =
j=1 (rCij − r̄Ci ) /(ni − 1), and Sδi =
j=1 (rT ij − r̄T i ) /(ni − 1), SCi =
Pni
2
j=1 (δij − δ̄i ) /(ni − 1). The procedures of Neyman (1923), Robins (1988) and Aronow
et al. (2014) can be readily extended to stratified designs where mi and ni −mi are sufficiently
large for each stratum i. However, these procedures have deficiencies when there are strata
for which either mi or ni − mi = 1, as these procedures require an estimate of the variance
of the treated and control groups in each stratum. When mi or ni − mi = 1, unbiased
2 do not exist. Matched sets returned by pair matching, fixed
estimators for ST2 i or SCi

ratio matching, variable ratio matching and full matching have this property, rendering the
existing bounding techniques based solely on in-sample estimates inapplicable.
Rigdon and Hudgens (2014) present two methods for conducting randomization inference
and constructing confidence intervals for the average treatment effect with binary outcomes
in an unstratified design. The first method proceeds by combining two tests on the attributable effect of Rosenbaum (2001) and Rosenbaum (2002b) through means of a Bonferroni correction. They then mention that this approach, while potentially conservative, can be
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readily applied to stratified randomized experiments. In the second method, hypothesis testing proceeds by conducting randomization inference on δ for all δ ∈ Dδ0 , meaning that this
procedure has level α for testing the corresponding composite null. Confidence intervals are
then constructed by inverting tests for values under the null δ0 ∈ {d/N : d ∈ [−N, N ] ∩ Z},
where Z again denotes the set of all integers. In their description, inference is conducted by
explicitly performing a randomization test for each δ ∈ Dδ0 . Noting the inherent computational burden in this process as N increases in an unstratified experiment, they suggest a
Monte Carlo procedure to approximate the required permutation test. For stratified experiments, they suggest that this approach becomes computationally unwieldy quite quickly,
thus advocating the use of a potentially conservative method based on the attributable effect
in this setting.
Our procedure combines elements of the classical Neyman approach and the hypothesis test
inversion approach of Rigdon and Hudgens (2014). Our approach is not purely Neymanian
in that although we are testing Neyman’s null hypothesis, we do not proceed by seeking a
consistent upper bound on var(δ̂); rather, we explicitly compute the largest value of var(δ̂)
possible among the elements of Dδ0 for each null hypothesis. The resulting bound on the
variance of the average treatment effect for a given null hypothesis is sharp, as it is attained
by a member of the composite null δ ∗ ∈ Dδ0 . As a test of a composite null hypothesis is size
α only if the supremum over all elements of the composite null of the probability of rejection
is α, asymptotically our testing procedure has size α so long as a normal approximation is
justified. This is because since the numerator is the same for the test statistic for any null in
Dδ0 , namely δ̂ − δ0 , the p-value computed under a normal approximation will be maximized
by the member of the composite null with the largest denominator of the test statistic, i.e,
the member with the largest variance. Rejection on the basis of this worst-case p-value then
implies rejection for all elements of the composite null. For finite samples, discrepancies in
actual versus advertised size stem only from the strength of the normal approximation. We
show in Appendix A.5 that for our case study, the true distribution of the average treatment
corresponding to the worst-case allocations of potential outcomes is well approximated by a
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normal distribution. In Appendix A.6, we discuss why our standard errors are necessarily
larger than those attained in other testing scenarios (for example, in testing Fisher’s sharp
null).
As will be discussed in Section 2.5.2, the use of a normal approximation allows us to overcome the computational issues encountered in Rigdon and Hudgens (2014). This normal
2 /(n −
approximation can be justified under very mild conditions. Let σi2 = n2i (ST2 i /mi + SCi
i
P
I
2
2 /n ) be the contribution to var(N δ̂) from stratum i (i.e.,
2
mi ) − Sδi
i
i=1 σi /N = var(δ̂)),
P
and let Σ = Ii=1 σi2 . Let n∗ be an upper bound on the maximal size of a stratum.
√ d
Theorem 1. If Σ → ∞ as I → ∞, then (N δ̂ − N δ)/ Σ → N (0, 1).

Proof. Since our outcomes are binary, the maximal contribution of an individual summand
P
ni δ̂i to Ii=1 ni δ̂i = N δ̂ is bounded in absolute value by n∗ . Using Lyapunov’s central limit
theorem applied to a sequence of independent bounded random variables (Lehmann, 2004,
d

Corrolary 2.7.1), we have that (N δ̂ − N δ) → N (0, Σ) as I → ∞ provided that Σ → ∞ as
I → ∞.

This requirement precludes a certain type of degeneracy. Namely, it cannot be the case that
only finitely many strata have nonzero variances for δˆi . This, coupled with a bound on the
maximal stratum size, suffices for asymptotic normality to hold.
2.5.2. Integer Programming for the Maximal Variance
In theory, the maximal variance for a given composite null, H0 : δ = δ0 , could be found by
enumerating all 2N possible allocations of unobserved binary potential outcomes, computing var(δ̂) through (2.1) for each allocation, and finding the maximal variance among the
allocations that satisfy δ ∈ Dδ0 . Such a naïve approach quickly becomes computationally
infeasible: in our application, this would would require enumerating 21208 sets of potential
outcomes.
Our approach is to instead pose the problem of maximizing the variance within a composite
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null as an integer program. Roughly stated, the resulting integer program optimizes the
variance over the values of the unobserved potential outcomes, subject to the resulting allocation of potential outcomes being a member of the composite null. Though many equivalent
formulations of the desired optimization problem are possible, the one we choose explicitly
avoids symmetric solutions, known to cripple the computation time of integer programs
(Margot, 2010), by having each decision variable correspond to a unique distribution on the
contribution to the overall estimated average treatment effect from a given stratum. Our approach exploits three essential facts. Firstly, there is often symmetry between strata in that
P i
Pn0i
P i
Pn0i
(a) ni = ni0 , (b) nj=1
Zij Rij = j=1
Zi0 j Ri0 j and (c) nj=1
(1−Zij )Rij = j=1
(1−Zi0 j )Ri0 j
for symmetric strata i and i0 , meaning that any allocation of potential outcomes for stratum
i is also a feasible allocation for stratum i0 . Secondly, there is often symmetry within strata
in that Zij = Zik and Rij = Rik for symmetric individuals j and k in stratum i, meaning
that the var(δ̂i ) remains the same if the values for the unobserved potential outcome are
permuted among symmetric individuals in stratum i. Finally, there is independence between
strata which allows us to sum stratum-wise variance contributions together to arrive at the
overall variance of the estimated average treatment effect. In combination, these three facts
allow this seemingly daunting optimization problem to be solved in a matter of seconds. See
Appendix A.7 for a detailed discussion of our integer programming formulation.

2.6. Inference for Severe Sepsis Mortality
We now proceed with randomization inference on the study population defined by our maximal box in Section 2.4.3. As a reminder, this consists of severe sepsis patients without
hemodynamic septic shock, with initial serum lactate between 1.2 and 5.8 mmol/L, and
with APACHE II scores between 5 and 29. Of the 1208 patients in our study population,
701 were admitted to the hospital ward and 507 were admitted to the ICU. Our causal
estimand is the difference between 60 day mortality rates if all patients had been admitted
to the ICU and if all patients had been admitted to the hospital ward. Before matching,
the unadjusted (and hence potentially biased) estimates for these rates under ICU and hos-
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Table 2: Estimated differences in severe sepsis mortality between patients admitted to the
ICU and the hospital ward in our study population, both overall and among patients with
cryptic septic shock. Positive values favor hospital ward admission, and negative values favor
ICU admission. The standard errors reported are the Wald-estimates (i.e. the maximal
standard errors at the estimated average treatment effects) and confidence intervals were
constructed by inverting a series of tests as described in Section 2.5.1.
Estimated ATE
(SE)
95% Conf. Int.

Overall
4.3%
(3.7%)
[-3.0%; 11%]

Cryptic S.S.
-0.8%
(9.0%)
[-18%; 17%]

pital ward admissions are 24.3% and 12.0% respectively overall, and are 27.7% and 21.2%
respectively within the cryptic septic shock subgroup.
After adjusting for measured confounders through covariate matching, the estimated mortality rates under ICU and hospital ward admission are 19.4% and 15.1% respectively overall,
and are 26.0% and 26.8% respectively within the cryptic septic shock subgroup. Table 2
shows the estimated average treatment effects (the differences between proportions under
ICU and hospital ward admission) both in our overall study population and among the cryptic septic shock subgroup. We also report 95% confidence intervals, which were formed by
inverting a series of hypothesis tests as discussed in Section 2.5.1. Both of these confidence
intervals contain 0, indicating that we lack substantial evidence to suggest that there is a
nonzero effect both overall and in the cryptic septic shock subgroup. Through our implementation, we were able to construct the reported confidence intervals in 0.42 seconds using
Gurobi (free for academic use), and 0.72 seconds to solve using lpSolve (free for all users)
on a desktop computer with a 3.40 GHz processor and 16.0 GB RAM. This demonstrates
that confidence intervals can be constructed using our integer programming formulation
efficiently using both commercial and freely available solvers.

2.7. Discussion
As expected, we found that common support was not present for the most severely ill
sepsis patients. The subset of septic shock patients, which include those with hemodynamic
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compromise or evidence of hypoperfusion, are routinely admitted directly to the ICU and
therefore an observational study cannot address the effect of these triage decisions. For the
population with substantial common support, our findings suggested that there was no clear
benefit to direct ICU admission for non-shock, severe sepsis patients. In fact, recognizing
our wide confidence intervals, the magnitude of the potential benefit of direct ICU admission
after adjusting for all measured confounders through matching at the leftmost extreme of
our confidence interval was relatively small at 3%. While larger studies are required to
substantiate our findings, under the assumption of no unmeasured confounding our analysis
finds no evidence to suggest that the common practice in hospitals with strained ICUs
(occupancy rates approaching 100%) to defer ICU admission for many severe sepsis patients
results in demonstrable harm for those who are less severely ill at the time of presentation
to the emergency department.
By using the maximal box problem to define a study population for further analysis, we
arrived at a study population with a readily interpretable definition in terms of important
covariates wherein acceptable balance could be attained. One downside of our method
is that it is not guaranteed that suitable balance can be attained in the resulting study
population. That is, one may arrive at a study population defined in terms of important
covariates where it is difficult to find a matching procedure that attains suitable balance on
all covariates. One option is to simply iterate: covariates for which suitable balance cannot
be achieved can be used in defining a study population through the maximal box problem,
and then one could again try to attain balance within the proposed study population. An
interesting area for future research would be to create a procedure where the returned
study population is guaranteed to have a match with acceptable balance. With fixed ratio
matching, recent work on mixed-integer programming matching (Zubizarreta, 2012) and
cardinality-matching (Zubizarreta et al., 2014) may provide insight into how to incorporate
the balancing constraints into the optimization problem.
In our application, we determined which covariates were most important for the treatment

31

and the outcome (and hence those for which we seek verifiable overlap) through consultation
with subject matter experts. In other applications, practitioners may not want to rely solely
on prior information for determining which covariates are important and rather allow the
data itself to attest to this. While model selection for the propensity score model can be
conducted without concern, one must be careful when assessing the impact of covariates on
the outcome variable as it could potentially bias the resulting inference by compromising the
“researcher blinding” that makes matching so appealing (Rubin and Waterman, 2006). One
path forward would be to employ sample splitting, thus assessing importance of covariates
for the outcome using data that is not involved in the matched analysis.
Through our analysis of the impact of ward versus ICU admission on 60 day mortality rates,
we have shown that the applicability of discrete optimization in causal inference extends far
beyond matching algorithms. In fact, discrete optimization provides a powerful set of tools
for solving many problems common to observational studies and, more broadly, statistics
in general. The availability of efficient solvers can serve as the impetus for new methods
that trade potentially unverifiable model assumptions for an increase in computation time.
This is not to say that computational burden should not be considered when developing
statistical methodology; rather, it is to caution against limiting the imagination solely on
the basis of the computational power of the present day. As history has borne out, what is
intractable today may be feasible tomorrow.
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CHAPTER 3 : Randomization Inference and Sensitivity Analysis for Composite
Null Hypotheses with Binary Outcomes in Matched Observational
Studies
Joint work with Pixu Shi, Mark Mikkelsen, and Dylan Small

3.1. Introduction
3.1.1. Challenges for Matched Observational Studies with Binary Outcomes
Matching is a simple, transparent and convincing way to adjust for overt biases in an observational study. In a study employing matching, treated subjects are placed into strata with
control subjects on the basis of their observed covariates. In each stratum, there is either
one treated unit and one or more similar control units, or one control unit and one or more
similar treated units (Hansen, 2004; Rosenbaum, 2010; Stuart, 2010). The overall covariate
balance between the two groups is then assessed with respect to the produced stratification,
and inference is only allowed to proceed if the balance is deemed acceptable. This procedure
encourages researcher blinding, as both the construction of matched sets and the assessment
of balance proceed without ever looking at the outcome of interest just as they would in a
blocked randomized trial.
Despite our best efforts, observational data can never achieve their randomized experimental
ideal as the assignment of interventions was conducted outside of the researcher’s control.
Nonetheless, randomization inference provides an appealing framework within which to operate for matched observational studies. The analysis initially proceeds as though the data
arose from a blocked randomized experiment, with the strata constructed through matching
now regarded as existing before random assignment occurred. Randomization inference uses
only the assumption of random assignment of interventions to provide a “reasoned basis for
inference” in a randomized study (Fisher, 1935). In the associated sensitivity analysis for an
observational study, departures from random assignment of treatment within each block due
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to unmeasured confounders are considered. The sensitivity analysis forces the practitioner
to explicitly acknowledge greater uncertainty about causal effects than would be present in a
randomized experiment due to the possibility that unmeasured confounders affect treatment
assignment and the outcome (Rosenbaum, 2002a, Section 4).
With binary outcomes, randomization inference and sensitivity analyses in matched observational studies raise computational challenges that have heretofore limited their use. When
the outcome is continuous rather than binary and an additive treatment effect is plausible,
hypothesis testing and sensitivity analyses for the treatment effect can be conducted for a
simple null hypothesis, and confidence intervals can then be found by inverting a series of
such tests. This is a straightforward task, since the potential outcomes under treatment and
control for each individual are uniquely determined by the hypothesized treatment effect
(Hodges and Lehmann, 1963). Inference under no unmeasured confounding merely requires
a simple randomization test, and a sensitivity analysis can be performed with ease through
the asymptotically separable algorithm of Gastwirth et al. (2000). When dealing with binary
responses, however, an additive treatment effect model is inapplicable: if an effect exists it
is most likely heterogeneous, as the intervention may cause an event for one individual while
not causing the event for another. As such, confidence intervals are instead constructed for
causal estimands whose corresponding hypothesis tests are composite in nature, meaning
there are many allocations of potential outcomes which yield the same hypothesized value
of the causal estimand; see Rosenbaum (2001, 2002b) for further discussion. To reject a
null hypothesis for a causal parameter of this sort, we must reject the null for all values of
the potential outcomes which satisfy the null. The situation is further complicated when
conducting a sensitivity analysis, as inference must also account for the existence of an unmeasured confounder with a range of impacts on the assignment of interventions within a
matched set. We now illustrate these points by investigating the causal effect of one posthospitalization protocol versus another after an acute care stay on hospital readmission
rates.
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3.1.2. Motivating Example: Effect of Post-Acute Care Protocols on Hospital Readmission
At the time of discharge after an acute care hospitalization, a fundamental question arises:
to where should the patient be discharged? The long-term goal shared by providers and
patients envisions a transition home and a return to normalcy, yet a premature discharge
home without appropriate guidance could impede a durable recovery.
An important measure of whether a patient has achieved a durable recovery is whether the
patient does not need to be readmitted to the hospital within a certain period of time. Different avenues for reducing rehospitalization rates have recently garnered significant attention
nationwide (Jencks et al., 2009), and post-acute care is one mechanism through which hospital readmission rates may be improved (Ottenbacher et al., 2014). For individuals who
are not gravely ill, post-acute care entails more intensive discharge options than a simple
discharge home without further supervision such as discharge home while receiving visits
from skilled nurses, physical therapy, and other additional health benefits (referred to henceforth as “home with home health services”); or discharge to an acute rehabilitation center.
Post-acute care use is on the rise in the United States; however, post-acute care services
can be quite costly, sometimes even rivaling the cost of a hospital readmission (Mechanic,
2014). It is thus of interest to assess the relative merits of various post-acute care protocols
for reducing hospital readmission rates.
We aim to assess the causal effect of being discharged to an acute rehabilitation center
versus home with home health services on hospital readmission rates through a retrospective
observational study. Hospital records for acute medical and surgical patients discharged from
three hospitals in the University of Pennsylvania Hospital system between 2010 and 2012
were collected; see Jones et al. (2015) for more details on this study. Within this data set,
there are 4893 individuals assigned to acute rehabilitation and 35,174 individuals assigned
to home with home health services, for 40,067 total individuals. We would like to assess
whether discharge to acute rehabilitation reduces the causal risk of hospital readmission
relative to discharge home with home health services. Beyond testing this hypothesis, we
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would also like to create confidence intervals for causal parameters that effectively summarize
the impact of discharge location on hospital readmission rates in our study population. Two
causal estimands of interest for this comparison are the causal risk difference, which is the
difference in proportions of readmitted patients if all patients had been assigned to acute
rehabilitation versus that if all patients had been discharged home with home health services;
and the causal risk ratio, which is the ratio of these two proportions.
Through the use of matching with a variable number of controls (Ming and Rosenbaum,
2000), individuals assigned to acute rehabilitation were placed in matched sets with varying
numbers of home with home health services individuals (ranging from 1 to 20) who were
similar on the basis of their observed covariates. We used rank-based Mahalanobis distance
with a propensity score caliper (estimated by logistic regression) of 0.2 as our distance metric
to perform the matching. We further required exact balance on the indicator of admission
to an intensive care unit to better control for whether an individual had a critical illness. In
Appendix B.1, we demonstrate that this stratification resulted in acceptable balance on the
basis of the standardized differences between the groups.
In the stratified experiment that our match aims to mimic, randomization inference can be
readily used to test Fisher’s sharp null of no effect. Under Fisher’s sharp null, the unobserved
potential outcomes are assumed to equal the observed potential outcomes for each individual.
The sharp null can then be assessed by noting that within each stratum, the number of
treated individuals for whom an event is observed follows a hypergeometric distribution.
The total number of treated individuals with events across all strata is then distributed as
the sum of independent hypergeometric distributions, forming the basis for what has become
known as the Mantel-Haenszel test (Mantel and Haenszel, 1959; Rosenbaum, 2002a).
Testing a null on the causal risk difference or the causal risk ratio presents challenges not
encountered when testing the sharp null, as many allocations of potential outcomes could
yield the same causal parameter. For example, if we are testing the null that the causal
risk difference is 0 without making further assumptions on the potential outcomes, the
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allocation under Fisher’s null is merely one of many choices (i.e., it is merely one element
of the composite null). Conducting a hypothesis test and performing a sensitivity analysis
requires assessing tail probabilities for all elements of the composite null, both under the
assumption of no unmeasured confounding and while allowing for an unmeasured confounder
of a range of strengths. Direct enumeration of all possible combinations of potential outcomes
is computationally infeasible for even moderate sample sizes. In our motivating example,
there are 240,067 possible combinations of potential outcomes, even without considering values
for the unmeasured confounder.
We instead aim to find the combination of potential outcomes and unmeasured confounders
that results in the worst-case p-value for the test being conducted. If the null hypothesis
corresponding to this worst-case allocation can be rejected, we can then reject all elements
of the composite null. Rosenbaum (2002b) uses a similar approach for inference on the
attributable effect, a quantity which is closely related to the risk difference. There it is shown
that under the assumption of a nonnegative treatment effect (i.e., the treatment may cause
an event, but does not preclude an event from happening if it would have happened under the
control) a simple enumerative algorithm yields an asymptotic approximation to the worstcase p-value for this composite null. This is because the impact on the p-value of attributing
an observed event to the treatment (stating that the unobserved potential outcome under
control is 0) can be well approximated through asymptotic separability (Gastwirth et al.,
2000), such that one can satisfy the null while finding the worst-case allocation by sorting
the strata on the basis of their impact on the p-value and attributing the proper number of
effects by proceeding down the sorted list. Recent works by Yang et al. (2014) and Keele
et al. (2014) discuss how the attributable effect can also be used to define estimands of
interest in instrumental variable studies.
Unfortunately, in the absence of a known direction of effect finding the worst-case allocation
does not simplify in the same manner. This is because finding the potential outcome allocation with the largest impact on the p-value on a stratum-wise basis does not readily yield an
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allocation that satisfies the composite null. The problem is not separable on a stratum-wise
basic even asymptotically, as the requirement that the composite null must be true necessarily links the strata together in a complex manner. There are two non-complementary
forces at play in the required optimization problem: for some strata, the potential outcome
allocations should maximize the impact on the p-value, while in other strata the missing
potential outcome allocations should work towards satisfying the composite null. For our
motivating example, there are over 300,000 types of contributions to the p-value that must
be considered in the sensitivity analysis when we do not assume a known direction of effect
(as is shown in Section 3.6.1). Explicit enumeration is intractable here, as we must consider
which allowed combinations of these contributions maximize the p-value while satisfying the
null in question. As such, a different approach is required to make the computation feasible.

3.1.3. Integer Programming as a Path Forward
In this paper, we show that hypothesis testing for a composite null with binary outcomes
can be performed by solving an integer linear program under the assumption of no unmeasured confounding. When conducting a sensitivity analysis by allowing for unmeasured
confounding of a certain strength, an integer quadratic program is required. These optimization problems yield the worst-case p-value within the composite null so long as a normal
approximation to the test statistic is justified. We show that our formulation is strong, in
that the optimal objective value for our integer program closely approximates that of the
corresponding continuous relaxation. As we demonstrate through simulation studies and
real data examples, this allows hypothesis testing and sensitivity analyses to be conducted
efficiently even with large sample sizes despite the fact that integer programming is N Phard in general, as discrete optimization solvers heavily utilize continuous relaxations in
their search path. Through comparing our formulation to an equivalent binary program
in the supplementary material, we also demonstrate that recent advances in optimization
software (Jünger et al., 2009) alone are not sufficient for solving the problem presented
herein; rather, a thoughtful formulation remains essential for solving large-scale discrete
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optimization problems expeditiously.

3.2. Causal Inference after Matching
3.2.1. Notation for a Stratified Randomized Experiment
Suppose there are I independent strata, the ith of which contains ni ≥ 2 individuals, that
were formed on the basis of pre-treatment covariates. In each stratum, mi individuals receive
the treatment and ni − mi individuals receive the control, and min{mi , ni − mi } = 1. We
proceed under the stable unit treatment value assumption (SUTVA), which entails that
(1) there is no interference, i.e. that the observation of one unit is not affected by the
treatment assignment of other units; and (2) there are no hidden levels of the assigned
treatment, meaning that the treatments for all individuals with the same level of observed
treatment are truly comparable (Rubin, 1986). Let Zij be an indicator variable that takes
the value 1 if individual j in stratum i is assigned to the treatment. Each individual has
two sets of binary potential outcomes: one under treatment, {rT ij , dT ij }, and one under
control, {rCij , dCij }. rT ij and rCij are the primary outcomes of interest, while dT ij and
dCij are indicators of whether or not an individual would actually take the treatment when
randomly assigned to the treatment or control group. The observations for each individual
are Rij = rT ij Zij + rCij (1 − Zij ) and Dij = dT ij Zij + dCij (1 − Zij ); see Neyman (1923) and
Rubin (1974) for more on the potential outcomes framework. In the classical experimental
setting, dT ij −dCij = 1 ∀i, j, and hence all individuals take the administered treatment. For a
randomized encouragement design, Zij represents the encouragement to take the treatment
(which is randomly assigned to patients), while dT ij and dCij are the actual treatment
received if Zij = 1 and Zij = 0 respectively (Holland, 1988). Matched observational studies
assuming strong ignorability (Rosenbaum and Rubin, 1983) aim to replicate a classical
stratified experiment, whereas matched studies employing an instrumental variable strive
towards a randomized encouragement design, with Zij being the instrumental variable.
There are N =

PI

i=1 ni

total individuals in the study. Each individual has observed covari-
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ates xij and unobserved covariate uij . Let R = [R11 , R12 , ...,, RInI ]T , Ri = [Ri1 , ..., Rini ]T ,
and let the analogous definitions hold for D, Di , Z, Zi . Let rT = [rT 11 , ..., rT InI ], rT i =
[rT i1 , ..., rT ini ], and let the analogous definitions hold for the other potential outcomes and
the unobserved covariate. Let X be a matrix whose rows are the vectors xij . Finally, let Ω
Q
be the set of Ii=1 ni possible values of Z under the given stratification. In a randomized
experiment, randomness is modeled through the assignment vector; each z ∈ Ω has probability 1/|Ω| of being selected, where the notation |B| denotes the number of elements in
the set B. Hence, quantities dependent on the assignment vector such as Z, R and D are
random, whereas F = {rT , rC , dT , dC , X, u} contains fixed quantities. For a randomized
experiment, P(Zij = 1|F, Z ∈ Ω) = mi /ni , and P(Z = z|F, Z ∈ Ω) = 1/|Ω|.
3.2.2. Conducting a Sensitivity Analysis
In an observational study, the I strata are still generated based on pre-treatment covariates
but are only created after treatment assignment has taken place. Furthermore, the treatment
assignment was conducted outside of the practitioner’s control which may introduce bias
due to the existence of unmeasured confounders. We follow the model for a sensitivity
analysis of Rosenbaum (2002a, Section 4), which states that failure to account for unobserved
covariates may result in biased treatment assignments within a stratum. This model can
be parameterized by a number Γ = exp(γ) ≥ 1 which bounds the extent to which the odds
ratio of assignment can vary between two individuals in the same matched stratum. Letting
πij = P(Zij = 1|F), we can write the allowed deviation as 1/Γ ≤ πij (1−πik )/(πik (1−πij )) ≤
Γ. This model can be equivalently expressed in terms of the observed covariates xij and
the unobserved covariate uij (assumed without loss of generality to be between 0 and 1),
as log (πij /(1 − πij )) = ζ(xij ) + γuij , where ζ(xij ) = ζ(xik ), i = 1, ..., I, 1 ≤ j, k ≤ ni . See
Rosenbaum (2002a, Section 4.2) for a discussion of the equivalence between these models.
The probabilities of each possible allocation of treatment and control are given by P(Z =
P
z|F, Z ∈ Ω) = exp(γzT u)/ b∈Ω exp(γbT u), where u = [u11 , u12 , ..., uI,ni ]. If Γ = 1,
the distribution of treatment assignments corresponds to the randomization distribution
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discussed in Section 4.2.1. For Γ > 1, the resulting distribution differs from that of a
randomized experiment with the extent of the departure controlled by Γ.
Consider a simple hypothesis test based on a test statistic of the form T = ZT q, where
q = q(rT , rC , dT , dC ) is a permutation invariant, arrangement increasing function. Most
commonly employed statistics are of this form; see Rosenbaum (2002a, Section 2.4) for a
detailed discussion. Without loss of generality reorder the elements of q such that within
each stratum qi1 ≤ qi2 ≤ .. ≤ qini . For a given value of Γ and for fixed values of the potential
outcomes, a sensitivity analysis proceeds by finding tight upper and lower bounds on the
upper tail probability, P(T ≥ t), by finding the worst-case allocation of the unmeasured
confounder u. One then finds the value of Γ such that the conclusions of the study would
be materially altered. The more robust a given study is to unmeasured confounding, the
larger the value of Γ must be to alter its findings.
As is demonstrated in Rosenbaum and Krieger (1990) for strata with mi = 1, for each
Γ an upper bound on P(T ≥ t) is found at a value of the unobserved covariate u+ ∈
+
+
U+
1 × ... × UI , where Ui consists of ni − 1 ordered binary vectors (each of length ni ) with
+
+
0 = u+
i1 ≤ ui2 ... ≤ uini = 1. Similarly, a lower bound on P(T ≥ t) is found at a vector
−
−
−
−
u− ∈ U−
1 × ... × UI with 1 = ui1 ≥ ui2 ... ≥ uini = 0. Under mild regularity conditions on q,

T is well approximated by a normal distribution. Large sample bounds on the tail probability
can be expressed in terms of corresponding bounds on standardized deviates. These results
can readily extended to stratifications yielded by a full match through a simple redefinition
of Z and q; see Rosenbaum (2002a, Section 4, Problem 12).

3.3. Composite Null Hypotheses
3.3.1. Estimands of Interest
To motivate our discussion, we will focus on three causal estimands of interest with binary
outcomes. Note however that the general framework for inference and sensitivity analyses
presented herein can be applied to any causal estimand for binary potential outcomes with
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an associated test statistic that can be written as ZT q for a function q(·) that satisfies the
conditions outlined in Section 3.2.2. The causal parameters we will consider are the causal
risk difference, causal risk ratio, and the effect ratio, defined as:
I

Risk Difference

Risk Ratio

Effect Ratio

n

i
1 XX
(rT ij − rCij )
N
i=1 j=1
PI Pni
i=1
j=1 rT ij
ϕ := PI Pn
i
i=1
j=1 rCij
PI Pni
i=1
j=1 (rT ij − rCij )
.
λ := PI Pn
i
i=1
j=1 (dT ij − dCij )

δ :=

As mentioned in the introduction, the causal risk difference measures the difference in proportions of observed events had all the individuals received the treatment and observed
events had all individuals received the control. Similarly, the causal risk ratio measures the
ratio of these two proportions. Each of these estimands has merits and shortcomings relative
to the other, owing to the fact that the risk difference measures an effect on an absolute
scale while the risk ratio measures an effect on a relative scale; see Appendix B.2 for further
discussion of these two measures. These estimands are appropriate under strong ignorability
(Rosenbaum and Rubin, 1983); in the corresponding idealized experiment, there are simply
treated and control individuals, and all individuals comply with their assigned treatment
regimen.
The effect ratio is a ratio of two average treatment effects, and hence serves as an assessment of the relative magnitude of the two treatment effects (Baiocchi et al., 2010; Yang
et al., 2014). It is a causal estimand of interest in instrumental variable studies. In the
idealized experiment being mimicked, Zij represents the randomized encouragement to take
the treatment or control, while dT ij and dCij indicate whether the treatment would be taken
if Zij = 1 and Zij = 0 respectively. The effect ratio then represents the ratio of the effect
of the encouragement on the outcome to the effect of the encouragement on the treatment
received. If the encouragement (1) is truly randomly assigned within strata defined by the
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observed covariates; and (2) can only impact the outcome of an individual if the encouragement changes the individual’s choice of treatment regimen (the exclusion restriction:
dT ij = dCij ⇒ rT ij = rCij ), Z is then an instrument for the impact of the treatment on
the response (Angrist et al., 1996). The parameter λ still has an interpretation in terms
of relative magnitude of the two effects even if the exclusion restriction is not met, but the
exclusion restriction coupled with monotonicity (dT ij ≥ dCij , also referred to as assuming
“no defiers”) give λ an additional interpretation as the average treatment effect among individuals who are compliers, i.e. individuals for which dT ij −dCij ; this is commonly referred to
as the local average treatment effect. While we will not always assume monotonicty holds,
we will make the assumption that the encouragement has an aggregate positive effect, i.e.
PI Pni
j=1 dT ij − dCij > 0, such that the effect ratio is well defined.
i=1
3.3.2. Testing a Composite Null
Note first that a null hypothesis on δ, ϕ, or λ corresponds to a composite null hypothesis
on the values of the potential outcomes, as multiple potential outcome allocations yield the
same value for the causal parameter. Let Θ(rT , rC , dT , dC ) be a function that maps a given
set of potential outcomes to the corresponding causal parameter value of interest, θ. We call
a set of potential outcomes {rT , rC , dT , dC } consistent with a null hypothesis H0 : θ = θ0
for a causal parameter θ if the following conditions are satisfied:
(A1) Consistency with observed data: Zij rT ij +(1−Zij )rCij = Rij ; Zij dT ij +(1−Zij )dCij =
Dij
(A2) Consistency with assumptions made on potential outcomes
(A3) Agreement with the null hypothesis: Θ(rT , rC , dT , dC ) = θ0
The first condition recognizes that we know the true values for half of the potential outcomes
based on the observed data. The second condition means that if the practitioner has made
additional assumptions on the potential outcomes, those assumptions must be satisfied in
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the allocations of potential outcomes under consideration. Assumptions could include a
known direction of effect, monotonicity, the exclusion restriction, and combinations thereof.
The third condition signifies that when testing a null hypothesis, we must only consider
allocations of potential outcomes where the corresponding causal parameter takes on the
desired value.
Let H(θ0 ) represent the set of potential outcomes satisfying conditions A1 - A3. As the
size of a composite null hypothesis test is the supremum of the sizes of the elements of the
composite null, to reject the null H0 : θ = θ0 at level α, we must reject the null for all
{rT , rC , dT , dC } ∈ H(θ0 ) at level α. As direct enumeration of H(θ0 ) is a laborious (and
likely computationally infeasible) task, we instead aim to find a single worst-case allocation
{rT , rC , dT , dC }∗ such that rejection of {rT , rC , dT , dC }∗ at level α implies rejection for all
{rT , rC , dT , dC } ∈ H(θ0 ).
We consider test statistics of the form T (θ0 ) =

PI

i=1 Ti (θ0 )

with expectation 0 under the null
PI
at Γ = 1. Let ψ(θ0 ; rT i , rCi , dT i , dCi ) = E[Ti (θ0 )]. Thus, i=1 ψ(θ0 ; rT i , rCi , dT i , dCi ) = 0
if and only if Θ(rT , rC , dT , dC ) = θ0 . For our three estimands of interest, the stratum-wise
contributions to the test statistic are

Ti (δ0 ) = −ni δ0 + ni

ni
X

(Zij Rij /mi − (1 − Zij )Rij /(ni − mi ))

j=1

Ti (ϕ0 ) = ni

Ti (λ0 ) = ni

ni
X
j=1
ni
X

(Zij Rij /mi − ϕ0 (1 − Zij )Rij /(ni − mi ))
(Zij (Rij − λ0 Dij )/mi − (1 − Zij )(Rij − λ0 Dij )/(ni − mi )) ,

j=1
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with respective stratum-wise expectations

ψ(δ0 ; rT i , rCi , dT i , dCi ) = −ni δ0 +

ni
X

(rT ij − rCij )

j=1

ψ(ϕ0 ; rT i , rCi , dT i , dCi ) =

ψ(λ0 ; rT i , rCi , dT i , dCi ) =

ni
X
j=1
ni
X

(rT ij − ϕ0 rCij )
(rT ij − λ0 dT ij − (rCij − λ0 dCij )).

j=1

To express these statistics in the required form for conducting a sensitivity analysis, define
Z̃ such that Z̃ij = Zij if mi = 1 and Z̃ij = 1 − Zij if mi > 1. If mi = 1, define q(·) as:




(q(δ0 ; rT i , rCi , dT i , dCi ))j = ni −δ0 + rT ij /mi −

X

rCik /(ni − mi )

k6=j





(q(ϕ0 ; rT i , rCi , dT i , dCi ))j = ni rT ij /mi −

X

ϕ0 rCik /(ni − mi )

k6=j





(q(λ0 ; rT i , rCi , dT i , dCi ))j = ni (rT ij − λ0 dT ij )/mi −

X

(rCik − λ0 dCik )/(ni − mi ) .

k6=j

The analogous definition holds when mi > 1: simply redefine q(·) within stratum i such
that the proper contribution is given to Ti (·) if unit j in stratum i receives the control (and
thus, all other units receive the treatment). The test statistic Z̃T q(·) then has the required
form for conducting a sensitivity analysis.
Under mild regularity conditions, Lyapunov’s central limit theorem yields that all three of
the test statistics T (θ0 ) under consideration are well approximated by a normal distribution
for Γ ≥ 1. See Chapter 2 for a discussion with regards to the risk difference (the risk ratio
follows through similar arguments), and see Baiocchi et al. (2010) for a discussion for the
effect ratio. Finding the worst-case allocation {rT , rC , dT , dC }∗ at a given Γ can be well
approximated by finding the allocation of potential outcomes and unobserved confounder
that results in the worst-case standardized deviate. While this observation simplifies our
task, it alone is not sufficient for making both inference and sensitivity analyses feasible
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for our estimands of interest; rather, we must exploit other features of the optimization
problem.

3.4. Symmetric Tables
We now introduce the required framework and notation for our optimization problem.
Though many equivalent formulations are possible, the one we describe has a decision variable for each unique distribution on a stratum’s contribution to the test statistic. This is
an extension of the formulation given in Chapter 2, which was catered towards maximizing the variance of the estimated causal risk difference under no unmeasured confounding.
In Section 3.5.3, we discuss the elements of our formulation which facilitate solving the
corresponding integer program efficiently.
Let Tizrd = {j : Zij = z, Rij = r, Dij = d}, (z, r, d) ∈ {0, 1}3 , i ∈ {1, ..., I}, denote the
eight possible partitions of indices of individuals in stratum i into sets based on their value
of the encouraged treatment, observed response, and taken treatment. Within each set, all
members share the same value of either rT ij or rCij , and of either dT ij or dCij . For example,
if j, k ∈ Ti011 , then rCij = rCik = dCij = dCik = 1, yet the values of rT ij , rT ik , dT ij , dT ik are
P
unknown. Note that for the stratifications under consideration (r,d)∈{0,1}2 |Ti0rd | = ni −mi ,
P
1rd | = m , and the minimum of these two quantities is always 1. |T zrd | can
i
i
(r,d)∈{0,1}2 |Ti
be thought of as the value in cell (z, r, d) of a 23 factorial table that counts the number of
individuals with each combination of (z, r, d) in stratum i.
Under no assumption on the structure of the potential outcomes, there are 22ni possible
sets of potential outcomes in stratum i that are consistent with the observed data, each
of which results in a particular distribution for the contribution to the test statistic from
stratum i, Ti (θ0 ). Fortunately, one need never consider all 22ni allocations. First, without
any assumptions on the potential outcomes, the 22ni possible sets of potential outcomes
Q
in stratum i only yield (z,r,d)∈{0,1}3 (|Tizrd | + 1)2 unique distributions for Ti (θ0 ). To see
this, note that the test statistics under consideration are permutation invariant within each

46

stratum. Let us examine the set Ti000 as an illustration. Here, we have dCij = rCij = 0 for
000 |

all j ∈ Ti000 . Of the 2|Ti

pairings [rT ij , rCij ], there are only |Ti000 | + 1 non-exchangeable

allocations of values for {rT ij : j ∈ Ti000 }: (0, 0..., 0), (1, 0, ..., 0), ..., and (1, 1, ..., 1). An
analogous argument shows that there are only |Ti000 | + 1 non-exchangeable arrangements
for dT ij , thus resulting in (|Ti000 | + 1)2 total non-exchangeable allocations. The same logic
yields a contribution of (|Tizrd | + 1)2 for each of the other seven partitions.
Additional structure is often imposed on the potential outcomes on top of consistency with
the observed data. For example, in the classical experiment we have that dT ij −dCij = 1 ∀i, j,
meaning that all patients comply with their assigned treatment. Hence, the four partitions
where Zi − Di 6= 0 are empty, and in the remaining partitions dT ij and dCij are fixed at 1
Q
and 0 respectively. This results in only (z,r)∈{0,1}2 (|Tizrz | + 1) allowed non-exchangeable
allocations within stratum i; note the lack of a square in the expression. This is also shown
in Rigdon and Hudgens (2015, Section 3). Other assumptions such as a known direction of
effect, monotonicity, and the exclusion restriction can be seen to similarly reduce the set of
allowed non-exchangeable allocations.
Q Q
It would seem as though we must consider at most Ii=1 (z,r,d)∈{0,1}3 (|Tizrd | + 1)2 different
P
distributions for T (θ0 ) = Ii=1 Ti (θ0 ) in our optimization problem. Fortunately, note first
that we assume independence between strata, and further note that we are using a normal
approximation to conduct inference. Hence, both the expectations and variances sum between strata and we do not need to consider covariances between strata. Further, in the
same way that there were a limited number of non-exchangeable allocations of potential
outcomes in each stratum due to repetition, many observed 23 factorial tables in the data
are repeated multiple times. For example, the matching with multiple controls described in
Section 3.1 returned 4893 strata, of which only 234 were unique.
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3.4.1. Expectation, Variance, and Null Deviation
We now introduce the requisite notation to exploit these facts to facilitate inference. Let
Ci = (|Ti000 |, ..., |Ti111 |) be the observed counts of the 23 tables for stratum i. C = {C1 , ..., CI }
is a (multi)set, where the number of unique elements equals the number of unique 23 tables
observed in the data, which will typically be much less than its dimension. Let S be the
number of unique tables, and let s ∈ {1, ..., S} index the unique tables. Define I(i) to be
a function returning the index of the unique table corresponding to the table observed in
stratum i. Hence, I(i) = I(`) if and only if Ci = C` . Let Ms = |I −1 (s)| be the number of
strata where unique table s was observed, and let ñs = nb for any b ∈ I −1 (s) be the number
of observations in unique table s. Finally, let Ps be the number of allowed non-exchangeable
potential outcomes for unique table s, and let {[rT [sp] , rC[sp] , dT [sp] , dC[sp] ]}, p ∈ {1, ..., Ps }
be the set of allowed potential outcome allocations that are consistent with unique table s,
where tablewise consistency refers to adherence to conditions A2 and A3 within table s.
Without loss of generality, we assume that the observed statistic, tθ0 , is larger than its
expectation under the null at Γ = 1, 0. In upper bounding the upper tail probability
P (T (θ0 ) ≥ tθ0 ), we thus restrict our search to the set of unobserved confounders u+ ∈ U+
as discussed in Section 3.2.2. The analogous procedure would hold for u− ∈ U− if tθ0 < 0.
For the sth unique table, and the pth set of allowed potential outcome allocations consistent
within table s, s ∈ {1, ..., S}, p ∈ {1, .., Ps }, form
q(θ0 )[sp]j = (q(θ0 ; rT [sp] , rC[sp] , dT [sp] , dC[sp] ))j . Reorder the q(θ0 )[sp]j such that q(θ0 )[sp]1 ≤
q(θ0 )[sp]2 ≤ .. ≤ q(θ0 )[sp]ñs . For a given value of Γ ≥ 1, we define µ(θ0 )[sp]a and ν(θ0 )[sp]a ,
a ∈ {1, ...ñs − 1}, as
Pa
µ(θ0 )[sp]a =

j=1 q(θ0 )[sp]j

+Γ

Pñs

j=a+1 q(θ0 )[sp]j

a + Γ(ñs − a)
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,

(3.1)

and
Pa
ν(θ0 )[sp]a =

j=1 (q(θ0 )[sp]j )

2

+Γ

Pñs

j=a+1 (q(θ0 )[sp]j )

a + Γ(ñs − a)

2

− (µ(θ0 )[sp]a )2 .

(3.2)

This notation is reminiscent of that of Gastwirth et al. (2000). The index a corresponds to the
the vector of unmeasured confounders u+ with a zeroes followed by ñs −a ones. µ(θ0 )[sp]a and
ν(θ0 )[sp]a represent the expectation and variance of the contribution to the test statistic T (θ0 )
from a matched set with observed table s, consistent set of potential outcomes p, and allocation of unmeasured confounders a. Let µθ0 = [µ(θ0 )[11]1 , ..., µ(θ0 )[SPS ],ñS −1 ], and let ν θ0 =
[ν(θ0 )[11]1 , ..., ν(θ0 )[SPS ],ñS −1 ]. Finally, recalling the definition of ψ(·) from Section 3.3 as the
expectation of the contribution to the test statistic T (θ0 ) from stratum i, define ψ(θ0 )[sp]j =
(ψ(θ0 ; rT [sp] , rC[sp] , dT [sp] , dC[sp] ))j , and define ψ θ0 = [ψ(θ0 )[11]1 , ..., ψ(θ0 )[SPS ],ñS −1 ].

3.5. Inference and Sensitivity Analysis
Let x[sp]a be an integer variable denoting how many times the set of potential outcomes p that
is consistent with unique table s with allocation of unmeasured confounders a is observed in
the data, s ∈ {1, ..., S}, p ∈ {1, ..., Ps }, a ∈ {1, ..., ñs − 1}, and let x = [x[11]1 , .., x[SPs ],ñS −1 ].
For a given θ0 being tested, µ(θ0 )[sp]a x[sp]a and ν(θ0 )[sp]a x[sp]a represent the contribution
to the overall mean and variance of the test statistic if the pth set of potential outcomes
in unique table s with allocation of unmeasured confounders a is observed x[sp]a times,
and µTθ0 x and ν Tθ0 x represent the overall expectation and variance across all unique tables,
PPs Pñs −1
potential outcomes and unmeasured confounders.
p=1
a=1 x[sp]a then represents how
many times the sth unique table was observed in the data, a number which we defined to
P s Pñs −1
be Ms . Hence, Pp=1
a=1 x[sp]a = Ms .
Note that through our formulation we have restricted optimization to the set of observations
that adhere to conditions A1 (consistency with the observed data) and A2 (consistency with
any other assumptions made by the modeler on the potential outcomes) of Section 3.3.2.
We enforce condition A3 (that the null must be true in the resulting allocation of potential
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outcomes) through adding a linear constraint to our optimization problem: ψ Tθ0 x = 0. The
following integer program facilitates hypothesis testing and confidence interval construction
under no unmeasured confounding (Section 3.5.1), as well as a sensitivity analysis for any
Γ > 1 (Section 3.5.2):

minimize (tθ0 − µTθ0 x)2 − κ(ν Tθ0 x)
x

subject to

Ps ñX
s −1
X

(P1)

x[sp]a = Ms ∀s

p=1 a=1

ψ Tθ0 x = 0
x[sp]a ∈ Z ∀s, p, a
x[sp]a ≥ 0 ∀s, p, a,

where Z are the integers and κ > 0 is a positive constant to be described. The above formulation is sufficient for tests on the risk difference and risk ratio. For the effect ratio, we can
P P i
dT ij −
impose the constraint of an aggregate positive effect of the intervention, Ii=1 nj=1
dCij > 0, through an additional linear inequality.
3.5.1. Hypothesis Testing and Confidence Intervals Under No Unmeasured Confounding
For conducting inference under pure randomization (that is, under Γ = 1), the value of
µTθ0 x is fixed to the expectation of the test statistic under the null, 0. Hence, (tθ0 − µTθ0 x) is
constant as well, and (MV) reduces to an integer linear program. This program is equivalent
to finding the largest variance over all feasible x. Call the optimal vector x∗θ0 , and call the
corresponding maximal variance ν Tθ0 x∗θ0 . The worst-case deviate for testing θ = θ0 can then
q
be found by setting zθ0 = tθ0 / νθT0 x∗θ0 .
To form a 100 × (1 − α)% confidence interval at Γ = 1, we simply invert a series of tests.
Explicitly, we find upper and lower bounds, θu and θ` , such that θ` =
q
q
n
o
n
o
T
∗
SOLVE θ : tθ / νθ xθ = z1−α/2 and θu = SOLVE θ : tθ / νθT x∗θ = zα/2 , where zq is
the q quantile of a standard normal distribution. These endpoints can be found through a
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grid search over θ, or by using the bisection algorithm.

3.5.2. Sensitivity Analysis through Iterative Optimization
For Γ > 1, (MV) is instead an integer quadratic program. First, note that we reject the
null with a two-sided alternative at size α if (tθ0 − µTθ0 x)2 /(ν Tθ0 x) ≥ χ21,1−α for all values
of the potential outcomes that are consistent with the null being tested, where χ21,1−α is
the 1 − α quantile of a χ21 distribution. Equivalently, we need only determine whether
(tθ0 − µTθ0 x)2 − χ21,1−α (ν Tθ0 x) ≥ 0 for all feasible x. This can be done by minimizing (MV)
with κ = χ21,1−α over all feasible x, and checking whether or not the objective value at x∗θ0
is greater than zero.
One may also be interested in knowing the worst-case deviate itself (equivalently, the worstcase p-value), rather than simply knowing the result of the test. The optimal vector x∗θ0
for (MV) at κ = χ21,1−α need not result in the worst-case deviate; however, we now show
that we can find the worst-case p-value through an iterative procedure based on (MV). To
proceed, we find the value κ = κ∗ such that the minimal objective value of (MV) equals 0.
As is proved in Dinkelbach (1967), such a value of κ∗ exactly equals the minimal squared
deviate. Interpreted statistically, the value κ∗ is the maximal critical value for the squared
deviate such that the null could be still be rejected, which is equivalent to the value of the
deviate itself. Although finding this zero could be performed using a grid search, we instead
solve for the optimal x∗θ0 through the following algorithm.
1. Start with an initial value κ(0) .
2. In iteration i ≥ 1, set κ = κ(i−1) in (MV).
∗(i)

∗(i)

3. Solve the resulting program, and set κ(i) = (tθ0 − (µTθ0 xθ0 ))2 /(ν Tθ0 xθ0 ).
∗(i)

4. If κ(i) = κ(i−1) terminate the algorithm: set x∗θ0 = xθ0 , and set κ∗ = κ(i) .
5. Otherwise, return to step 2. Repeat until convergence.
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Note that the sequence {κ(i) } is bounded below by 0. It is also monotone decreasing for i ≥ 1,
∗(i+1) 2
∗(i+1)
) − κ(i) (ν Tθ0 xθ0
)

as (tθ0 − µTθ0 xθ0

∗(i+1)

κ(i) ≥ (tθ0 − (µTθ0 x∗(i+1) ))2 /(ν Tθ0 xθ0

∗(i)

∗(i)

≤ (tθ0 − µTθ0 xθ0 )2 − κ(i) (ν Tθ0 xθ0 ) = 0, which implies
) = κ(i+1) . Hence, this algorithm will converge to a

stationary point κ∗ . In practice, we find that this is achieved very quickly, frequently within
2 or 3 steps. At κ∗ , note that it must be the case that the objective value in (MV) equals
0. This means that at the termination of the iterative procedure, we have converged to the
√
√
minimal deviate. The maximal p-value is then Φ(− κ∗ ) for a one-sided test or 2×Φ(− κ∗ )
for a two-sided test, where Φ(·) is the CDF of a standard normal distribution.
3.5.3. Computation Time
In the past, researchers have been dissuaded from suggesting methodology that requires
the solution of an integer program, as problems of this sort are N P-hard in general. In
this section, we present simulation studies to assuage fears that our integer linear (Γ = 1)
and quadratic (Γ > 1) programs may have excessive computational burden. Before doing
so, we discuss two properties of an integer programming formulation that substantially
influence the performance of integer programming solvers: the strength of the corresponding
continuous relaxation, and the avoidance of symmetric feasible solutions (Bertsimas and
Tsitsiklis, 1997).
A strong formulation of an integer program is one for which the polyhedron defined by the
constraint set, P = {x : Ax ≤ b, x ∈ R}, is close to the integer hull, PI = Conv{x : x ∈
P ∩ Z}. In an ideal world, the integer hull and the relaxed polyhedron would align, meaning
that any linear programming relaxation would be guaranteed to have an integral optimal
solution since any linear program has an optimal solution at the vertex of its corresponding
polyhedron. For a quadratic program, having PI = P does not guarantee coincidence of the
true and relaxed optimal solutions, as a quadratic program may have a solution at an edge.
Nonetheless, having P far from PI can hamper the progress of a mixed integer programming
solver, as it increases the number of cuts required by branch-and-cut algorithms to strengthen
the continuous relaxation (Mitchell, 2002).
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A symmetric formulation is one in which variables can be permuted without changing the
structure of the problem. Formulations of this sort can also cripple standard integer programming solvers even with modest problem size. This is due in large part to the generation
of isomorphic solution paths by branch-and-bound and branch-and-cut algorithms, which
in turn complicates the process by which a given node is proven optimal or suboptimal.
Although methods exist to detect symmetry groups in a given formulation, formulations
that explicitly avoid such groups are strongly preferred; see Margot (2010) for a discussion
of these points.
We now present simulation studies to demonstrate that neither weakness nor symmetry of
formulation proves inimical to conducting hypothesis testing and sensitivity analyses using
the methodology outlined in this paper, even with large data sets and large stratum sizes. In
our first setting, in each of 1000 iterations we sample 1250 matched sets from the strata in our
motivating example from Section 3.1.2. We assign treated individuals and control indivduals
an outcome of 1 with probability 0.75 and 0.25 respectively. Each iteration thus has strata
ranging in size from 2 to 21, and each data set has an average of roughly 10,000 individuals
within it. Large strata affect computation time, as they result in larger numbers of nonexchangeable potential outcome allocations within a stratum and fewer duplicated 2 × 2
tables in the data. In our data set, 25% of the matched strata had one acute rehabilitation
individual and 20 home with home health services patients. This simulation setting thus
produces particularly challenging optimization problems: on average, each iteration had
170,000 variables over which to optimize. As we demonstrate in Appendix B.3, the number
of variables, itself affected by the number and size of the unique observed tables, is a primary
determinant of computation time for the optimization routine.
We conduct two hypothesis tests in each iteration: a null on the causal risk difference,
δ = 0.2, and on the causal risk ratio, ϕ = 1.75. For both of the causal estimands being
assessed, we test the stated nulls with two-sided alternatives at Γ = 1 (no unmeasured
confounders, integer linear program) and Γ = 3 (unmeasured confounding exists, integer
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quadratic program). We record the required computation time for each data set, which
includes both the time taken to define the necessary constants for the problem and also the
time required to solve the optimization problem. To measure the strength of our formulation,
we also recorded whether or not the initial continuous relaxation had an optimal solution
which was itself integral, and if not the relative difference in optimal objective function values
between the integer and continuous formulations (defined to be the absolute difference of
the two, divided by the absolute value of the relaxed value). Simulations were conducted
on a desktop computer with a 3.40 GHz processor and 16.0 GB RAM. The R programming
language was used to formulate the optimization problem, and the R interface to the Gurobi
optimization suite was used to solve the optimization problem.
Table 12 shows the results of this simulation study. As one can see, our formulation yields
optimal solutions in well under a minute for both the integer linear and integer quadratic
formulations despite the magnitude of the problem at hand. The strength of our formulation
is further evidenced by the typical discrepancy between the integer optimal solution and that
of the continuous relaxation. For testing the causal risk difference, we found that in all of the
simulations performed assuming no unmeasured confounding the integer program and its
linear relaxation had the same optimal objective value. When testing at Γ = 3 the quadratic
relaxation differed from the integer programming solution in roughly 2/3 of the simulations;
however, the resulting average relative gap between the two was a minuscule 3 × 10−4 %. For
testing the causal risk ratio, the objective values tended not to be identically equal at Γ = 1
or Γ = 3, which has to do with the existence of fractional values in the row of the constraint
matrix enforcing the null hypothesis; nonetheless, the average gap among those iterations
where there was a difference was 4 × 10−5 % for the linear program, and 0.002% for the
quadratic program. This suggests not only that we have arrived upon a strong formulation,
but that one could in practice accurately approximate (MV) by its continuous relaxation.
Appendix B.3 contains additional simulation studies which serve not only to further illustrate
the strength of our formulation, but also to provide insight into what elements of the problem
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Table 3: Computation times for tests of δ = 0.2 and ϕ = 1.75 at Γ = 1 (integer linear
program) and Γ = 3 (integer quadratic program), along with percentages of coincidence of
the integer and relaxed objective values, and average gaps between integer solution and the
continuous relaxation if a difference existed between the two.
H0
Γ
δ = 0.2; Γ = 1
δ = 0.2; Γ = 3
ϕ = 1.75; Γ = 1
ϕ = 1.75; Γ = 3

Avg. Time (s),
Integer
5.88
9.77
5.86
10.85

Avg. Time (s),
Relaxation
5.59
7.14
5.62
7.82

%(objint = objrel )
100%
36.9%
0%
3.2%

Avg Gap
If Different
NA
3 × 10−4 %
4 × 10−5 %
0.002%

affect computation time. We present simulations varying the value of Γ used, the number
of matched sets, the null hypothesis being tested, the magnitude of the true effect, and the
prevalence of the outcome under treatment and control in order to assess the impact of
each of these factors on the time required to define the required constants and to carry out
the optimization. We then compare our formulation to an equivalent, but highly symmetric,
formulation in order to highlight the importance of avoiding symmetry for achieving a strong
formulation with reasonable computation time. We also present a simulation study akin to
the one presented in this section but using real data for the outcome variables as opposed
to simulated outcomes. Finally, we provide advice for using our procedure under time
constraints for the optimization routine.

3.6. Data Examples
We employ our methodology in two data examples. In Section 3.6.1, we present hypothesis
testing and a sensitivity analysis for the causal risk difference and causal risk ratio in our
motivating example from Section 3.1, wherein we compare hospital readmission rates for two
different post-hospitalization protocols after an acute care hospitalization. In Section 3.6.2,
we reexamine the instrumental variable study of Yang et al. (2014) comparing mortality
rates for premature babies being delivered by c-section versus vaginal births. In addition to
inference, confidence intervals, and sensitivity analyses, we also provide point estimators for
the causal estimands of interest. These are formed by using our test statistic, T (θ), as an
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estimating equation for an m-estimator (Van der Vaart, 2000), i.e θ̂ := SOLVE{θ : T (θ) =
0}; see Appendix B.4 for further discussion.
As will be shown, the findings in both of our examples exhibit varying degrees of sensitivity
to unmeasured confounding: under the strongest assumptions, we fail to reject the null of
no treatment effect after Γ = 1.157 in our first example and after Γ = 1.67 in our second.
To provide context for the levels of robustness possible in a well designed observational
study, Section 4.3.2 of Rosenbaum (2002a) notes that the finding of a causal relationship
between smoking and lung cancer in Hammond (1964) continued to be significant until
Γ = 6, meaning that an unmeasured confounder would have had to increase the odds of
smoking by a factor of six while nearly perfectly predicting lung cancer in order to overturn
the study’s finding.
3.6.1. Risk Difference and Risk Ratio
We now return to our study of the impact of discharge to an acute rehabilitation center
versus to home with home health services on hospital readmission rates after an acute care
hospitalization. We use sixty day hospital readmission after initial hospital discharge as our
outcome of interest. In terms of counterfactuals, we want to compare sixty day hospital
readmission rates if all patients had been sent to acute rehabilitation with readmission rates
if all patients had been assigned to home with home health services. We define Rij = 1
if an individual was readmitted to the hospital, and 0 otherwise. We let Zij = 1 if an
individual was assigned to acute rehabilitation. The marginal proportions of sixty day
hospital readmission after accounting for observed confounders through matching are 0.206
for acute rehabilitation, and 0.243 for home with home health services. We will analyze this
data set with and without the assumption of a known direction of effect. When assuming a
direction of effect we assume that it is nonpositive in this example, meaning that going to
acute rehabilitation can never hurt an individual: an individual who would not be readmitted
to the hospital within sixty days after being discharged to home with home health services
could not have been readmitted to the hospital within sixty days after being discharged to
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acute rehabilitation.
The estimated risk difference is δ̂ = −0.0369 (favoring acute rehabilitation) regardless of
whether we assume a nonpositive treatment effect. We construct confidence intervals by
inverting a series of hypothesis tests on {δ0 }. Without assuming a nonpositive treatment
effect, we find a 95% confidence interval for δ of [-0.0557; -0.0175]. With the assumption of
a nonpositive effect, the 95% confidence interval shrinks to [-0.0535; -0.0202]. We conduct
inference on the risk ratio, ϕ, in a similar manner. The estimated risk ratio was ϕ̂ = 0.848
(favoring acute rehabilitation); 95% confidence intervals for ϕ are [0.773; 0.927] and [0.780;
0.916] without and with assuming a nonpositive treatment effect respectively.
The results of a sensitivity analysis for a test of δ = 0 ⇔ ϕ = 1 with a lower one-sided
alternative are shown in Table 4. As one can see, the result is sensitive to unobserved
biases under both scenarios, but far more so when we do not make an assumption on the
direction of effect. To better understand this, it is useful to think of the corresponding
integer programs that result in these worst-case bounds. The optimization problem with
the assumption of a nonpositive treatment effect has 2,830 variables associated with it, with
variables only corresponding to a choice of vector u−
i in a given stratum. Without making
this assumption, the number of variables grows to 321,860, as we must consider all nonexchangeable allocations of potential outcomes and all choices for the vector of unmeasured
confounders. The difference in problem size impacts not only robustness against unmeasured
confounding, but also computation time. The computations for each value of Γ > 1 shown
took an average of 1.5 seconds under the assumption of non-negativity, but 75 seconds
without this assumption. See Appendix B.5 for a discussion of why the assumption of a
known direction of effect has such a substantial impact. Considering the sheer size of the
problem, this bears testament to the strength of our formulation: for all of the Γ values
tested, the continuous relaxation had an integer solution.
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Table 4: Sensitivity analysis for a one-sided test with alternative hypothesis δ < 0 ⇔ ϕ <
1. Worst case p-values are shown with (rightmost column) and without (middle column)
assuming a known direction of effect.
Γ

rT ij R rCij

rT ij ≤ rCij

1.000
1.080
1.095
1.157

1.0×10−4

6.1×10−6
0.0016
0.0028
0.050

0.0306
0.050
0.420

3.6.2. Effect Ratio
Yang et al. (2014) present an observational study comparing the effect of cesarian section
versus vaginal delivery on the survival of premature babies of 23-24 weeks gestational age,
where Rij = 1 if a baby survives. The analysis used whether or not a baby was delivered
at a hospital with “high” rates of c-section as a potential instrumental variable. We present
a sensitivity analysis for these data under combinations of assumptions of varying strength.
In so doing, we aim to assess the impact of various assumptions on the inference’s perceived
sensitivity to unmeasured confounding. 1489 pairs of babies were formed, with a baby in
the “high” group being matched to baby in the “low” group who was similar on the basis of
all other pre-treatment covariates. Let Zij = 1 if the baby was delivered at a hospital with
a high c-section rate, and let Dij = 1 if the baby was delivered by a c-section. As such, the
“randomized encouragement” is the type of hospital at which the baby was delivered, and
the treatment of interest is the actual method of delivery.
We present inference on the effect ratio under all eight combinations of enforcing and not
enforcing a nonnegative direction of effect (DE) : rT ij ≥ rCij ∀i, j; monotonicty (MO):
dT ij ≥ dCij ∀i, j , and the exclusion restriction (ER): dT ij = dCij ⇒ rT ij = rCij ∀i, j. In
the context of this example, the effect ratio is the ratio of the increase in survival rate to
the increase in rate of c-sections for premature babies of 23-24 weeks gestational age that
occurs with being delivered at a hospital with a high rate of c-sections. If we additionally
assume that both monotonicity and the exclusion restriction hold, then the effect ratio has
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Table 5: Minimal value of Γ such that conclusion of the hypothesis test on λ is reversed
under eight combinations of assumptions.
H0 : λ = 0
No (ER)
Yes (ER)
H0 : λ = 0.1
No (ER)
Yes (ER)

No (DE)
No (MO)
1.292
1.292
No (DE)
No (MO)
1.213
1.225

No (DE)
Yes (MO)
1.292
1.371
No (DE)
Yes (MO)
1.220
1.270

Yes (DE)
No (MO)
1.677
1.677
Yes (DE)
No (MO)
1.407
1.408

Yes (DE)
Yes (MO)
1.677
1.677
Yes (DE)
Yes (MO)
1.409
1.410

the additional interpretation of being the effect of delivering at a hospital with high rates
of c-sections among babies who would have been delivered by c-section if and only if they
were delivered at a hospital with a high rate of c-sections.
Under any combination of assumptions, the estimated effect ratio is λ̂ = 0.866. Assuming
none of (DE), (MO), (ER), the 95% confidence interval is [0.50; 1.47], and there are 256
decision variables in the optimization problem. Assuming all of (DE), (MO), (ER), the 95%
confidence interval shrinks to [0.58; 1], and there are 49 decision variables in the optimization
problem.
In Table 6, we present the values of Γ required to overturn the rejection of the nulls that
λ = 0 and λ = 0.1, both with an upper one-sided alternative at α = 0.05. For the null of
λ = 0, this test boils down to a test on the average treatment effect, but with a range of
restrictions on the potential outcomes. Once a nonnegative direction of effect is imposed
(the bottom four cells of the table), the test of λ = 0 simply becomes a test of Fisher’s
sharp null; see Appendix B.5 for further discussion. Because of this, the assumptions of
monotonicity and the exclusion restriction cannot impact the sensitivity analysis at λ = 0
unless non-negativity is not enforced. Furthermore, without assuming a direction of effect,
monotonicity can only affect the performed inference if it is enforced in concert with the
exclusion restriction at λ = 0 and vice versa. For λ = 0.1, the test no longer corresponds
exclusively to one of Fisher’s sharp null when non-negativity is imposed. We thus see that
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each assumption impacts the study’s robustness against unmeasured confounding to varying
degrees. For all combinations of assumptions and each value of Γ tested, the corresponding
integer quadratic program solved in under 2 seconds.

3.7. Discussion
Our formulation exploits attributes of the randomization distributions for our proposed
test statistics which are unique to inference after matching. While this is sufficient for
our purposes, one resulting limitation is that our method will likely not be practicable in
observational studies or randomized clinical trials where there either are no strata, or where
each stratum contain a large number of both treated and control individuals; see Rigdon
and Hudgens (2015) for a discussion of the difficulties of conducting randomization inference
with binary outcomes in these settings. In these settings, the work of Cornfield et al. (1959)
presents a method for sensitivity analysis for the risk ratio, and Ding and Vanderweele
(2014) extend this approach to the risk difference. Another limitation is that as with any
N P-hard endeavor, it is difficult to anticipate ahead of time how long our method will take
on a given data set with a given match structure; however, through a host of simulation
studies presented both in Section 3.5.3 and Appendix B.3 we have provided further insight
into these matters for practitioners interested in using our methods.
We have framed hypothesis testing and sensitivity analyses for composite null hypotheses
with binary outcomes in matched observational studies as the solutions to integer linear
(Γ = 1) and quadratic (Γ > 1) programs. An interesting consequence of our formulation is
that it readily yields a method for performing a sensitivity analysis for simple null hypotheses under general outcomes without reliance on the asymptotically separable algorithm of
Gastwirth et al. (2000); see Appendix B.6 for details and a data example. We have shown
that our method can be practicable even with large data sets and large stratum sizes. We
have further demonstrated through simulation studies and real data examples that our formulation explicitly avoids issues known to hinder the performance of integer programming
algorithms such as looseness of formulation and symmetry. In so doing, we hope to shed
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further light on the usefulness of integer programming for solving problems in causal inference.
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CHAPTER 4 : Sensitivity Analysis for Multiple Comparisons in Matched
Observational Studies through Quadratically Constrained Linear
Programming
Joint work with Dylan Small

4.1. Introduction
4.1.1. Unmeasured Confounding with Multiple Outcomes
Conclusions drawn from an observational study should be subjected to additional scrutiny
due to their vulnerability to unmeasured confounding. Unlike with a randomized experiment,
a covariate which has not been adjusted for in the primary analysis may very well drive
the observed relationship, thus nullifying the study’s original finding. This necessitates an
additional step known as a sensitivity analysis to assess the robustness of an observational
study’s conclusions. A sensitivity analysis seeks an answer to the following question: how
extreme would hidden bias have to be in order for the conclusions of a study to be materially
altered? A study whose findings could be overturned with a small amount of unmeasured
confounding invites warranted skepticism, while a study’s conclusions are bolstered if a large
degree of unmeasured confounding is required.
A sensitivity analysis computes worst-case bounds on the desired inference at a given level
of unmeasured confounding. In observational studies employing matching to adjust for
overt biases, the corresponding sensitivity analysis has been well studied when there is a
single outcome variable of interest; see Section 4 of Rosenbaum (2002a) for a comprehensive
overview. It is parameterized by a number Γ ≥ 1 which controls the allowable departure
from purely random assignment for individuals who are similar on the basis of their observed
covariates: two individuals in the same matched set can, due to the presence of unmeasured
confounding, differ in their odds of assignment to treatment by at most Γ. Higher values of Γ
thus allow for unmeasured confounding to more substantially bias the treatment assignment
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probabilities for individuals in the same matched set. As discussed in Section 4.2.2, the
impact of unmeasured confounding can be encoded by a scalar latent variable, uij , which
represents the aggregate impact of unmeasured confounding on the assignment probabilities
for individual j in matched set i. Individuals in the same matched set with higher values
for uij have higher probabilities of assignment to treatment. At each level of Γ, one finds
the vector of unmeasured confounders for all individuals in the study, u, which maximizes
the p-value, hence yielding the worst possible inference for a given departure from purely
random assignment.
Matched observational studies may seek to investigate the impact of a single treatment on
multiple outcome variables; see Sabia (2006), Voigtländer and Voth (2012), and Obermeyer
et al. (2014) for recent examples from policy analysis, economics, and health care. When
there are multiple outcome variables of interest, there may exist unmeasured factors that
influence a particular outcome while not impacting others. In order for these factors to
affect the performed inference (and hence, to be confounders in the sense of VanderWeele
and Shpitser (2013)), these factors must also impact the treatment assignment probabilities. Figure 3 demonstrates that these factors yield an aggregate impact on the assignment
probabilities (U in the figure) despite affecting the outcomes differently. Controlling for the
aggregate impact of unmeasured confounding on the assignment probabilities is sufficient
for identifying the causal effect of the treatment on all of the outcome variables of interest,
as these probabilities are themselves a minimally sufficient adjustment set (Rosenbaum and
Rubin, 1983). The reader should keep in mind that uij truly reflects a dimension reduction of all unmeasured confounders to their relevant scalar component for impacting the
assignment probabilities, and hence that this model for a sensitivity analysis does not limit
the potential impact of unmeasured confounding on any of the outcome variables. Moving
forward, we will refer to uij interchangeably as the “unmeasured confounder" and “unobserved covariate" for individual j in matched set i, as is conventional in sensitivity analyses
following the model of Rosenbaum (2002a).
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W12

W2
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Z
R1

R2

Figure 3: A Directed Acyclic Graph (DAG) showing how our method accounts for unmeasured
confounding on multiple outcome variables by controlling for their joint effect on the treatment.
W1 , W2 , W12 represent unmeasured factors which affect outcome R1 , outcome R2 , and both outcomes
respectively. U is an aggregate measure of the impact of {W1 , W2 , W12 } on the treatment assignment
vector, Z. For any known value of U , only the direct causal pathway of the treatment, Z, on the
outcome variables, R1 and R2 , remains open if we condition on U (denoted by the square around
U ). Implicit in this diagram is that adjustment has been made for any observed pre-treatment
confounders, X.
When conducting a sensitivity analysis with multiple outcomes, the unmeasured confounder
which affects assignment probabilities in the worst-case manner for outcome k, u∗k , may not
be worst-case for outcome k 0 ; in fact, it may actually result in more favorable inference for
outcome k 0 . As is noted in Rosenbaum and Silber (2009), naïvely combining the results
of outcome-specific sensitivity analyses while accounting for multiple comparisons is unduly
conservative precisely because of this: it allows the worst-case unmeasured confounder to
affect the probabilities of assignment to treatment differently from one outcome to the next
for the same test subject. Consequently, a uniform improvement in the power of a sensitivity
analysis for testing the overall null hypothesis for any subset of outcomes could be attained by
eliminating this logical inconsistency. As tests for the overall null hypothesis with respect
to subsets of outcomes form the basis of multiple comparisons procedures such as closed
testing (Marcus et al., 1976), hierarchical testing (Meinshausen, 2008), and the inheritance
procedure (Goeman and Finos, 2012), such an advance would also uniformly improve the
power of a sensitivity analysis for testing null hypotheses for particular outcomes while
strongly controlling the familywise error rate.
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The approaches for conducting a sensitivity analysis with a single outcome heavily utilize
the fact that within each matched set, the search for the worst-case unmeasured confounder
can be restricted to a readily enumerable set of binary vectors (Rosenbaum and Krieger,
1990). When testing whether the treatment has an effect on at least one of many outcome
variables of interest, this is no longer the case. Thus, the potential gain in power cannot
be actualized through simple extensions of existing methods. In this work, we present a
new formulation of the required optimization problem as a quadratically constrained linear
program which allows one to claim improved robustness to unmeasured confounding in an
observational study with multiple outcomes when testing the overall null. This can, in turn,
improve the reported robustness of individual level outcomes through its incorporation into
certain sequential rejection procedures (Goeman and Solari, 2010). To illustrate these ideas,
we now present an observational study on the impact of smoking on naphthalene levels in
the body.

4.1.2. Motivating Example: Naphthalene Exposure in Smokers
Naphthalene is a simple polycyclic aromatic hydrocarbon (PAH) which has been linked to
numerous adverse health outcomes. Exposure to excessive amounts of naphthalene can cause
hemolysis (abnormal damage to or destruction of red blood cells in the body), which can in
turn lead to hemolytic anemia (Todisco et al., 1991; Sanctucci and Shah, 2000). Further,
naphthalene has been shown to be carcinogenic in animal studies (Hecht, 2002), prompting
the International Agency for Research on Cancer (IARC) to label it as “possibly carcinogenic
to humans” (IARC, 2002). Given the potential for adverse health outcomes from exposure to
naphthalene, it is of interest to assess the impact of other sources of exposure to naphthalene
on levels of naphthalene metabolites found in the body.
In the 2007-2008 National Health and Nutrition Examination Survey (NHANES), urinary
concentrations of two monohydroxylated naphthalene metabolites, 1- and 2-naphthol (also
known as α- and β-naphthol) were collected for 1706 patients from a representative sample
of adults aged 20 and older in the United States. Through this study, we seek to address
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the following question: after controlling for other sources of exposure and other relevant demographic variables, does smoking (one source of exposure to naphthalene) lead to elevated
naphthalene metabolite levels in our study population? If this were the case, it would lend
further credence to the belief that naphthalene is a useful biomarker for exposure to PAHs
through inhalation (Nan et al., 2001; Hecht, 2002; Preuss et al., 2004), and it may serve to
further highlight the health risks from smoking.
Through full matching (Hansen, 2004), 453 current smokers were placed into matched sets
with 1253 non-current smokers who were similar on the basis of pre-treatment variables
which, following the criterion for confounder selection of VanderWeele and Shpitser (2011),
were deemed important to the decision to be a smoker or the outcomes; see Appendix C.1
for further details on the performed matching. Our two outcome variables were the urinary
concentrations of 1- and 2-naphthol. Using an aligned rank test (Hodges and Lehmann,
1962) within the stratification yielded by our full match, we sought to determine whether
there was evidence for smoking causing elevated levels for at least one of the two metabolites,
and also whether smoking caused elevated metabolite levels for 1-naphthol and 2-naphthol
considered individually. Assuming a multiplicative treatment effect model (additive on the
log-scale), under no unmeasured confounding smoking was estimated to elevate urinary
concentrations by a factor of 4.66 and 3.29 for 1- and 2-naphthol respectively using a HodgesLehman estimator (Hodges and Lehmann, 1963), with 95% confidence intervals of [4.00;
5.41] and [2.92; 3.69] attained by inverting a series of tests on the value of the multiplicative
effect (Lehmann, 1963). Correcting for multiple comparisons using Holm-Bonferroni (Holm,
1979), the asymptotically separable algorithm of Gastwirth et al. (2000) applied individually
to each metabolite yielded strong insensitivity to unmeasured confounding: the minimum
and maximum of the two outcome-specific findings were below 0.025 and 0.05 respectively
until a Γ of 7.78. This means that an unmeasured confounder would have to result in a
difference in the odds of smoking for two individuals in the same matched set by a factor of
7.78 while nearly perfectly predicting naphthalene metabolite concentrations to render our
results insignificant.
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Based on these results, we can also attest to the robustness of a rejection of the overall null of
no effect for either naphthalene metabolite: we have evidence for significance of at least one
naphthalene metabolite at Γ = 7.78. As previously mentioned, this is conservative as using
Holm-Bonferroni to combine individual sensitivity analyses allows for differing worst-case
confounders for each outcome for the same individual. Naturally, the worst-case unmeasured
confounder for 2-naphthol need not be the worst-case confounder for 1-naphthol. In fact, at
Γ = 7.78 the worst-case u for 2-naphthol actually yields a significant result for 1-naphthol,
and similarly the worst-case u for 1-naphthol makes our result for 2-naphthol significant.
Through the methodology presented in this paper, it can be determined there is no vector
of hidden covariates that simultaneously makes 1- and 2-naphthol insignificant at this level
of unmeasured confounding. In fact, it takes a Γ of 10.22 to overturn the rejection of
the overall null of no effect for either naphthalene metabolite. Thus Γ = 7.78 actually
understates the robustness of a test of overall significance. Furthermore, we show in Section
4.5 that through a closed testing procedure we can actually claim robustness of the particular
metabolites up until Γ = 7.83 for 1-naphthol and Γ = 8.20 for 2-naphthol, which are the
same levels of robustness to unmeasured confounding that would have been arrived upon
without controlling for multiple comparisons.
Section 4.2 provides notation for and a review of randomization inference and sensitivity
analysis within a matched observational study. Section 4.3 introduces testing and sensitivity
analysis for the overall null hypothesis when there are multiple outcomes. After highlighting
the room for improvement relative to combining sensitivity analyses for each outcome, Section 4.4 formulates a quadratically constrained linear program which allows us to perform
a sensitivity analysis for the overall null hypothesis while enforcing that for each outcome,
the unmeasured confounder must be the same for each individual. Section 4.5 describes
how our method can facilitate strong familywise error control for testing null hypotheses on
particular outcomes through its incorporation into certain sequential rejection procedures.
In Section 4.6, we present a simulation study demonstrating the potential gains in power of
a sensitivity analysis on the overall null and on outcome-specific nulls using this procedure.
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We return to our motivating example in Section 4.7, where we elucidate the improvements
in reported robustness to unmeasured confounding attained through our procedure as they
pertain to testing elevated naphthalene levels in smokers.

4.2. Notation for a Matched Observational Study
4.2.1. A Stratified Experiment with Multiple Outcomes
We now present notation for the idealized experiment targeted by matching algorithms
wherein each treated unit is placed in a matched set with one or more control units. This
framework can be trivially extended to dealing with strata resulting from full matching, such
as the one presented in Section 4.1.2; see Rosenbaum (2002a, Section 4, Problem 12) for
details. Suppose there are I independent strata, the ith of which contains ni ≥ 2 individuals,
that were formed on the basis of pre-treatment covariates. In each stratum, 1 individual
receives the treatment and ni − 1 individuals receive the control. There are K outcome
variables collected for each individual. For each outcome k, individual j in stratum i has
two potential outcomes: one under treatment, rT ijk , and one under control, rCijk ; let rT ij
and rCij be the K-dimensional vector of potential outcomes for this individual. The observed
response vector for each individual is Rij = rT ij Zij + rCij (1 − Zij ), where Zij is an indicator
variable that takes the value 1 if individual j in stratum i is assigned to the treatment; see,
for example, Neyman (1923) and Rubin (1974). Each individual has a vector of observed
covariates xij and an unobserved covariate uij .
There are N =

PI

i=1 ni

total individuals in the study. Let Z = [Z11 , Z12 , ...,, ZInI ]T be the

binary vector of treatment assignments, and let R, rT , and rC be the N × K matrices of
observed responses and potential outcomes under treatment and control. Let Ω be the set
Q
of Ii=1 ni possible values of Z under the given stratification. In randomization inference
for a randomized experiment, randomness is modeled solely through the assignment to
treatment or to control (Fisher, 1935). Quantities dependent on Z, such as the observed
outcomes R, are random, while rT ij , rCij , xij , and uij are fixed across randomizations. Let
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F be the set of such fixed quantities. For a randomized experiment adhering to this design
P(Zij = 1|F, Z ∈ Ω) = 1/ni and P(Z = z|F, Z ∈ Ω) = 1/|Ω|, where |A| denotes the number
of elements in a finite set A.

4.2.2. Randomization Inference and Sensitivity Analysis
For each outcome k, we consider hypotheses of the form Hk : fT k (rT ijk ) = fCk (rCijk ) ∀i, j
for specified functions fT k (·) and fCk (·). For example, Fisher’s sharp null of no effect can be
tested through fT k (rT ijk ) = rT ijk and fCk (rCijk ) = rCijk , and a test of an additive treatment
effect τk can be tested by setting fT k (rT ijk ) = rT ijk and fCk (rCijk ) = rCijk + τk . While
tests for Neyman’s weak null of no average treatment effect cannot be accommodated within
the framework that follows, other choices of fT k (·) and fCk (·) can yield tests allowing for
subject-specific causal effects such as tests of effect modification, dilated treatment effects,
displacement effects, tobit effects, and attributable effects; see Rosenbaum (2002a, Section
5) and Rosenbaum (2010, Sections 2.4-2.5) for an overview.
From our data alone we observe Fijk = fT k (rT ijk )Zij + fCk (rCijk )(1 − Zij ); let Fk =
[F11k , ..., FInI k ] . Under Hk , the vectors fCk = [fCk (rC11k ), ..., fCk (rCInI k )] and fT k =
[fT k (rT 11k ), ..., fT k (rT InI k )] are known to be equal, and hence are entirely specified. Further, they are constant across randomizations as they are known functions of the potential
outcomes. Hence, under the null Fk = fT k = fCk ∈ F, which in turn allows us to use randomization inference to test Hk . Specifically, under Hk and under the stratified experiment
discussed in Section 4.2.1 the null distribution of a test statistic tk (Z, Fk ) can be written as:

P{tk (Z, Fk ) ≥ a|F, Z ∈ Ω; Hk } =

|z ∈ Ω : tk (z, fCk ) ≥ a|
,
|Ω|

(4.1)

where we use fCk in the right-hand side to emphasize that this distribution is known under
the null.
The distribution of tk (Z, Fk ) in (4.1) is appropriate if the observed data truly resulted
from the randomized experiment described in Section 4.2.1. In an observational study
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employing matching, we aim to replicate this idealized randomized experiment by creating
strata wherein individuals are similar on the basis of their observed covariates, xij (Ming
and Rosenbaum, 2000; Hansen, 2004; Stuart, 2010). While this seeks to control for observed
confounders, individuals placed in a given stratum i may be different on the basis of the
unobserved covariate uij . If this uij is influential for the assignment of treatments and the
response, the distribution in (4.1) may yield highly misleading inferences.
We follow the model for a sensitivity analysis discussed in Rosenbaum (2002a, Section 4),
which states that failure to account for unobserved covariates may result in biased treatment
assignments within a stratum. This model can be parameterized by a number Γ = exp(γ) ≥
1 which bounds the extent to which the odds ratio of assignment can vary between two
individuals who are in the same matched stratum. Under this formulation, the probability
of a given allocation of treatment and control within the stratification under consideration
P
can be stated in the form P(Z = z|F, Z ∈ Ω) = exp(γzT u)/ b∈Ω exp(γbT u), where u =
[u11 , u12 , ..., uI,ni ] ∈ [0, 1]N =: U is a vector of unmeasured confounders for the individuals
in the study. Note that Γ = 1 corresponds to the randomization distribution discussed in
Section 4.2.1, while for Γ > 1 the resulting distribution differs from that of a randomized
experiment, with Γ controlling the extent of this departure.
We consider test statistics of the form tk (Z, Fk ) =

PI

i=1

Pni

j=1 Zij qijk ,

where qijk are func-

tions of Fk . Under Hk these values become functions of fCk , and hence are known quantities
fixed across randomizations. Let qk = [q11k , ..., qInI k ], and let qik = [qi1k , ..., qini k ]. Many
commonly employed statistics can be written in this form. For example, suppose we are
testing Fisher’s sharp null, so that Fijk = Rijk , within the block-randomized experiment deP
scribed in Section 4.2.1. Setting qijk = j 0 6=j (Fijk −Fij 0 k )/(I(ni −1)), tk (Z, Fk ) is the mean
over the I matched sets of the average treated-minus-control difference in each matched set
for outcome k. In the case of a matched pairs design, ni = 2 ∀i, this yields the paired
P
permutation t-test. If qijk are the ranks of the aligned response Fijk − nj 0i=1 Fij 0 k /ni from 1
to N , then a test on tk (Z, Fk ) yields the aligned rank test of Hodges and Lehmann (1962).
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To recover Wilcoxon’s signed rank statistic for a matched pairs design, let dik be the ranks
of |Fi1k − Fi2k | from 1 to I, and let qijk = dik 1{Fijk > Fij 0 k }. See Rosenbaum (2002a) for
additional examples and further discussion.
For any given value of Γ ≥ 1, a sensitivity analysis proceeds by finding the allocation of
the unmeasured confounder u∗ which maximizes the p-value for the hypothesis test being
conducted. While not explicitly noted, this worst-case unmeasured confounder can vary
with the value of Γ under investigation. One then finds the smallest value of Γ such that the
conclusions of the study would be altered (i.e., such that the conclusion of the hypothesis
test would change from rejecting to failing to reject the null hypothesis). The more robust
a given study is to unmeasured confounding, the larger the value of Γ must be to alter its
findings. Under mild regularity conditions on qk , the distribution under the null of tk (Z, Fk )
converges to that of a normal random variable as I → ∞ for the worst-case confounder u∗
at any Γ. An example of regularity conditions on the constants qijk is that the Lindeberg
P i
Zij qijk (Lehmann, 2004, Theorem
condition holds for the random variables Bik := nj=1
A.1.1). While the value of Γ itself does not affect the limiting distribution, it does influence
the rate at which this limit is reached as larger values of Γ allow for larger discrepancies
in the assignment probabilities within a matched set. Under asymptotic normality, large
sample bounds on the tail probability can instead be expressed in terms of corresponding
bounds on standardized deviates.
For further discussion of sensitivity analyses, including illustrations and alternate models,
see Cornfield et al. (1959), Marcus (1997), Imbens (2003), Yu and Gastwirth (2005), Wang
and Krieger (2006), Egleston et al. (2009), Hosman et al. (2010), VanderWeele and Arah
(2011), Zubizarreta et al. (2013), Liu et al. (2013) and Ding and Vanderweele (2014).
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4.3. Sensitivity Analysis for Overall Significance
4.3.1. Testing the Overall Null Hypothesis
We begin with notation for the truth of the null hypotheses on all K outcomes; extensions of
notation to dealing with subsets of outcomes, which will in turn facilitate strong familywise
error control for testing individual outcomes, will be made in Section 4.5. There are K
hypotheses, H1 , ..., HK , and we are interested in testing the overall truth of the hypotheses
{H1 , .., HK } while strongly controlling the familywise error rate at level α for a range of Γ.

Ho :

Ha :

K
^
k=1
K
_

Hk
Hkc

k=1

We will refer to a test of Ho as a test of the overall null. Moving forward, we assume each
individual hypothesis Hk has an associated test statistic tk (Z, Fk ) of the form discussed in
Section 4.2.2.

4.3.2. Combining Individual Sensitivity Analyses is Conservative
A simple approach for conducting a sensitivity analysis at a given Γ would be to separately
find the worst-case p-value for each hypothesis test, call it Pk∗ with corresponding allocation
of worst-case confounder u∗k , and suggest through the use of a Bonferroni correction that
at least one hypothesis is false if mink Pk∗ ≤ α/K. This trivially controls familywise error
rate at α as desired; however, as is noted in Rosenbaum and Silber (2009, Section 4.5), this
approach is conservative as the worst-case p-value for hypothesis test k may be found at a
different allocation of the unmeasured confounder as that of hypothesis test k 0 6= k for k, k 0 ∈
{1, ..., K} (i.e., u∗k 6= u∗k0 ). In other words, the biased treatment assignment probabilities
caused by unmeasured confounding that yield the worst-case inference for outcome k and
outcome k 0 need not be the same. This can be better understood in light of the following
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well known minimax inequality (for instance, Karlin, 1992, Lemma 1.3.1)

min

max Pk,u ≥ max

k∈{1,..,K} u∈U

min

u∈U k∈{1,..,K}

Pk,u .

(4.2)

Combining the results of K separate hypothesis tests and Bonferroni correcting corresponds
to the left-hand side of (4.2). Strict inequality is possible in (4.2): it could be the case that
mink maxu∈U Pk > α/K, meaning that we would fail to reject the overall null hypothesis if
we conducted sensitivity analyses separately for each k and then Bonferroni corrected, while
in reality maxu∈U mink Pk ≤ α/K, such that we should have rejected the overall null. This
would occur if for each k there exists a u∗k ∈ U such that Hk is not rejected, yet there does
not exist a single u∗ ∈ U for which all Hk are simultaneously not rejected.
A uniform improvement over combining individual sensitivity analyses could be achieved
by a procedure which directly solved for the right-hand side of (4.2). Such a procedure
cannot be derived by extending existing methods for conducting individual level sensitivity
analyses, as these methods rely upon the fact that the search for a worst-case confounder
can be restricted to vectors in U + or U − for any particular hypothesis k. Unfortunately, it
is not the case that vector u∗ which achieves
maxu∈U mink∈{1,..,K} Pk,u lies within an easily enumerated set of vertices of U; in fact,
the solution need not even lie at a vertex. To exploit this potential improvement, a new
formulation of the required optimization problem that allows for solutions in all of U is thus
required.

4.4. Improving Power through Quadratically Constrained Linear Programming
In this section, we assume the individual level hypotheses Hk have two-sided alternatives;
simple extensions to the one-sided case are discussed in Appendix C.2. Using a normal
approximation, we can equivalently express our problem as minimizing over U the maximal
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squared deviate over the K hypotheses in question:

min

max

u∈U k∈{1,..,K}

(tk − µk,u )2
,
2
σk,u

(4.3)

where tk is the observed value of the statistic tk (Z, Fk ), and µk,u = EΓ,u [ZT qk |F, Z ∈ Ω] and
2
σk,u
= VarΓ,u (ZT qk |F, Z ∈ Ω) are the means and variances of the test statistic tk (Z, Fk )

with a given value of Γ and vector u under the permutation distribution given by (4.1).
Under a normal approximation for tk (Z, Fk ), the squared deviate follows a χ21 distribution.
Hence, a determination of whether or not we can reject at least one null hypothesis can be
made by checking whether or not the solution to (4.3) is greater than or equal to χ21,1−α/K ,
where χ21,1−α/K is the 1 − α/K quantile of a χ21 distribution.
Moving forward, all expectations and variances are taken with respect to the distribution
in (4.1), i.e. under the truth of the null hypothesis Hk for each k, and are conditional on
P
F and Z ∈ Ω; this is omitted for notational ease. Let %ij = exp(γuij )/ nj 0i=1 exp(γuij 0 ) =
P(Zij = 1|F, Z ∈ Ω). Let %i = [%i1 , .., %ini ], and let % = [%11 , .., %InI ]. Note that we can
P
express our test statistics as the sums of stratum-wise contributions, tk (Z, Fk ) = Ii=1 Bik
P i
Zij qijk . The expectation and variance of the contribution from stratum
where Bik := nj=1
i, Bik , can be written as
E[Bik ; %] = %Ti qik
Var(Bik ; %) = %Ti q2ik − (%Ti qik )2 ,

where the simplified form of Var(Bik ; %) comes from the constraint that

Pni

j=1 Zij

= 1 ∀i.

For a given %, we can reject the null hypothesis for a two sided alternative at level α/K if (tk −
P
E[tk (Z, Fk ); %])2 /Var(tk (Z, Fk ); %) ≥ χ21,1−α/K , where E[tk (Z, Fk ); %] = Ii=1 E[Bik ; %], and
P
Var(tk (Z, Fk ); %) = Ii=1 Var(Bik ; %) due to independence between strata. This is equivalent to rejecting if ζk (%) := (tk − E[tk (Z, Fk ); %])2 − χ21,1−α/K Var(tk (Z, Fk ); %) ≥ 0. If we
can determine that ζk (%) ≥ 0 for all feasible values of % at a given value of Γ, we can then
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say that we have rejected the null at level of unmeasured confounding Γ; otherwise, we fail
to reject.
Consider the following optimization problem:

minimize ζk (%)
%ij ,si

subject to

ni
X

(Hk )

%ij = 1 ∀i

j=1

si ≤ %ij ≤ Γsi ∀i, j
%ij ≥ 0 ∀i, j

The variables si stem from an application of a Charnes-Cooper transformation,
P
si = 1/ nj 0i=1 exp(γuij 0 ) (Charnes and Cooper, 1962), and allow us to incorporate the
restrictions on the allowable departure from pure randomization, 1 ≤ exp(γuij ) ≤ Γ ∀i, j,
in terms of the probabilities themselves.
Problem (P2) is a quadratic program, which can be readily solved using a host of free and
commercially available solvers; however, solving this problem merely results in a sensitivity
analysis for a particular hypothesis Hk , rather than one of the overall null ∧Hk . Towards this
end, define ζ(%) = max{ζ1 (%), ..., ζK (%)}. We can now pose our problem as finding min% ζ(%)
subject to constraints on % imposed by Γ. This optimization can be performed through
incorporating an auxiliary variable y and solving the following quadratically constrained
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linear program:

minimize y

(∧Hk )

y,%ij ,si

subject to y ≥ ζk (%) ∀k
ni
X

%ij = 1 ∀i

j=1

si ≤ %ij ≤ Γsi ∀i, j
%ij ≥ 0 ∀i, j

The auxiliary variable y is forced to be larger than ζk (%) for all k, and by minimizing
over y the optimization problem searches for the feasible value of % that allows for y to
become as small as possible, hence minimizing the maximum value as desired. This is a
commonly employed device for solving minimax problems; see, for example, Charalambous
and Conn (1978). To determine whether or not we can reject at least one null hypothesis,
we simply check whether the optimal value y ∗ ≥ 0. If it is, we can reject at least one null
hypothesis; otherwise, we cannot. Quadratically constrained linear programs can be solved
using many available solvers; we provide an implementation using the R interface to Gurobi,
a commercial solver which is freely available for academic use. Henceforth, we will refer to
this procedure for conducting a sensitivity analysis the overall null with K outcomes as the
“minimax” procedure (for minimizing the maximum squared deviate).

4.5. Familywise Error Control for Individual Null Hypotheses
By addressing the right-hand side of (4.2), the minimax procedure provides a sensitivity
analysis for the overall null hypothesis that uniformly dominates combining individual sensitivity analyses. In this section, we discuss how the minimax procedure can be used with
sequential rejection procedures (Goeman and Solari, 2010) which progress through testing
the overall null for a sequence of subsets of outcomes (henceforth referred to as intersection nulls) to provide uniform improvements in power for testing hypotheses on particular
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outcome variables. Sequential rejection procedures of this sort include closed testing (Marcus et al., 1976), hierarchical testing (Meinshausen, 2008), and the inheritance procedure
(Goeman and Finos, 2012). These procedures have appealing properties for conducting a
sensitivity analysis, often allowing researchers to claim improved robustness of a study’s
findings against unmeasured confounding; see Rosenbaum and Silber (2009) for a discussion
of this fact as it relates to closed testing procedures.
We now introduce notation for the class of sequential rejection procedures which can be
used in conjunction with our method, i.e. those for which each step involves testing the
truth of an intersection null hypothesis for a subset of the K outcome variables. There
are L intersection null hypotheses ordered from 1,...,L, the `th of which, Ho` , pertains to
the null hypothesis being true for all outcomes in the subset K` ⊆ {1, ..., K}. That is,
V
Ho` = k∈K` Hk` . |K` | ≤ K is the number of outcomes being tested in the `th subset;
|K` | = 1 then corresponds to a test of a particular outcome. Let H be the set of these L
intersection null hypotheses, H = {Ho1 , ..., HoL }.
Following Goeman and Solari (2010), let Ra ⊆ H be the collection of intersection nulls
rejected after step a of the sequential rejection procedure, and let N (Ra ) be the set of
intersection nulls that can now be rejected in step a + 1 if all elements of Ra have been
rejected by step a. The sequential rejection procedure can then be defined by

R0 = ∅
Ra+1 = Ra ∪ N (Ra ),

and is repeated until convergence (i.e., until Ra+1 = Ra ). Goeman and Solari (2010) show
that sequential rejection procedures strongly control the familywise error rate at α under
the conditions (1) the procedure controls the familywise error at α for the so-called critical
case in which procedure has rejected all of the false overall null hypotheses and none of the
true overall nulls and (2) no false rejections in the critical case implies no false rejections in
situations with fewer rejections than the critical case.
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Closed testing, hierarchical testing, and the inheritance procedure can all be recovered
through specific choices of N (·) that provably adhere to these conditions. Testing the intersection nulls Ho` for any ` at level of unmeasured confounding Γ as required by these
procedures can be performed using the minimax procedure of Section 4.4, which through
inequality (4.2) provides improved power for each subset tested.
To illustrate, suppose one is interested in using a closed testing procedure to conduct a
sensitivity analysis with K = 2 outcomes; this is the procedure used for multiple testing
in our motivating example. In this case, L = 3, K1 = {1, 2}, K2 = {1}, K3 = {2}. The
function N (·) then takes on the following form:

N (∅) =

N (Ho1 ) =




H

o1

if reject H1 ∧ H2 at level α



∅
otherwise




{Ho1 , Ho2 , Ho3 }







{Ho1 , Ho2 }



{Ho1 , Ho3 }







{Ho1 }

if H1 and H2 each reject individually at level α
if only H1 rejects at level α
if only H2 rejects at level α
otherwise,

and N (A) = A if A 6= ∅ and A 6= Ho1 . In this example, the test of Ho1 can be performed
using the minimax procedure with a test that is locally level α; the tests of Ho2 and Ho3 only
involve one outcome and thus can be conducted through the usual methods for a sensitivity
analysis which, by the closure principle, can be performed locally at level α while strongly
controlling the familywise error rate.

4.6. Simulation Study: Gains in Power of a Sensitivity Analysis
4.6.1. Overall Null Hypothesis
Through the minimax procedure, we arrive at a uniform improvement for testing the overall
null relative to combining the results of individual sensitivity analyses. In this section, we
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present a simulation study to demonstrate the potential gains in power for testing the overall
null. In each of 24 simulation settings, we simulate 10,000 data sets with I = 250 pairs and
K = 5 outcome variables of interest. The vector of treated-minus-control paired differences
Di are simulated iid from a multivariate normal with mean vector τ and covariance matrix
Σ. For each outcome, we use an M-statistic of the type favored by Huber (1981), tk (Z, Fk ) =
PI
i=1 ψ(Dik /sk ), to conduct inference, where sk is the median of |Dik | across individuals
i and ψ(y) = sign(y) min(|y|, 2.5). See Maritz (1979) for a discussion of randomization
inference for M -statistics, and see Rosenbaum (2007, 2013, 2014) for various aspects of
sensitivity analyses for M -statistics.
In evaluating these two procedures, we assume as is advocated in Rosenbaum (2004, 2007)
that unbeknownst to the practitioner the paired data at hand truly arose from a stratified
randomized experiment (i.e., Γ = 1). Hence, using a standard randomization test without
assuming unmeasured confounding would provide honest type I error control. The practitioner, blind to this, would like to not only perform inference under the assumption of no
unmeasured confounding, but also assess the robustness of the study’s findings to unobserved
biases of varying severity.
Our 24 simulation settings are the 8 possible combinations of the following mean and covariance vectors, each tested at Γ = 1.25, 1.5 and 1.75:
1. τ (1) = [0.25, 0.25, 0.25, 0.25, 0.25]; τ (2) = [0.25, 0.25, 0.25, 0.25, 0];
τ (3) = [0.3, 0.3, 0, 0, 0]; τ (4) = [0.3, 0, 0, 0, 0]
(2)

(2)

2. Σ(1) = Diag(1); Σij = 1 if i = j, Σij = 0.5 otherwise.
All hypothesis tests are of Fisher’s sharp null, and are conducted with two-sided alternatives
at α = 0.05. Table 6 displays the probabilities of (correctly) rejecting the overall null of
no effect for any of the outcomes. The first column contains the probabilities of rejection
when combining the results of individual sensitivity analyses, while the second contains these
probabilities for the minimax procedure. The relative improvement through the minimax
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Table 6: Power of a sensitivity analysis for the overall null.
Gamma Moments Separate Minimax
τ (1) , Σ(1)
0.94
0.99
τ (1) , Σ(2)
0.77
0.80
(2)
(1)
τ ,Σ
0.89
0.96
(2) , Σ(2)
τ
0.73
0.77
Γ = 1.25
(3)
(1)
τ ,Σ
0.92
0.96
τ (3) , Σ(2)
0.85
0.87
(4)
(1)
τ ,Σ
0.72
0.72
τ (4) , Σ(2)
0.71
0.72
(1)
(1)
τ ,Σ
0.34
0.78
τ (1) , Σ(2)
0.25
0.33
(2)
(1)
τ ,Σ
0.28
0.66
(2) , Σ(2)
τ
0.21
0.28
Γ = 1.5
(3)
(1)
τ ,Σ
0.45
0.65
τ (3) , Σ(2)
0.39
0.45
(4)
(1)
τ ,Σ
0.26
0.26
τ (4) , Σ(2)
0.25
0.25
(1)
(1)
τ ,Σ
0.04
0.36
τ (1) , Σ(2)
0.03
0.06
(2)
(1)
τ ,Σ
0.03
0.23
(2) , Σ(2)
τ
0.03
0.05
Γ = 1.75
(3)
(1)
τ ,Σ
0.09
0.24
τ (3) , Σ(2)
0.09
0.12
(4)
(1)
τ ,Σ
0.05
0.05
τ (4) , Σ(2)
0.04
0.04
procedure can be quite substantial when the paired differences are independent across outcomes (Σ(1) ), while more modest improvements are attained when the paired differences
are positively correlated (Σ(2) ). With positively correlated differences across outcomes, the
worst-case unmeasured confounder for a particular outcome begins to align more closely
with the worst-case unmeasured confounder for the other outcomes, while for independent
paired differences this often is not the case. For both independent and correlated paired
differences, gains are also more substantial when there are 5 or 4 nonzero treatment effects
(τ (1) and τ (2) ) versus 2 larger nonzero effects (τ (3) ), and with only one large nonzero effects
(τ (4) ) the two methods tend to coincide. With fewer nonzero effects, the significance of the
overall null at a given level of unmeasured confounding depends on the pattern of paired
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differences in a small number of outcomes, such that even if the worst-case unmeasured
confounder for an outcome with a nonzero effect actually improves the squared deviate for
an outcome with zero effect it is unlikely to elevate said deviate to a level of significance.
Naturally, the probabilities of rejection decrease as Γ increases for each combination of mean
vector and covariance matrix. We also note that as Γ increases, the gains from using the
minimax procedure also increase . For example, with combination τ (2) , Σ(1) the powers of
the combined approach versus the minimax approach are 0.89 and 0.96 at Γ = 1.25, and are
0.28 versus 0.66 at Γ = 1.5. These simulations indicate that conducting a sensitivity analysis
for the overall null by minimizing the maximum squared deviate allows for substantial and
clinically relevant gains in the power of a sensitivity analysis. Additionally, the computational burden of the required optimization problem was minimal in these simulations: across
all 24 simulation settings, the average computation time on a desktop computer with a 3.40
GHz processor and 16.0 GB RAM was 0.12 seconds.
4.6.2. Individual Hypotheses
As discussed in Section 4.5, the benefits of our procedure extend beyond testing the overall null, and can in fact yield improved power for a sensitivity analysis on hypotheses for
individual outcomes. To illustrate this fact, we present a simulation study assessing the
individual-level power of a sensitivity analysis for each of K = 3 outcomes. We use a closed
testing procedure in order to test hypotheses on individual outcomes. Briefly, the closed
testing principle states that if there are K hypotheses H1 , ..., HK that are of interest, we
can reject any particular hypothesis Hk with familywise error control at α if all intersections
of hypotheses including Hk can be rejected with tests that are individually level α. For
example, with three outcomes we can reject H1 if we can reject H1 ∧ H2 ∧ H3 , H1 ∧ H2 ,
H1 ∧ H3 , and H1 with tests that are locally level α. When combining the results of individual sensitivity analyses, this equates to the Holm-Bonferroni procedure. When using the
minimax procedure for closed testing, one instead solves problem (∧Hk ) for each intersection
hypothesis.
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Gamma

Γ = 1.25

Γ = 1.375

Γ = 1.5

Table 7: Power of closed testing for individual nulls.
Separate
Minimax
Moments H1
H2
H3 ∧Hk H1
H2
H3
τ (1) , Σ(1) 0.27 0.40 0.54 0.74 0.33 0.46 0.60
τ (1) , Σ(2) 0.29 0.40 0.53 0.62 0.31 0.43 0.56
τ (2) , Σ(1) 0.65 0.86 0.96 0.99 0.68 0.88 0.97
τ (2) , Σ(2) 0.65 0.85 0.95 0.97 0.66 0.86 0.96
τ (3) , Σ(1) 0.32 0.59 0.95 0.97 0.35 0.63 0.97
τ (3) , Σ(2) 0.34 0.58 0.94 0.95 0.35 0.60 0.95
τ (4) , Σ(1) 0.09 0.27 0.94 0.95 0.11 0.29 0.95
τ (4) , Σ(2) 0.11 0.27 0.93 0.94 0.11 0.28 0.94
τ (1) , Σ(1) 0.09 0.16 0.27 0.41 0.14 0.22 0.34
τ (1) , Σ(2) 0.11 0.18 0.27 0.35 0.13 0.20 0.30
τ (2) , Σ(1) 0.37 0.63 0.85 0.94 0.42 0.70 0.90
τ (2) , Σ(2) 0.39 0.62 0.84 0.87 0.41 0.65 0.85
τ (3) , Σ(1) 0.12 0.31 0.83 0.87 0.16 0.37 0.88
τ (3) , Σ(2) 0.14 0.32 0.82 0.83 0.16 0.35 0.83
τ (4) , Σ(1) 0.02 0.10 0.81 0.83 0.03 0.12 0.85
τ (4) , Σ(2) 0.03 0.11 0.82 0.82 0.03 0.12 0.82
τ (1) , Σ(1) 0.03 0.06 0.11 0.18 0.05 0.09 0.16
τ (1) , Σ(2) 0.03 0.06 0.12 0.16 0.05 0.08 0.14
τ (2) , Σ(1) 0.16 0.38 0.64 0.77 0.22 0.48 0.76
τ (2) , Σ(2) 0.18 0.38 0.64 0.69 0.20 0.42 0.68
τ (3) , Σ(1) 0.04 0.13 0.62 0.66 0.06 0.18 0.71
τ (3) , Σ(2) 0.04 0.14 0.62 0.63 0.05 0.16 0.64
τ (4) , Σ(1) 0.00 0.03 0.62 0.63 0.01 0.04 0.67
τ (4) , Σ(2) 0.01 0.04 0.62 0.62 0.01 0.04 0.63

∧Hk
0.84
0.65
1.00
0.97
0.99
0.95
0.97
0.94
0.61
0.39
0.99
0.89
0.95
0.84
0.89
0.82
0.36
0.19
0.95
0.74
0.84
0.66
0.73
0.63

In each of 24 simulation settings, we simulate 10,000 data sets under no unmeasured confounding with I = 250 pairs for the three outcome variables of interest and again use Huber’s
M-statistic. For each of the 8 combinations of treatment effects and covariances, closed testing is used to test individual hypotheses, and tests are run at Γ = 1.25, 1.375, and 1.5. We
also include the power for rejecting the overall null for each combination and at each level
of Γ. The values for the treatment effect vector and the covariances were as follows:
1. τ (1) = [0.2, 0.225, 0.25]; τ (2) = [0.25, 0.3, 0.35]; τ (3) = [0.2, 0.25, 0.35];
τ (4) = [0.15, 0.25, 0.35]
(2)

(2)

2. Σ(1) = Diag(1); Σij = 1 if i = j, Σij = 0.5 otherwise.
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Table 13 shows the power for rejecting Fisher’s sharp null for each outcome under four different vectors of true treatment effect values and two different forms of the covariance matrix.
The magnitude of the improvement attained through the minimax procedure can be seen
to depend on many factors. All else equal, as Γ increases the gains in power also increase.
The gains in power tend to be more substantial in the iid cases (Σ(1) ) versus the positively
correlated case (Σ(2) ), as for each intersection hypothesis the minimax procedure tends to
resemble more closely the individual testing approach when there is positive correlation since
the worst-case confounders across outcomes tend to align more closely. For example, with
τ (2) = [0.25, 0.3, 0.35] at Γ = 1.5, the power after combining individual sensitivity analyses
and after using the minimax procedure are [0.16, 0.38, 0.64] versus [0.22, 0.48, 0.76] when
the paired differences are independent across outcomes, yet were [0.18, 0.38, 0.64] versus
[0.20, 0.42, 0.68] when positively correlated. Gains are also most apparent when the treatment effects are of roughly the same magnitude (τ (1) and τ (2) ), while the gains tail off as one
outcome increasingly determines the rejection of the overall null (compare τ (2) , τ (3) , τ (4) ).
Thus, while the gains for testing the overall null hypothesis may be most apparent, the
minimax procedure can provide meaningful improvements for testing nulls on individual
outcomes.
In Appendix C.3, we show that our procedure does provide strong familywise error control
in the presence of true intersection nulls as desired.

4.7. Improved Robustness to Unmeasured Confounding for Elevated Napthalene in
Smokers
4.7.1. Conflicting Desires for the Worst-Case Confounder
To make concrete the factors allowing for the gains discussed in this work, Table 8 show
the values and aligned ranks for loge urinary concentrations of 1-naphthol and 2-naphthol
for two individuals, one smoker and one nonsmoker, who were matched as a pair by the full
match described in Appendix C.1. Both individuals are Hispanic males aged over 50, are
similar in terms of height and weight, and are both exposed to PAHs occupationally, yet the
83

Table 8: Worst-Case Confounders in a Particular Pair at Γ = 10

NS
S

Rij1
6.39
8.54

1-Naphthol
qij1 u∗ij1 E[Ti1 ] Rij2
353
0
1274
8.63
1366
1
7.07
Minimax
u∗
E[Ti1 ]
[0.562, 0]
571

2-Naphthol
qij2
u∗ij2
1350
1
363
0

E[Ti2 ]
1260

E[Ti2 ]
1137

smoker (labeled S) has higher levels of 1-naphthol and lower levels of 2-naphthol.
The tests of both 1-naphthol and 2-naphthol had observed test statistics that were larger
than their expectations under Fisher’s sharp null with Γ = 1. Hence, the individual sensitivity analyses will choose the binary vector of u∗k such that the individual with the larger
observed response is given the value 1, thus having the higher probability of smoking. For
1-naphthol this is the smoker, but for 2-naphthol this is the nonsmoker, as is shown in Table
8. Although we do not know the value of this unmeasured confounder, we do know that logically, the unmeasured confounder cannot simultaneously increase the odds that individual 1
smokes relative to individual 2 and the odds that individual 2 smokes relative to individual
1. Simply combining these two sensitivity analyses would ignore the contradictory values
of u∗k . Table 8 also gives the expectation of the test statistic for the individual outcomes
assessed separately at Γ = 10, a value of Γ for which the minimax procedure rejects the
overall null, but using Holm-Bonferroni to combine sensitivity analyses fails to reject. Conducting sensitivity analyses separately and allowing for an illogical effect of the unmeasured
confounder, the worst-case expectations for the contribution from this matched set to the
test statistics’ expectations are 1274 and 1260 for 1- and 2-naphthol.
Recognizing that the unmeasured confounders must have the same impact on odds of treatment for individuals in a matched set yields markedly different results for the overall sensitivity analysis in this pair, as is demonstrated in the section labeled “Minimax” in Table
8. First, we note that the values of the unmeasured confounder for both individuals are
fractional, an occurrence which is provably impossible when conducting sensitivity analyses
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for any given outcome (Rosenbaum and Krieger, 1990). This makes the probabilities of
assignment to treatment and control much less extreme than they possibly could have been:
conditional on one of the two individuals receiving the treatment, the smoker is given a
probability of exp{log(10)0.391}/(exp{log(10)0.391} + exp{log(10).953}}) = 0.22 of being
a smoker, while at Γ = 10 this probability could have been as low as 1/(1 + 10) and as high
as 10/(1 + 10). In minimizing the maximal deviate, the optimization problem determined
that a compromise should be made between the two conflicting desires of the individual level
sensitivity analysis, but that it should favor making 2-naphthol more significant. Hence, we
see that the contribution to the overall expectation of the two test statistics is larger than
what it would have been at no unmeasured confounding for 2-naphthol (1137 vs 856.5), but
is actually smaller for 1-naphthol (571 vs 859.5).
4.7.2. Sensitivity of Overall and Outcome Specific Effects
As was stated in Section 4.1.2, the conclusions of either of the individual level tests on 1and 2-naphthol were both overturned at Γ = 7.78 when using Holm-Bonferroni. This is also
the maximal level of Γ at which we can claim overall significance of at least one of these
metabolites. The minimax procedure for testing the overall null hypothesis was able to claim
robustness of this same finding up until Γ = 10.22, representing a substantial increase in
robustness. In this application the overall null is of interest, as both naphthalene metabolites
are indicators of naphthalene exposure. Hence, rejecting the overall null implies that we can
suggest that at least one of our indicators of naphthalene exposure is significantly elevated
for smokers relative to nonsmokers, even if we are not able to identify a particular metabolite
that is significant at that level of unmeasured confounding.
To exploit the potential gains in power for individual tests of 1-naphthol and 2-naphthol, we
use a closed testing procedure. In our example, doing so means that if we reject the null H1 ∧
H2 at level 0.05 through our minimax procedure we can then test the individual hypotheses
H1 and H2 at level 0.05 (rather than 0.025) and still maintain the proper familywise error
rate. Since our test of the overall null rejects until Γ = 10.22, the closed testing procedure

85

allows us to perform individual tests up to that level of unmeasured confounding. The
individual tests of 1- and 2-naphthol without a Bonferroni correction (i.e., tested at α = 0.05)
were not overturned until a Γ of 7.83 and 8.20 respectively. As our minimax procedure rejects
the overall null H1 ∧ H2 for all Γ between 7.78 and 8.20, we can declare improved robustness
of the individual level tests. That is, we can reject the null of no effect for 1- and 2-naphthol
at all levels of Γ up to Γ = 7.83 and 8.20, rather than Γ = 7.78.

4.8. Discussion
In a randomized clinical trial, counfounders not accounted for in the trial’s design are, on
average, balanced through randomized assignment of the intervention. As such, there is less
of a concern that the observed results are driven by a causal mechanism other than the one
under investigation. In observational studies, there is no such guarantee of balance on the
unmeasured confounders between the two groups under comparison. When testing for a
causal effect on multiple outcome variables, concerns about a loss of power by controlling
the familywise error rate both under the assumption of no unmeasured confounding and
within the sensitivity analysis may arise. We have demonstrated through this work that
when dealing with multiple comparisons in a sensitivity analysis, the loss in power from
controlling the familywise error rate can be attenuated.
As mentioned in Section 4.5, our method can be used in conjunction with sequential rejection
procedures which proceed by rejecting intersection null hypotheses on a sequence of subsets
of outcomes, {K` }. For certain types of null hypotheses, such as those for the value of an
additive treatment effect with one sided alternatives, our method could also be used while
employing the partitioning principle of familywise error control (Finner and Strassburger,
2002). One deficiency of our method is that it does not account for correlation between
test statistics, which can greatly improve power in the presence of dependence (Westfall and
Young, 1993; Romano and Wolf, 2005). While the simulation studies of Section 4.6 reveal
marked improvements when test statistics are independent, these gains are far more modest
when the test statistics are correlated and further improvements are desired. Deriving
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methods for sensitivity analyses which exploit correlation between test statistics remains
a topic of ongoing research. Another limitation is that our method can only be used for
sensitivity analyses after matching, as the structure of matched sets returned by matching
algorithms allows for a straightforward relationship between the assignment probabilities
and the variances of our test statistics. In unmatched or stratified analyses, while the
logical inconsistencies noted herein are still present, optimizing over the unknown assignment
probabilities can no longer be expressed as a quadratically constrained linear program.
In our motivating example, we argue that if smoking causes increased naphthalene exposure, it would elevate levels of both 1- and 2-naphthol in the body. Though related, these
metabolites are not affected equally by measured and unmeasured confounding variables: for
example, there are certain genetic variants that are only believed to affect the prevalence of
particular naphthalene metabolites (Yang et al., 1999). When focusing on a single outcome
variable, the worst-case confounder is allowed to optimally align itself with the responses
in each matched set through selecting the worst-case allocation of treatment assignment
probabilities. If we are instead trying to disprove the overall truth of null hypotheses on
multiple outcomes, the worst-case confounder likely cannot affect the treatment assignment
probabilities in a way that simultaneously yields the worst-case inference for all outcomes.
Exploiting this fact not only lends higher power to a sensitivity analysis for the overall null
across all outcomes, but also increases power for testing hypotheses on individual outcomes
through the use of certain sequential rejection procedures.
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CHAPTER 5 : Sensitivity Analysis for the Average Treatment Effect in Matched
Observational Studies
Inspired by work of Paul Rosenbaum

5.1. Introduction
In the analysis of observational studies, unease is sometimes expressed with the assumption
of a constant treatment effect for each individual in the study; see, for example, Heckman
et al. (2006) and Rosenbaum (2002c, Discussion and Rejoinder). To address this unease, we
present a new method for conducting a sensitivity analysis for the average treatment effect
in a paired observational study while allowing for heterogeneous individual effects. Through
this work we hope to further facilitate the conducting of sensitivity analyses in the analysis
of observational data, as in many fields the average treatment effect represents the most
common quantification of intervention’s impact (Imbens, 2004).

5.2. A Paired Observational Study
5.2.1. Notation for Paired Experiments and Observational Studies
There are I independent matched pairs. In each of i matched pairs, there is one individual
who receives the treatment, denoted as Zij = 1, and one who receives the control, denoted
as Zij = 0, such that Zi1 +Zi2 = 1 for each i. These matched pairs are formed on the basis of
observed pre-treatment covariates xij , so that xi1 = xi2 for each pair i; however, individuals
may differ on the basis of an unobserved covariate uij , such that ui1 6= ui2 . Each individual
has a potential outcome under treatment, rT ij , and under control, rCij . The fundamental
problem of causal inference is that (rT ij , rCij ) are not jointly observable; rather, we observe
the response Rij = rT ij Zij + rCij (1 − Zij ) for each individual. See Neyman (1923) and
Rubin (1974) for more on the potential outcomes framework.
Let ΩI be the set of 2I possible values of Z under the matched pairs design. In a paired
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randomized experiment, randomness is modeled through the assignment vector; each z ∈ ΩI
has probability 2−I of being selected. Hence, quantities dependent on the assignment vector
such as Z, R are random, whereas FI = {(rT ij , rCij , xij , uij } contains fixed quantities.
For a randomized experiment, πi := P(Zi1 = 1|FI , Z ∈ ΩI ) = 1/2. In an observational
study, it may be the case that πi 6= 1/2 due to differences in ui1 and ui2 for the individuals
in matched pair i of I. As such, the probability of an observed allocation z must instead be
written as:

P(Z = z|FI , Z ∈ ΩI ) =

I
Y

πizi1 (1 − πi )1−zi1

i=1

Without control over the assignment mechanism, the probabilities πi are unknown to the
researcher. Through a sensitivity analysis, one seeks to assess the robustness of a study’s
finding to departures from an idealized paired experiment. A sensitivity analysis places
bounds on the allowable departure from a pure randomized experiment for two individuals
in the same matched pair. We use the model of Rosenbaum (1987), which controls the
allowable departure from a paired randomized experiment through a parameter Γ ≥ 1. In
each matched pair, we bound πi above and below by
1
Γ
≤ πi ≤
.
1+Γ
1+Γ
This model can be derived as a simplification of the model in Rosenbaum (2002a, Section
4) in the case of matched pairs. The sensitivity analysis proceeds by, for a given value of
Γ, finding the worst-case null distribution for the inferential problem at hand. One then
iteratively increases the value of Γ until the null hypothesis can no loner be rejected. This
changepoint Γ then serves as a measure of robustness of the study’s findings to unmeasured
confounding.
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5.3. The Average Treatment Effect
Define ϕi1 = rT i1 − rCi2 and ϕi2 = rT i2 − rCi1 to be the observed paired difference if the
Zi1 = 1 and Zi1 = 0 respectively. The treated minus control difference in pair i that is
actually observed can then be written as:

Yi = Zi1 (ϕi1 ) + (1 − Zi1 )ϕi2

The average treatment effect in a paired experiment or observational study is defined as
2
I X
X
¯ := 1
∆
(rT ij − rCij )
2I
i=1 j=1

=

I
1 X
(ϕi1 + ϕi2 )
2I
i=1

We consider the estimator Ȳ = I −1

PI

i=1 Yi ,

and use it henceforth as a test statistic for

¯ In a purely randomized matched pairs design with πi = 1/2, Ȳ is an
inference on ∆.
¯ (Rosenbaum, 2002a). In an observational study, πi = 1/2 would
unbiased estimator of ∆
¯
represent a specious assumption and Ȳ may well be biased for ∆.
If we were to further assume an additive treatment effect model, rT ij = rCij + τ , then a null
¯ would be sharp, in that it would entirely specify the pairs (rT ij , rCij ) for each
hypothesis on ∆
individual, hence facilitating the use of randomization tests to assess statistical significance
and allowing one to use the methods of Rosenbaum (2007) to conduct a sensitivity analysis
¯ = ∆0 is
for Ȳ . In the absence of an assumption of additivity, a null hypothesis H0 : ∆
composite, in that there are in fact infinitely many allocations for the 2I missing potential
outcomes that satisfy the null in question. We call a set of potential outcomes consistent
with the null in question if the following three conditions hold.
(A1) Consistency with observed data: Zi1 ϕi1 + (1 − Zi1 )ϕi2 = Yi
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(A2) Consistency with additional assumptions made on potential outcomes (for example,
additive treatment effect; nonnegative treatment effect)
(A3) Agreement with the null hypothesis:

PI

i=1 (ϕi1

¯0
+ ϕi2 ) = 2I ∆

The first condition recognizes that we know the true values for half of the potential outcomes
based on the observed data. The second condition means that if the practitioner has made
additional assumptions on the potential outcomes, those assumptions must be satisfied in
the allocations of potential outcomes under consideration. The third condition signifies that
when testing a null hypothesis, we must only consider allocations of potential outcomes
where the corresponding causal parameter takes on the desired value.
¯ 0 ) represent the set of potential outcomes satisfying conditions A1 - A3. As the
Let H(∆
size of a composite null hypothesis test is the supremum of the sizes of the elements of
¯ 0 at level α, we must reject the null for all
the composite null, to reject the null H0 : ∆
¯ 0 ) at level α. As will now be made clear, such a pursuit would be a fool’s
{ϕi1 , ϕi2 } ∈ H(∆
errand without a further restriction on the set of consistent allocations of potential outcomes
over which we aspire towards type I error control.
¯ 0.
Example 1 (Motivating a Further Restriction). Suppose without loss of generality ȳ > ∆
Let mi be the missing paired difference in matched set i, and set mi as

mi =




¯ 0 − ȳ) + I max{|yi |}
(2∆

i ∈ {1, ..., I/2}



¯ 0 − ȳ) − I max{|yi |}
(2∆

i ∈ {I/2 + 1, ..., I}

¯ 0 ). However, for this allocation, under no unmeasured confounding
Clearly, {ϕi1 , ϕi2 } ∈ H(∆
P

PI
I/2
we see that P(Ȳ ≥ ȳ|FI , Z ∈ ΩI ) > P
→ 0.5 as
i=I/2+1 Zi1 |FI , Z ∈ ΩI
i=1 Zi1 >
I → ∞. Furthermore, this probability could be made strictly larger in the corresponding
sensitivity analysis.
This problem plagues not only the analysis of observational studies, but even the analysis
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of randomized experiments through the potential outcomes framework. In contemplating
how to proceed, we now discuss, and subsequently borrow from, the standard procedure for
inference on the average treatment effect in randomized experiments.
5.3.1. Asymptotic Normality and Estimating an Upper Bound on the Variance
¯ 0 ) over which we will
In this section, we describe the subset of the composite null H0 (∆
perform both inference under no unmeasured confounding and a sensitivity analysis. Our
first condition will be fairly benign, while the second will deserve closer consideration. We
initially restrict attention to elements of the composite null for which the estimator Ȳ is
asymptotically normal. One set of conditions given by Hájek and Sĭdák (1967) is as follows.
P
Proposition 1 (Hájek and Sĭdák (1967)). If Ii=1 (ϕi1 − ϕi2 )2 / max (ϕi1 − ϕi2 )2 → ∞ and
1≤i≤I
PI
2
−1
I
i=1 (ϕi1 − ϕi2 ) → η > 0 then

P
PI
d
I
2
I Ȳ → N
i=1 πi (1 − πi )(ϕi1 − ϕi2 )
i=1 (πi ϕi1 + (1 − πi )ϕi2 ),
Assuming these necessary conditions for asymptotic normality does not alleviate the problems raised in the previous section, as the allocation of missing potential outcomes given in
Example 1 satisfies these conditions. Nonetheless, employing asymptotic normality when
conducting inference does lead to a natural additional condition to impose to make the
problem tractable. Under a normal approximation and assuming no unmeasured confound¯ 0 ) only differs due to their
ing, the distribution of Ȳ generated by different elements H(∆
effect on the variance of Ȳ . When using the potential outcomes framework in randomized
experiments, randomization inference for the average treatment effect typically proceeds by
finding a consistent estimator of an upper bound on the variance of the estimated ATE, and
using that variance to conduct inference under a normal approximation; see Neyman (1923)
and Ding (2014) among many. Might a similar approach be employed in the analysis of the
average treatment effect in observational studies?
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Under a matched pairs design, the variance of the average treatment effect is given by:

var(Ȳ |FI , Z ∈ ΩI ) = I −2

I
X

πi (1 − πi )(ϕi1 − ϕi2 )2

i=1

This variance is unknown not only due to the unobserved potential outcomes, but also
due to the fact that the in an observational study, the values of {πi } are unknown to the
researcher. Nonetheless, we now demonstrate that for a given maximal allowable departure
from a matched pairs design Γ, one can similarly upper bound the variance in a sensitivity
analysis.
¯ =∆
¯ 0 , and consider the estimator V̄¯Γ := 2Γ/(1 +
Suppose we are testing the null that ∆
P
¯ 0 )2 + (1 − Zi1 )(ϕi2 − ∆
¯ 0 )2 ).
Γ) Ii=1 (Zi1 (ϕi1 − ∆
Proposition 2.
E[V̄¯Γ |FI , Z ∈ ΩI ] ≥ I 2 var(Ȳ |FI , Z ∈ ΩI )

Proof.
E[V̄¯Γ |FI , Z ∈ ΩI ] = 2Γ/(1 + Γ)

I
X

¯ 0 )2 + (1 − πi )(ϕi2 − ∆
¯ 0 )2 )
(πi (ϕi1 − ∆

i=1

≥2

≥

=

I
X

¯ 0 )2 + (ϕi2 − ∆
¯ 0 )2 )
πi (1 − πi )((ϕi1 − ∆

i=1
I
X

¯ 0 )2 + (ϕi2 − ∆
¯ 0 )2 − 2(ϕi1 − ∆
¯ 0 )(ϕi2 − ∆
¯ 0)
πi (1 − πi )((ϕi1 − ∆

i=1
I
X

πi (1 − πi )(ϕi1 − ϕi2 )2 = I 2 var(Ȳ |FI , Z ∈ ΩI )

i=1

Let v̄¯Γ denote the observed value of the random variable V̄¯Γ . Moving forward, we proceed
with inference for the composite null containing potential outcomes such that the following
three conditions hold:
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¯ 0)
1. {ϕi1 , ϕi2 } ∈ H0 (∆
2.

PI

i=1 πi (1

− πi )(ϕi1 − ϕi2 )2 ≤ v̄¯Γ

3. Ȳ is asymptotically normal.

5.4. Sensitivity Analysis for the Average Treatment Effect
Without loss of generality, suppose the our estimate of the average treatment effect exceeds
¯ 0 . Further, assume for notational convenience that
its null expectation at Γ = 1, i.e. ȳ > ∆
in each pair the first individual received the treatment so Zi1 = 1 ∀i. Hence, ϕi1 is known
and ϕi2 is unknown.
Employing a normal approximation for the average treatment effect, consider the following
optimization problem

PI
minimize
{πi ,ϕi2 }

subject to

ϕi1
i=1
q

−

PI

i=1 (πi ϕi1

+ (1 − πi )ϕi2 )

(P1)

PI

I
X
i=1
I
X

2
i=1 πi (1 − πi )(ϕi1 − ϕi2 )

¯0
ϕi1 + ϕi2 = 2I ∆
πi (1 − πi )(ϕi1 − ϕi2 )2 ≤ v̄¯Γ

i=1

1
Γ
≤ πi ≤
1+Γ
1+Γ

Problem (P1) encodes the desired sensitivity analysis at level of unmeasured confounding
Γ, as under the normal approximation minimizing the standardized deviate is equivalent to
maximizing the p-value for the performed hypothesis test. Unfortunately, the above problem
is not convex. We will now take steps to facilitate its computation.
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We begin by, through the following lemma, simplifying the optimization problem with respect to the unknown {πi }
Lemma 1. Suppose 1/(1 + Γ) ≤ πi ≤ Γ/(1 + Γ) ∀i. Then, P(Ȳ ≥ ȳ) ≤ P(I −1

PI

i=1 Ỹi

≥ ȳ),

iid

where Ỹ = Z̃i max{ϕi2 , ϕi1 } + (1 − Z̃i ) min{ϕi2 , ϕi1 }, and Z̃i ∼ Bern(Γ/(1 + Γ)).
Proof. For any πi ∈ [1/(1 + Γ), Γ/(1 + Γ)], P(Yi = max{ϕi2 , ϕi1 }) ≤ P(Ỹi = max{ϕi2 , ϕi1 }).
As Yi and Ỹi only take on the values min{ϕi2 , ϕi1 } and max{ϕi2 , ϕi1 }, Ỹi is stochastically
larger than Yi . The result then follows from preservation of stochastic ordering under independent convolutions.

For any fixed values of {ϕi1 , ϕi2 }, the worst-case unmeasured confounder would thus attribute πi =

Γ
1+Γ

if ϕi1 ≥ ϕi2 , and πi =

1
1+Γ

otherwise. This suggests that instead of

optimizing over πi ∈ [1/(1 + Γ), Γ/(1 + Γ)] we can express πi as a function of ϕi1 and ϕi2 ,
πi (ϕi1 , ϕi2 ) = wi /(1 + Γ) + (1 − wi )Γ/(1 + Γ), where wi = 1{ϕi2 ≥ ϕi1 }. Before proceeding
as such, we need to ensure that for any allocation of potential outcomes and true treatment assignment probabilities satisfying the constraints of Problem (P1), the corresponding
worst-case allocation also satisfies the above constraints. This is indeed true, as the following
trivial lemma indicates:
Lemma 2. For any {πi } ∈ [1/(1 + Γ), Γ/(1 + Γ)]I :
I
X

πi (1 − πi )(ϕi1 − ϕi2 )2 ≥

I
X
Γ
(ϕi1 − ϕi2 )2
(1 + Γ)2
i=1

i=1

Hence, for any allocation of {πi , ϕi1 , ϕi2 } with a variance for the estimated average treatment
effect that is less than or equal to the variance upper bound, the worst-case distribution based
upon {ϕi1 , ϕi2 } has a variance that is also less than or equal to the variance upper bound.
Lemmas 1 and 2 allows us to consider the following simplified optimization problem:
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PI
minimize
{πi ,ϕi2 }

I
X

subject to

PI

i=1 (πi ϕi1 + (1 − πi )ϕi2 )
PI
Γ
2
i=1 (ϕi1 − ϕi2 )
(1+Γ)2

i1
i=1 ϕ
q

−

(P2)

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X
Γ
(ϕi1 − ϕi2 )2 ≤ v̄¯Γ
(1 + Γ)2
i=1

πi = wi /(1 + Γ) + (1 − wi )Γ/(1 + Γ)
wi = 1{ϕi2 ≥ ϕi1 }

The above problem could be formulated as an integer program through the use of a “BigM" formulation, as is discussed in Section 5.5; however, such formulations have notoriously
weak continuous relaxations and can thus be very slow in practice for even moderately sized
problems (Bertsimas and Tsitsiklis, 1997). Fortunately, such an approach is not necessary. In
fact, as we now demonstrate, a solution to problem (P1) can be attained in O(I) operations.
5.4.1. A Linear Time Algorithm
To proceed, define Cs+ and Cs− , s ∈ {1, ..., I − 1}, as
Cs+

=

¯0 − 2
2I ∆

PI

i=1 ϕi1

s

s
4
Cs−

=

PI

¯
i=1 (∆0 −

ϕi1 ) I−s
s

− Cs− (I − s)

−2

I−s
s



2I


P
2 
(1+Γ)2 ¯
I
¯
I Γ v̄Γ − 4
i=1 (∆0 − ϕi1 )
I−s
s



2
Furthermore, define µ0 , µ1 , ..., µI−1 and ν02 , ν12 , ..., νI−1
as:
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µ0 =






2
1+Γ

PI

i=1 (ϕi1

¯ 0)
−∆



−∞

P
Γ
−1 ( I (∆
¯0
4I
2
i=1
(1+Γ)

− ϕi1 ))2 ≤ v̄¯

,

otherwise

ν02 =

I
X
Γ
−1
¯ 0 − ϕi1 ))2
4I
(
(∆
(1 + Γ)2
i=1

and, for s ∈ {1, ..., I − 1},

µs =

I
X

ϕi1 +

i=1

ΓCs+
Cs−
s+
(I − s)
1+Γ
1+Γ

νs2 = v̄¯

Finally, define the deviate a as:

a :=

Theorem 2. Suppose that

PI

i=1 (ϕi1

I ȳ − µs
νs
s∈{0,...,I−1}
min

− ϕi2 )2 / max (ϕi1 − ϕi2 )2 → ∞ and I −1
1≤i≤I

PI

i=1 (ϕi1

−

ϕi2 )2 → η > 0. Consider conditional probabilities of receiving the treatment 1/(1 + Γ) ≤
πi ≤ Γ/(1 + Γ) for each matched pair. Then, for any allocation of potential outcomes such
¯ 0 ) and (b) PI πi (1 − πi )(ϕi1 − ϕi2 )2 ≤ v̄¯:
that (a) {ϕi1 , ϕi2 } ∈ H0 (∆
i=1

lim P(Ȳ ≥ ȳ|FI , Z ∈ ΩI ) ≤ 1 − Φ(a),

I→∞

where Φ(·) is the standard normal CDF. That is, the deviate a is the solution to Problem
(P1).
97

The proof is deferred to Appendix D.1. This algorithm is similar in spirit to the one presented
in Rosenbaum (2002b) for conducting a sensitivity analysis for the attributable effect, in
that a seemingly complicated optimization problem over a composite null hypothesis can be
reduced to a small number of simple evaluations.

5.5. Known Direction of Effect
Oftentimes it is reasonable to assume that while a treatment may have heterogeneous effects
from one individual to the next, the direction of the effect lies in the same direction for all
individuals. Without loss of generality, we will proceed assuming the treatment effect is
nonnegative for each individual, i.e. that rT ij ≥ rCij ∀i, j. This restriction can be added to
Problem (P2) as follows:

PI
minimize
{πi ,ϕi2 }

subject to

i1
i=1 ϕ
q

−

PI

Γ
(1+Γ)2

I
X

i=1 (πi ϕi1 + (1 − πi )ϕi2 )
PI
2
i=1 (ϕi1 − ϕi2 )

(P3)

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X
Γ
(ϕi1 − ϕi2 )2 = v̄¯Γ
(1 + Γ)2
i=1

πi = wi /(1 + Γ) + (1 − wi )Γ/(1 + Γ)
wi = 1{ϕi2 ≥ ϕi1 }
ϕi2 ≥ −ϕi1

An area of ongoing research is to seek a computationally scalable manner for solving Problem
(P3). We can find the worst-case expectation for the estimated average treatment effect by
solving the following integer program.
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I

I

i=1

i=1

X
Γ X
maximize
ϕi1 +
−
1+Γ
{wi ,x+
i ,xi }
subject to

I
X



1
Γ
Γ−1
x−
x+
ϕi1 wi
i +
i −
1+Γ
1+Γ
1+Γ


(P4)

+
¯
ϕi1 + x−
i + xi = 2I ∆0

i=1

− (1 − wi )ϕi1 ≤ x−
i ≤ (1 − wi )ϕi1
¯
wi ϕi1 ≤ x+
i ≤ wi (2I ∆0 − ϕi1 )
I
X
Γ
+ 2
¯
(ϕi1 − x−
i − xi ) ≤ v̄Γ
(1 + Γ)2
i=1

wi ∈ {0, 1} ∀i
−
x+
i + xi ≥ −ϕi1 ∀i

A conservative approach to finding the worst-case deviate would then be to simply use the
¯
variance upper bound to create, denoting the solution of Problem (P4) by µ̄
¯
I ȳ − µ̄
.
a= √
v̄¯Γ

¯ = 0. In the case of
One instance in which this is provably conservative is under the null ∆
a nonnegative treatment effect, the only allocation of potential outcomes satisfying this null
is that under Fisher’s sharp null of no effect. Hence, the standard sensitivity analysis for
¯ = 0.
Fisher’s sharp null then yields a valid sensitivity analysis for the null of ∆

5.6. Bigger Effect for Individuals More Likely to Receive Treatment
One particular case of heterogeneity often considered in economics as an argument against
assuming an additive treatment effect is known as “essential heterogeneity," wherein individuals who will benefit more from a given treatment are more likely to decide to take said
treatment (Heckman et al., 2006). In the context of a paired observational study, this restriction could be written in the form πi − (1 − πi ) ≥ 0 ⇔ (rT i1 − rCi1 ) ≥ (rT i2 − rCi2 ). One
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might think that such a consideration would impose a further constraint on a sensitivity
analysis; however, the following proposition demonstrates, this turns out not to be the case.
Proposition 3. The solutions to Problem (P1) under no assumption on the direction of
effect and to Problem (P3) under a known direction of effects are also solutions under the
constraint that the individual in a matched pair with the higher treatment effect has the higher
probability of receiving the treatment

Proof. We begin without assuming a known direction of effect. The solution returns worstcase ϕi2 = rT i2 − rCi1 . The values of rT i1 and rCi2 are fixed. Suppose πi = Γ/(1 + Γ) (the
proof for πi = 1/(1 + Γ) is analogous). To make it the case that rT i1 − rCi1 ≥ rT i2 − rCi2 , set
rT i2 = c + ϕi2 , set rCi1 = c, and simply solve for the c such that the two treatment effects
are equal. Doing so, we have rT i1 − c = c + ϕi2 − rCi2 ⇒ c = (rT i1 + rCi2 − ϕi2 )/2. For any
c0 < c, rT i1 − rCi1 ≥ rT i2 − rCi2 as desired.
Under the assumption of non-negativity, we know that for any solution to Problem (P3)
ϕi1 + ϕi2 ≥ 0. Equivalently, this implies that rT i1 − rCi1 + rT i2 − rCi2 ≥ 0. Suppose that
πi = Γ/(1 + Γ) (the proof for πi = 1/(1 + Γ) is analogous). Then, setting rT i2 = rCi2 and
rT i1 − rCi1 = ϕi1 + ϕi2 satisfies the constraint imposed by essential heterogeneity.

Hence, we can interpret the methods for a sensitivity analysis developed in the previous
section as encompassing this particular form of heterogeneity.

5.7. Simulation: The Impact of Assumptions on Sensitivity to Unmeasured Confounding
In this section, we assess the power of a sensitivity analysis for the average treatment effect
under the assumptions of additivity, nonnegative treatment effects, and no known direction
of effect. We borrow the simulation setting of Rosenbaum (2005), which sought to assess
the role of heterogeneity reduction in reducing sensitivity to unmeasured confounding under
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an additive treatment effect model. In this simulation study, we hope to not only compare
sensitivity analyses for the average treatment effects under assumptions of varying strength
on the potential outcomes, but also to assess the role of heterogeneity reduction in reducing sensitivity to unmeasured confounding when an additive treatment effect model is not
assumed.
In evaluating these assumptions, our simulation study assumes as is advocated in Rosenbaum
(2004, 2007) that unbeknownst to the practitioner the paired data at hand truly arose from
a paired randomized experiment (i.e., Γ = 1). The practitioner, blind to this, would like to
not only perform inference under the assumption of no unmeasured confounding, but also
assess the robustness of the study’s findings to unmeasured confounding.
In the first simulation setting, called larger, more heterogeneous (LM), we draw, in each iteriid

ation, I = 400 paired differences Yi with Yi ∼ N (1/2, 1). In the second, called smaller, less
iid

heterogeneous (SL), we draw I = 100 paired differences with Yi ∼ N (1/2, (1/2)2 ). In both
LM and SL, the estimated average treatment effect Ȳ , is distributed as Ȳ ∼ N (1/2, 1/400);
the settings differ only in the heterogeneity of the observed paired differences.
In each setting, we simulate 1000 data sets. We then perform a sensitivity analysis for a
¯0 = 0
range of Γ, and assess the probability of correctly rejecting the null hypothesis of (a) ∆
¯ 0 = 0.1.
and (b) ∆
The results are shown in Figure 4. We first compare within the LM and SL settings. We note
that for both null hypotheses in question, the sensitivity analysis for the average treatment
effect without assumptions on the potential outcomes is less powerful than that performed
under both an additive treatment effect model and a nonnegative treatment effect model.
¯ 0 = 0, we see that the additive treatment effect model and the nonnegative
For the null ∆
treatment effect model coincide, as here the null of zero average treatment effect under a
nonnegative treatment effect model implies that Fisher’s sharp null holds. When the null
¯ 0 = 0.1, we see that the sensitivity analysis assuming an additive treatment
in question is ∆
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effect model is more powerful than that assuming a nonnegative treatment effect, which is
in turn more powerful than that without an assumption of a known direction of effect.
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Figure 4: Power of a Sensitivity Analysis for the Average Treatment Effect. This figure shows
the power for a sensitivity analysis as a function of Γ for testing null hypotheses on average treatment effect under additivity, a nonnegative treatment effect, and without further assumptions under
scenarios LM and SL.

Now looking between the LM and SL settings, we note that setting SL yields a more powerful
sensitivity analysis than LM for all three sets of assumptions on the potential outcomes;
however, it appears as though the differences are most drastic under the assumption of
additivity, and less so under the other two assumptions. Nonetheless, this settings lends
further support to the importance of matching in observational studies as a means of reducing
heterogeneity.

5.8. Discussion
In this work, we develop methods for conducting a sensitivity analysis for the average treatment effect with and without assuming a known direction of effect. This work indicates
that not assuming additivity weakens the power of a sensitivity analysis to unmeasured confounding, which is consistent with the findings in Chapter 3 of this dissertation with respect
to sensitivity analyses for the risk difference. These results should, by no means, be viewed
as an indictment of additivity as a useful model for treatment effects. For example, even if
102

the overall assumption of additivity were to fail due to the presence of effect modification, it
may be plausible for individuals within a given subgroup defined by the effect modifiers. In
this case, Hsu et al. (2013, 2015) present methods for both discovering effect modification
and subsequently testing for additivity within subgroups defined by the effect modifiers.
Furthermore, Rosenbaum (2002c, Rejoinder, Section 3) notes that randomization inference
assuming an additive treatment effect model is also the only non-parametric inference under
the assumption that the marginal distributions of treatment and control potential outcomes
adhere to an additive shift model for fixed values of the covariates. It is our belief that rather
than supplanting the model of additivity, analyses with and without said assumption should
be presented jointly as a means of further elucidating evidence for the strength of a given
causal effect. As noted inRosenbaum (2002c, Rejoinder, Section 6), even if one is not certain
that an additive treatment effect holds, confidence intervals for an additive treatment effect
can nonetheless illustrate which additive effects are not plausible.
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CHAPTER 6 : Discussion
One immediate area for future research is an extension of the work in Chapter 4 of the
dissertation to methods for multiple comparisons which utilize sums of test statistics rather
than the maxima of test statistics, and is joint work with Matt Olson and Dylan Small.
Borrowing notation from Chapter 4 of this dissertation, and letting µ(%) and Σ(%) be the
mean vector and covariance matrix for the test statistics, we seek to solve the following
problem:

min max

%ij ,si

2
λT (t − µ(%))
λT Σ(%)λ

λk

subject to

ni
X

%ij = 1 ∀i

j=1

%ij ≥ 0 ∀i, j
si ≤ %ij ≤ Γsi ∀i, j
||λ|| ≤ 1

Additional constraints on λ (say, λk ≥ 0) can yield a one-sided test. We have demonstrated
that, utilizing a projected subgradient descent algorithm, the above problem can be solved
expeditiously. This procedure yields improved power in finite samples in the presence of
strongly correlated outcome variables, and can be shown to, asymptotically, have higher
design sensitivity for the test of the overall null than the procedure presented in Chapter 4.
More generally, in the next few years I hope to assess the extent to which clever applications of optimization routines can help quantify the relative merits of various approaches
for the design and analysis of observational studies. Much advice on research designs and
strategies for judging causality exists outside of statistics; however, as noted in Rosenbaum
(2004), such advice is not always explicitly tied to tangible benefits for the resulting analysis.
Rosenbaum (2004) discusses how exhibiting multiple operationalism and dose-response rela-
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tionships yields enhanced robustness against unmeasured confounding as measured by both
design sensitivities and the power of the resulting sensitivity analysis. Yet another example
of a strategy yielding a quantifiable benefit is the use of “control” outcomes, i.e. outcomes
known to be unaffected by the treatment (in the sense described in Rosenbaum (2002a,
Section 6) that a purported significant treatment effect on the control outcome would make
us question the study’s design more strongly than our belief in the absence of an effect). In
Rosenbaum (1992), it is demonstrated that through convex optimization control outcomes
can be used to confidently eliminate certain types of unmeasured confounding. This has
potential to strengthen the evidence in favor of a proposed causal mechanism, as the search
for the worst-case unmeasured confounder is now limited to those which do not yield a significant result for the control outcome. This strategy can be made actionable through the
formulation presented in Chapter 4, as it merely requires an additional quadratic constraint
in the optimization problem. I hope to explore the extent to which known directions of effect and known directions of bias can also be exploited in this manner, hence furthering the
connection between qualitative advice and quantitative improvement for causal inference in
matched observational studies.
This thesis has investigated the role of modern optimization in the design and analysis
of observational studies. Several of the methods presented herein require the solution of
integer programs, which are N P-hard in general. Owing to this, many of these proposed
methods (and with them, certain chapters of this dissertation) may have been eschewed
by statisticians on the grounds of practicability in the past. Through my work, I have
come to the conclusion that these perceptions of old must be revisited and revised. In
fact, over the past 25 years, a combination of algorithmic advances and improvements in
computing power have yielded an astounding 200 billion factor speedup in solving Mixed
Integer Optimization problems (Bertsimas et al., 2016). This is not to say that one should
be contented with any integer programming formulation, as not all formulations are created
equal. As is demonstrated in this dissertation, thinking critically about the strength of the
derived formulation remains essential to expeditiously attaining a globally optimal solution.
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Rather, paraphrasing a conversation I once had with Andreas Buja, we cannot allow the
perceived computational constraints of the present day to overly restrict the imagination.
What seems infeasible today may be feasible tomorrow, or even today if we are clever enough
about it.
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APPENDIX A
A.1. Summary Statistics and Percentages Missing for Covariates Used in Matching
In Table 9, we list the means and standard deviations for our non-binary covariates. Table
10 gives the percentages of ones for the binary covariates. Table 11 lists the percentages of
missing values for the 13 covariates with missing data. All tables provide summaries within
the ICU and hospital ward group before matching, both in our original population and in
our study population defined through the solution to the maximal box problem described
in Section 2.4.3.
Table 9: Means and Standard Deviations for Non-Binary Covariates Before Matching, Original Population and Study Population. The column “Tier” corresponds to the tier of importance of a given covariate as it relates to (1) the decision to admit to the hospital ward or
the ICU and (2) an individual’s 60 day mortality rate, as assessed by expert consultation.
The next two columns are the covariate means (standard deviations) in the initial study
population, and the last two columns are the covariate means (standard deviations) in the
study population defined in Section 2.4.3.
Covariate

Tier

Age

1

Charlson comorbity index

1

Initial serum lactate

1

APACHE II score

1

Maximal heart rate/min

2

Maximal temperature (◦ F)

2

Maximal resp. rate/min

2

White blood cell count

2

Lowest systolic bp, mm Hg

2

Year of study (5-9)

2

Original Population
ICU
Ward
60.1
55.1
(17.4)
(18.4)
2.52
2.41
(2.81)
(2.64)
4.26
2.56
(2.98)
(1.23)
17.7
13.6
(6.37)
(5.27)
120
114
(23.6)
(17.8)
99.8
100.8
(2.97)
(2.01)
28.2
23.0
(9.03)
(5.77)
14.9
13.0
(10.7)
(9.36)
103.2
107.3
(23.0)
(21.3)
6.73
6.98
(1.38)
(1.37)
107

Study Population
ICU
Ward
60.56
55.88
(17.1)
(18.3)
2.43
2.48
(2.70)
(2.65)
3.22
2.61
(1.24)
(0.956)
16.9
13.8
(5.46)
(4.73)
120
115
(23.0)
(17.8)
100.0
100.8
(2.90)
(2.00)
27.9
23.2
(8.98)
(5.90)
14.9
13.0
(10.5)
(8.34)
103.4
108.0
(23.1)
(21.3)
6.65
7.00
(1.38)
(1.36)

Table 10: Percentages for Binary Covariates Before Matching, Original Population and
Study Population. The column “Tier” corresponds to the tier of importance of a given
covariate as it relates to (1) the decision to admit to the hospital ward or the ICU and (2)
an individual’s 60 day mortality rate, as assessed by expert consultation. “Exact” means that
we matched exactly on that covariate. The next two columns are the percentages of ones
for the covariates in the initial study population, and the last two columns are percentages
of ones for the covariates in the study population defined in Section 2.4.3. Abbreviations:
DNR = Do Not Resuscitate; CAD = Coronary artery disease; CHF = Congestive heart
failure; COPD = Chronic obstructive pulmonary disease; ESRD = End stage renal disease.
Covariate
Female
Oncology
Transplant
Acute kidney infection
DNR order
Hypotension
Gastrointestinal infection
Urinary infection
Cellulitis
Bacteremia
Respiratory infection
CAD
CHF
COPD
Chronic liver disease
Chronic renal disease
Diabetes
ESRD
HIV
Hypertension
Cryptic septic shock

Tier
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
Exact

Original Population
ICU
Ward
56%
53%
28%
35%
10%
10%
27%
15%
4.3%
3.3%
32%
23%
12%
12%
20%
26%
8.3%
13%
22%
35%
61%
68%
11%
10%
12%
8.6%
8.3%
5.9%
5.2%
3.2%
15%
13%
21%
20%
7.9%
7.9%
4.7%
3.2%
48%
42%
44%
10%
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Study Population
ICU
Ward
55%
54%
28%
36%
12%
10%
25%
15%
4.0%
3.0%
32%
22%
11%
12%
21%
26%
9.0%
13%
25%
31%
63%
68%
11%
10%
13%
8.2%
8.4%
5.8%
3.9%
3.1%
15%
13%
22%
20%
8.5%
8.0%
3.9%
3.6%
50%
42%
31%
9.0%

Table 11: Percentages of Missing Values, Original Population and Study Population. The
column “Tier” corresponds to the tier of importance of a given covariate as it relates to
(1) the decision to admit to the hospital ward or the ICU and (2) an individual’s 60 day
mortality rate, as assessed by expert consultation. The next two columns are the percentage
missing in the initial study population, and the last two columns are the percentage missing
in the study population defined in Section 2.4.3. Any covariate not listed here did not have
missing values. Abbreviations: CAD = Coronary artery disease; CHF = Congestive heart
failure; ESRD = End stage renal disease.
Covariate
Maximal heart rate/min
Maximal temperature (◦ F)
Maximal resp. rate/min
White blood cell count
Lowest systolic bp, mm Hg
Bacteremia
Respiratory infection
CAD
CHF
ESRD

Tier
2
2
2
2
2
2
2
3
3
3

Original Population
ICU
Ward
0.3%
0%
1.0%
0.7%
0.4%
0.2%
0%
0.1%
0.4%
0%
51%
58%
37%
47%
1.3%
0.8%
1.2%
0.7%
0.1%
0%
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Study Population
ICU
Ward
0.2%
0
0.6%
0.9%
0.2%
0.3%
0%
0.1%
0.2%
0%
49%
59%
34%
47%
1.4%
0.7%
0.8%
0.7%
0.2%
0%

A.2. Interpolation Overlap in High Dimensions
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Figure 5: Proportion of individuals identified by the method of King and Zeng (2006) as lying
within the area of common support as a function of covariate dimension.

To assess how attainable the interpolation overlap criterion of King and Zeng (2006) is
in moderate and high dimensions we conducted a simulation study wherein treated and
control individuals were truly drawn from the same multivariate distribution of increasing
dimension. There were 15 simulation settings, corresponding to a covariate dimension of 1 up
to 15. In the pth simulation setting and for each of 1000 iterations within the pth setting, we
drew 1500 individuals from a p dimensional multivariate normal with a common mean and
covariance matrix. After randomly assigning 750 individuals each to the treatment group
and the control group, we recorded the proportion of individuals that the method of King
and Zeng (2006) designated as lying within the area of interpolation overlap. For each p, we
calculated the average of these proportions across iterations. The results are shown in Figure
5. As the figure displays, large percentages are identified as having counterfactuals which are
estimable through interpolation in low dimensions, an occurrence one would expect since the
covariates of the treated and control groups have the same joint distribution. Unfortunately,
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one sees a marked decrease in the percentage of individuals lying in the area of interpolation
overlap for even a moderate number of covariates despite the fact that the treated and control
units are drawn from the same joint distribution. By p = 15, under 2% of individuals are
identified as lying in the area of common support.

A.3. An Extension of the Maximal Box Problem
We now present a generalization of the maximal box problem proposed in Eckstein et al.
(2002) and discussed in Section 2.4. Suppose one has a finite collection of vectors {xj }, j =
1, ..., N, that can be partitioned into two disjoint sets of “positive” points, X + and “negative” points, X − . The generalized maximal box problem aims to find the lower and upper
boundaries of a box, [˜`, ũ], such that the corresponding box contains the maximal number
of points in X + while containing a fixed number C of the points in X − . Explicitly, [˜`, ũ] is
the arg max of the following optimization problem (GMB, for generalized maximal box):

maximize |[`, u] ∩ X + |

(GMB)

subject to |[`, u] ∩ X − | = C,

where the notation |A| denotes how many points are in set A, and C ∈ {0, 1, ..., |X − |}
Additional discussion of the value C is warranted. C controls how many times the maximal
box is allowed to include a point which was designated to lie outside of the area of covariate
overlap based on the exclusion function D(xj , X, Z). Larger values of C will allow for
maximal boxes that include a larger number of individuals deemed as being viable, but at
the risk of including individuals for whom inference corresponds to an extrapolation of the
form described in King and Zeng (2006). If one believes with absolute certainty that the
elements of X + are the only individuals within the area of viable covariate overlap, then
allowing for C > 0 would result in extrapolation and C should be set to 0. Perhaps more
pragmatically, if the rule used for designating a positive point is merely a means towards
an end (namely, a means towards arriving at a study population wherein balance can be
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attained on all covariates while overlap is present for important covariates), it is possible
that allowing a small but nonzero value for C may be sensible, particularly if the maximal
box returned with C = 0 only contains a small number of individuals. The binary nature
of D(xj , X, Z) is such that individuals who are designated as falling outside the area of
common support may, in fact, be close to many viable individuals based on those most
important covariates used to construct the maximal box. By allowing C > 0, one might still
be able to arrive at a matching with good balance while increasing the sample size in the
study population used for further analysis. Using a non-zero value of C could be thought
of as recognizing that the designation of whether or not a point is inside the area of viable
support will be based on guidelines which are sensible and theoretically motivated yet are
not incontrovertible; see Hill et al. (2011) for further discussion of this.

A.4. Defining a Study Population through the Maximal Box Problem
In Section 2.4.3, the process of arriving at the study population used for further analysis
is described in detail. Therein, we note that we designate points for exclusion from the
resulting study population based on a propensity score fit on our four tier 1 covariates. As
we demonstrate in Figure 1, this study population resulted in covariate overlap with respect
to our most important covariates. Furthermore, this strategy resulted in a study population
wherein balance could be attained on all of the covariates upon which we matched.
An alternative strategy would be to use the propensity score model fit on all covariates to
designate whether or not a point should be excluded from the analysis while still defining
the maximal box in terms of the most important covariates. When this was done with our
data set, only 149 individuals (80 treated individuals, 69 control individuals) were included
in the maximal box defined by our four tier 1 covariates when using the Crump et al. (2009)
exclusion criterion. When using the less restrictive criterion employed within Dehejia and
Wahba (1999), this number increased to 669 (347 treated, 322 control), yet over half of the
individuals in our original population were nonetheless discarded. As our study population
defined through the propensity score model fit on the tier 1 covariates ultimately allowed
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for suitable balance to be attained, excluding such large numbers of treated and control
individuals appears overly wasteful.
To see whether the exclusion of such large numbers of individuals when using the full propensity score model was a limitation of our method versus a more general issue with attaining
common support in high dimensions, we also used the procedure of King and Zeng (2006)
with all of our covariates. As a reminder, the method of King and Zeng (2006) does not
utilize propensity scores and instead defines the area of common support as the intersection
of the convex hulls of covariates for treated and control individuals. Using this definition
with all of our covariates, we found that no individuals were identified as lying within the
area of viable common support: no treated individuals were within the convex hull of the
control units, and no control individuals were within the convex hull of the treated units.
Given these developments, we see our procedure as pursuing a goal which may be more
attainable in practice: attaining overlap and balance with respect to the important covariates
while seeking balance on all covariates. As such, we fit our propensity score model with
respect to only the tier 1 covariates. An extreme estimated propensity score based on these
important covariates then indicates that an observation is “extreme” with respect to the
distributions of the most important covariates for either the treated or control groups. As
mentioned in the manuscript, using this limited model to create the maximal box resulted
in 1208 individuals in our subpopulation (507 ICU, 701 hospital ward). We also used the
method of King and Zeng (2006) with respect to these most important covariates, and found
that 1227 individuals were designated as lying within the area of common support (505 ICU,
722 hospital ward). The advantage of our method over that of King and Zeng (2006) is that
the study population used for further analysis based on the maximal box is easily described
and interpreted in terms of ranges of covariate values.
While we were able to attain balance in our study population, this need not be the case with
other data sets. Although overlap should be attained with respect to the most important
covariates imbalances may persist even after matching, particularly for covariates not used to
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define the study population. One approach for dealing with this would be an iterative process
wherein covariates which cannot be suitably balanced even after matching are used to define
a new maximal box. One would then create a new match in this new study population,
and reassess the resulting balance after matching. Iteratively refining the study population
would not bias the resulting analysis; rather, the individuals to whom the inference applies
would change with each iteration.

A.5. Strength of the Normal Approximation Under the Worst-Case Allocation of
Potential Outcomes
Our procedure for testing the composite null hypothesis δ = δ0 hinges upon the appropriateness of the normal distribution in approximating the randomization distribution of
the estimated average treatment effect, δ̂. In Section 2.5.1 we prove asymptotic normality
of δ̂ under mild conditions, but we would like to see how well the normal approximation
holds for the example at hand. Our optimization problem returns vectors of potential outcomes under treatment and control corresponding to the worst-case variance of δ̂. To assess
whether the normal approximation is reasonable for this allocation, we perform a Monte
Carlo simulation to generate samples from the true randomization distribution of δ̂ using
the worst-case potential outcomes for inference within the full match described in Section
2.4.3. Randomization occurs independently across strata. In stratum i, we randomly generate a vector Zi with mi ones and ni − mi zeroes, corresponding to the assignment to treatment and control respectively. The observed outcome for individual j in stratum i is then
Rij = rT ij Zij + rCij (1 − Zij ). This yields the estimated average treatment effect in stratum
P i
P
i: δ̂i = nj=1
(Zij Rij /mi − (1 − Zij )Rij /(ni − mi )). Finally, we form δ̂ = Ii=1 (ni /N )δ̂i .
Figure 6 shows the resulting randomization distribution under this worst-case allocation of
potential outcomes. We first note that the distribution is centered at E[δ̂] = 0, as we are
testing the composite null that δ = 0. Furthermore, we note that both the histogram and the
normal quantile plot indicate that the randomization distribution can be well approximated
by a normal distribution.
114

^
Histogram of δ

^
Normal Quantile Plot for δ
0.10
Sample Quantiles

−0.10

200

−0.05

0.00

0.05

1000
800
600
400

Frequency

●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●

0
−0.15

●

−0.05

0.05 0.10

−4

−2

0

2

4

Figure 6: Randomization distribution of δ̂i under the worst-case allocation of potential outcomes
returned by the optimization procedure described in Section 2.5.2. The dotted vertical line in the
histogram corresponds to average treatment effect under the null, 0.

A.6. A Comparison of Standard Errors
We compare the value of the standard error used in conducting our hypothesis test, 3.67%,
to standard errors associated with three other hypothesis tests:
1. A simple two-sample test for differences in proportion assuming iid draws from the two
populations of interest. That is, we do not take the stratification into account, and find
the standard errors under a biased analysis assuming two iid samples. SE(δ̂) = 2.26%
2. A test of δ = 0 using the Mantel-Haenszel risk difference estimator (Greenland and
Robins, 1985). We assume independent sampling across strata, that we have independent draws within each stratum from each of the two groups being compared, and that
there is a common treatment effect across all strata (δi = δ0 ∀i). Given the nature of
our stratification (a large number of strata with a limited number of observations in
each stratum), we use the variance estimator of Sato et al. (1989) which is consistent
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under sparse stratification. SE(δ̂) = 2.59%
3. A test of Fisher’s sharp null under our stratification (rT ij = rCij ∀i, j).
SE(δ̂) = 2.67%
Note that the first procedure has a larger effective sample size than that of our idealized
stratified experiment since it assumes iid draws from two populations, while the other two
estimators account for the stratification at hand. Given our estimated ATE of 4.3%, we
would still fail to reject the null with any of these alternate standard errors. None of these
three alternate procedures have size α for all alignments of potential outcomes within the
composite null hypothesis, as our procedure finds the actual worst-case standard error over
all elements of the composite null.
Perhaps most interesting is the comparison of our maximal standard error to that attained
under Fisher’s sharp null. Clearly, the sharp null of no treatment effect is an element of
the composite null δ = 0. To see why the variances are so different, note that under the
sharp null, any stratum with Rij = Rik for all j, k ∈ {1, ..., ni } yields var(δ̂i ) = 0, since
the missing potential outcome for each individual must equal the observed value for that
individual. Under the general composite null δ = 0, we can arrange the potential outcomes
across strata in such a way that the variances of stratum-specific ATEs are positive even
if Rij = Rik for all j, k ∈ {1, ..., ni }. As a simple illustration of this, consider testing the
null of δ = 0 under both the sharp null and under the composite null with two strata. In
stratum 1, suppose R11 = R12 = 1, while in stratum 2 suppose R21 = R22 = 0, where
without loss of generality the first individual in each matched set received the treatment. If
we assume the sharp null holds, rC11 = 1, rT 12 = 1, rC21 = 0 and rT 22 = 0. Within each of
these strata, the variance of the stratum-specific average treatment effect is 0. On the other
hand, we can also satisfy the composite null δ = 0 by setting rC11 = 1, rT 12 = 0, rC21 = 0,
rT 22 = 1, which would yield var(δ̂i ) > 0 for i = 1, 2. Neyman’s null offers more flexibility
for the optimization problem, which is why we see the discrepancy between the standard
errors from our procedure with those under the sharp null. Strata where Rij = Rik for all
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j, k ∈ {1, ..., ni } occur regularly in our example (182 out of 312 strata), which explains the
magnitude of the difference between the two standard errors.

A.7. Formulating the Maximal Variance Problem
We now introduce notation for maximizing the variance within a composite null through
integer programming. While many different formulations are possible, the one we choose
explicitly avoids symmetry by having each decision variable correspond to a unique distribution on the contribution to the overall estimated average treatment effect from a given
stratum. As discussed in Margot (2010), the avoidance of symmetry is crucial in formulating
an integer program that can be solved in a reasonable amount of computation time.
Let Tizr = {j : Zij = z, Rij = r}, (z, r) ∈ {0, 1}2 , i ∈ {1, ..., I}, denote the four possible
partitions of indices of individuals in stratum i into sets based on the values of their treatment
assignment and observed response. Within each set, all members share the same value for
either rT ij or rCij . For example, if j, k ∈ Ti01 , then rCij = rCik = 1, yet the values of rT ij
and rT ik are unknown. |Tizr | can be thought of as the value in cell (z, r) of a 2 × 2 table
that counts the number of individuals for each combination of (z, r) in stratum i. To tie
notation together, we have that |Ti11 | + |Ti10 | = mi , and |Ti01 | + |Ti00 | = ni − mi
There are 2ni possible sets of potential outcomes in stratum i that are consistent with
the observed data.

As we now show, we need not consider all 2ni possible combina-

tions of potential outcomes, but rather only those which correspond to unique distributions of δˆi . This is beneficial as the 2ni possible sets of potential outcomes in stratum
Q
i only yield (z,r)∈{0,1}2 (|Tizr | + 1) unique distributions for δ̂i . This is demonstrated in
Rigdon and Hudgens (2014, Section 3), and the argument is reproduced here. Consider
Ti00 . The potential outcomes under treatment are unknown in this set; however, since
the potential outcomes under control are the same for all individuals, the possible allocations of {rT ij : j ∈ Ti00 } only result in |Ti00 | + 1 non-exchangeable distributions.
These are attained by setting {rT ij : j ∈ Ti00 } equal to any one of the ordered vectors
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(0, 0, ..., 0), (1, 0, ..., 0),..., and (1, 1, ..., 1). The same argument holds for the other three sets
of indices in stratum i, thus completing the proof. Note further that since ni and mi are fixed
Q
across randomizations and min{mi , ni − mi } = 1, we have that (z,r)∈{0,1}2 (|Tizr | + 1) =
nQ
o
Q
0r
1r
2 × max
(r)∈{0,1} (|Ti | + 1),
(r)∈{0,1} (|Ti | + 1) .
It would seem as though we must consider

QI

i=1

Q

zr
(z,r)∈{0,1}2 (|Ti |+1)

different distributions

for the estimated average treatment effect in our optimization problem. Fortunately, two
facts allow us to consider a much smaller number of variables. First, there is independence
between strata which allows us to sum stratum-wise variance contributions together to
arrive at the overall variance of the estimated average treatment effect. Second, many of
the stratum-specific 2 × 2 tables are observed multiple times across strata. As an example,
our full match returned 312 strata, of which there were only 48 unique tables.
In light of these facts, we introduce notation to facilitate the solution of our optimization
problem. Let Ci = (|Ti00 |, |Ti01 |, |Ti10 |, |Ti11 |) be the observed counts of the 2 × 2 table for
stratum i. C = {C1 , ..., CI } is a (multi)set, where the number of unique elements equals the
number of unique 2 × 2 tables observed in the data and is typically much smaller than I.
Let S be the number of unique tables and let s ∈ {1, ..., S} index the unique tables. Define
I(i) to be a function returning the index of the unique table corresponding to the table
observed in stratum i. Hence, I(i) = I(`) if and only if Ci = C` . Let Ms = |I −1 (s)| be the
number of strata where unique table s was observed, and let ñs = nb and m̃s = mb be the
number of total units and treated units respectively in unique table s for any b ∈ I −1 (s).
Let Ps be the number of allowed non-exchangeable potential outcomes for unique table s,
and let {[rT [sp] , rC[sp] ]}, p ∈ {1, ..., Ps } be the set of allowed potential outcome allocations
P s
for unique table s. Finally, let δ[sp]j = rT [sp]j − rC[sp]j , and let ∆[sp] = ñj=1
δ[sp]j .
Define ν[sp] as:

ν[sp]

ñ2
= s2
N

ST2 [sp]
m̃s

+

2
SC[sp]

ñs − m̃s
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−

2
Sδ[sp]

ñs

!
,

P s
P s
2
(rC[sp]j − r̄C[sp] )2 /(ñs − 1), and
(rT [sp]j − r̄T [sp] )2 /(ñs − 1), SC[sp]
= ñj=1
where ST2 [sp] = ñj=1
P s
2
Sδ[sp]
= ñj=1
(δ[sp]j − δ̄[sp] )2 /(ñs − 1). ν[sp] then represents the variance of the contribution
to the overall estimated average treatment effect from table s under potential outcome
allocation p. Let ν = [ν[11] , ..., ν[sp] ].
Let x[sp] be an integer decision variable denoting how many times the set of potential outcomes p that is consistent with unique table s is observed in the data, s ∈ {1, ..., S},
p ∈ {1, ..., Ps }, and let x = [x[11] , .., x[SPs ] ]. ν[sp] x[sp] represents the contribution to the
overall variance of the test statistic if the pth set of potential outcomes in unique table s is
observed x[sp] times, and ν T x represents the overall variance across all unique tables and
PPs
th
potential outcomes that are observed in the data.
p=1 x[sp] is how many times the s
unique table was observed in the data, which through our definition of Ms results in the
P s
constraint that Pp=1
x[sp] = Ms ∀s. Finally, we force the resulting optimal solution to have
an allocation of potential outcomes such that the null hypothesis in question is satisfied
(that is, δ ∈ Dδ0 ) through an additional constraint. Given our definition of ∆[sp] , the conP
P s
∆[sp] x[sp] = N δ0 . Finding
straint that the null must be true can be written as Ss=1 Pp=1
the maximal variance over all δ ∈ Dδ0 can then be written as the following linear integer
program (MV, for maximal variance):

maximize ν T x

(MV)

x

subject to

Ps
X

x[sp] = Ms ∀s

p=1
Ps
S X
X

∆[sp] x[sp] = N δ0

s=1 p=1

x[sp] ∈ Z ∀s, p
x[sp] ≥ 0 ∀s, p,

where Z denotes the set of integers.
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For a given δ0 , we can then use the objective value of (MV) at the optimal value x = x∗δ0
to perform a hypothesis test of δ = δ0 . This procedure is not conservative for testing the
composite null, as the maximal variance is attained by a member of the composite null:
there is an allocation of potential outcomes that satisfies the null, aligns with the observed
data, and has this variance. Confidence intervals can then be attained by inverting tests
on a sequence of values of {δ0 }. To aid in finding the endpoints of this interval, we can
start with a Wald-type confidence interval found by finding the maximal variance at δ0 = δ̂,
q
forming an interval of the form δ̂ ± z1−α/2 ν T x∗ , and then refining the endpoints through
δ̂

a series of tests for values of δ0 near the endpoints of the Wald interval.
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APPENDIX B
B.1. Balance on Observed Covariates in Our Motivating Example
Standardized Differences Before and After Matching
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Figure 7: Covariate Imbalances Before and After Matching. The dotplot (a Love plot) shows the
absolute standardized differences without matching, and after conducting a matching with a variable
number of controls. The vertical dotted line corresponds to a standardized difference threshold of
0.2, which is often regarded as the maximal allowable absolute standardized difference (Rosenbaum,
2010). As one can see, marked imbalances existed between the two populations before matching.
All standardized differences were below 0.2 after matching, and most covariates saw substantial
improvements in balance through matching.

B.2. Usage of Risk Differences and Risk Ratios
The risk difference and risk ratio are two measures of the causal effect of an intervention
on a binary outcome. A common viewpoint taken in the statistics literature is that the
appropriateness of using the risk ratio (also called the relative risk) versus the risk difference
depends on the scale of the problem, with certain measures being appropriate for certain
inferences. This is discussed in Hernán and Robins (2016) in the following paragraph:
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Each effect measure may be used for different purposes. For example, imagine a
large population in which 3 in a million individuals would develop the outcome
if treated, and 1 in a million individuals would develop the outcome if untreated.
The causal risk ratio is 3, and the causal risk difference is 0.000002. The causal
risk ratio (multiplicative scale) is used to compute how many times treatment,
relative to no treatment, increases the disease risk. The causal risk difference
(additive scale) is used to compute the absolute number of cases of the disease
attributable to the treatment. The use of either the multiplicative or additive
scale will depend on the goal of the inference. (Hernán and Robins, 2016, pages
7-8)
Of course, the converse can be true: if 85% develop the outcome if treated and 80% develop
the outcome if not treated, the risk ratio is then 1.0625 while the risk difference is 0.05.
Grieve (2003) provides additional discussion of these two estimands, noting that in deciding
which estimand to use one must consider “whether interest is centered on absolute or relative
effects, and the extent to which those who are to use them understand them” (Grieve, 2003,
page 88).
The summary measure chosen can also affect the extent to which a study’s findings influence
future action. Misselbrook and Armstrong (2001) note that when deciding whether or not
to take a proposed treatment the percentage of individuals who end up agreeing to take
the treatment can vary substantially depending on whether the benefits of a treatment are
presented in the form of a risk ratio or a risk difference. Forrow et al. (1992) note that the
manner in which information on a causal effect is presented can affect not only how likely
patients are to take a recommended treatment, but also how likely a doctor is to prescribe
a treatment in the first place.
Poole (2010) states that in epidemiology, it has been treated as a seemingly self-evident
truth that “relative effect measures should be used to assess causality and that absolute
measures should be used to assess impact.” (Poole, 2010, page 3). An early defense of this
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stance can be found in the work of Cornfield et al. (1959) on smoking and lung cancer:
Both the absolute and the relative measures serve a purpose. The relative measure is helpful in (1) appraising the possible noncausal nature of an agent having
an apparent effect; (2) appraising the importance of an agent with respect to
other possible agents inducing the same effect; and (3) properly reflecting the
effects of disease misclassification or further refinement of classification. The absolute measure would be important in appraising the public health significance
of an effect known to be causal. (Cornfield et al., 1959)
Both Poole (2010) and Ding and Vanderweele (2014) refute the superiority of the risk ratio to the risk difference in making causal claims, presenting examples where the use of
evidence presented by the risk difference exhibits much stronger robustness to unmeasured
confounding than evidence presented by the risk ratio, thus aiding in discovering causal
effects.
In the clinical trials literature, both effect measures are viewed as having their own relative
merits and downsides. Schechtman (2002) takes a pragmatic approach and suggests that in
order to paint a clearer picture of the treatment effect, one should report both the estimated
risk difference and risk ratio. See Cook and Sackett (1995), Jaeschke et al. (1995), and
Sinclair and Bracken (1994) for further discussion of this matter.

B.3. Simulation Studies for Computation Time
Our methodology can, for the purposes of computation time, be thought of as containing
three components with worst case complexities as follows:
1. Defining groups of symmetric tables: O(I 2 )
2. Defining constants and constraints for unique tables:


P
Q
O S + Ss=1 (ñs − 1) (z,r,d)∈{0,1}3 (|Tszrd | + 1)2
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3. Solution of integer program: N P-hard
For the first component, the total number of matched sets plays a role in determining computation time as in formulating the problem, we must sort the individual matched sets
into symmetry groups corresponding to uniquely observed tables. The second component
is affected not only by the number of uniquely observed tables, but also the number of observations in a table and the cells of said table. As discussed in Section 3.4, each table s
Q
yields at most (z,r,d)∈{0,1}3 (|Tszrd |+1)2 unique distributions, while for a sensitivity analysis
there are ñs − 1 alignments of the unmeasured confounders to be considered for each distribution. These unique contributions correspond to variables in our optimization problem.
The number of variables is also influenced by assumptions made on the potential outcomes,
as assumptions eliminate the need to consider certain possible values for the unobserved
potential outcomes.
The simulation studies presented herein provide further insight into various aspects of problem (P1) which can affect the solution of the integer program itself (component 3), as this
is the only N P-hard endeavor and hence may, in theory, lead to unpredictable computation
time. Unless otherwise stated, all of the simulations presented are modifications of the same
basic set up. In each of 1000 iterations we sample I matched sets from the strata in our
motivating example from Section 3.1.2. Each iteration has strata ranging in size from 2 to
21, and each data set has an average of roughly 8 × I individuals within it. Large strata
affect computation time, as they result in larger numbers of non-exchangeable potential
outcome allocations within a stratum and fewer duplicated 2 × 2 tables in the data. In our
data set, 25% of the strata had one acute rehabilitation individual and 20 home with home
health services patients. Treated and control individuals are assigned an outcome of “1”
with probability pT and pC respectively.
In each iteration, we test a null on the causal risk difference, δ = δ0 . We test the stated null
with a two-sided alternative at level of unmeasured confounding Γ. We record the required
time for the optimization problem itself for each simulation. Simulations were conducted
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on a desktop computer with a 3.40 GHz processor and 16.0 GB RAM. The R programming
language was used to formulate the optimization problem, and the R interface to the Gurobi
optimization suite was used to solve the optimization problem.
B.3.1. Increasing the Number of Matched Sets
In this simulation, we fix pT = 0.75, pC = 0.25, Γ = 2, δ0 = 0.2, and conduct 1000 iterations
at I = 7, 13, 65, 125, 625. As Figure 8 demonstrates, the time for the optimization routine
itself appears to increase with I, the number of matched sets. Figure 8 also demonstrates that
time is increasing with the average number of variables in the corresponding optimization
problem.
To demonstrate that the role that I plays is only indirect (through its effect on the number
of variables in the optimization problem), we also present a simulation study with matched
sets of size three. We will focus on the effect ratio in this simulation study. Each set consists
of three individuals, one encouraged to take the treatment and the other two encouraged
to take the control. For each individual, the probability of compliance with the assigned
treatment is set to 0.9. We set pT = 0.75 and pC = 0.25 based on which treatment the
individual actually received. We set Γ = 2 and λ0 = 0.2, and conduct 1000 iterations with
I = 25, 50, 250, 500, 2500, 5000, 25000, 50000, 250000. In the corresponding inference, we do
not assume that the exclusion restriction holds. We also do not assume monotonicity holds,
nor do we assume a known direction of effect.
Figure 9 shows that as I increases the time required for only solving the optimization problem
initially increases, but then begins to level off. The reason for this is also demonstrated
in the figure: as I increases, the average number of variables in the optimization problem
appears to be approaching an asymptote, rather than continually increasing. This is because
under the assumptions used for the performed inference, the maximal number of unique
allocations of unobserved potential outcomes and unmeasured confounders that must be
P
Q
considered is 4384, calculated using the formula Ss=1 (ñs − 1) (z,r,d)∈{0,1}3 (|Tszrd | + 1)2 =
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Figure 8: (Top-left) Optimization time and the number of matched sets; (top-right) optimization
time and the number of optimization variables; and (bottom) log number of matched sets and log
number of optimization variables.
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Figure 9: (Top-left) Optimization time and the number of matched triples; (top-right) optimization
time and the average number of variables; and (bottom) average number of variables and the number
of matched triples.
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Figure 10: Optimization time and value of Γ.
2 × (4 × 32 × 22 + 32 × 26 ). This illustrates one of the key advantages of our formulation:
by expressing the problem in terms of unique contributions to the test statistic we greatly
enhance the scalability of our method, particularly when the matched sets are of limited
size. In fact, the average computation time for the optimization problem was under a tenth
of a second for all values of I in this simulation setting.
B.3.2. Increasing the Value of Γ
In this simulation we fix pT = 0.75, pC = 0.25, I = 125, δ0 = 0.2, and conduct 1000 iterations
at each of Γ = 1, 1.5, , ..., 3.5, 4. We see in Figure 10 that while there is a substantial increase
in solution time when going from Γ = 1 to Γ > 1, the solution time is roughly constant at
all values of Γ > 1 tested. Γ = 1 corresponds to an integer linear program while any Γ > 1
is an integer quadratic program, which accounts for the initial jump. Increasing Γ further
does not change the fact that it is an integer quadratic program, nor does it increase the
average number of variables in the optimization problem; rather, it changes the values of
the constants associated with each of the variables in the objective function.
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Figure 11: Optimization time and null hypothesis being tested. The true risk difference was set to
zero throughout

B.3.3. Altering the Hypothesized Risk Difference
In this simulation we fix pT = 0.5, pC = 0.5, I = 125, Γ = 2, and conduct 1000 iterations at
each of δ0 = −0.4, −0.3, ..., 0.3, 0.4. As we see in Figure 11, average solution time is shortest
when the true risk difference is closest to the hypothesized risk difference, and increases as
the hypothesized risk difference moves away from the truth in either direction. Note that
both the number of variables and the number of constraints in the optimization problem
remain constant on average as the hypothesized risk difference varies, meaning that neither
can explain the difference in solution times. As δ0 moves further away from the true risk
difference the average number of feasible solutions decreases, as the discrepancy between the
observed potential outcomes and the null hypothesis affords less and less flexibility to the
allocation of the unobserved potential outcomes. This can, in turn, make the corresponding
integer program more difficult to solve.
B.3.4. Jointly Altering the Outcome Prevalence Under Treatment and Control
In this simulation we fix I = 125, Γ = 2, δ0 = 0, and conduct 1000 iterations at each
of [pC , pT ] = [0.05, 0.15], [0.15, 0.25], ..., [0.85, 0.95]. Hence, the distance between the null
hypothesis and the true risk difference remains constant at 0.1. In Figure 12, we see that
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Figure 12: (Left) Optimization time and overall outcome prevalence; and (right) number of variables
and outcome prevalence.

simulation time is greatest when the outcomes have the highest variance (i.e., when the
treated and control prevalences are closest to 0.5), but drop off when the outcome becomes
either rarer or highly prevalent. Figure 12 also shows the relationship between the number
of variables and the outcome prevalence. The number of unique contributions to the overall
test statistic from a given unique table (i.e. the number of variables) is maximized when the
outcome prevalences are closest to 0.5, which accounts for the observed computation time
pattern.
B.3.5. Separately Altering the Outcome Prevalence Under Treatment and Control
In our first simulation, we fix pC = 0.1, I = 125, Γ = 2, δ0 = 0, and conduct 1000 iterations at
each of pT = 0.1, ..., 0.9. In Figure 13, we see that the outcome prevalence under treatment
affects computation time by increasing the number of variables in the optimization problem.
Next, we fix pT = 0.9, I = 125, Γ = 2, δ0 = 0, and conduct 1000 iterations at each of
pC = 0.1, ..., 0.9. In Figure 14, we see that the outcome prevalence under control affects
computation time by increasing the average number of variables in the optimization problem.
Note that altering the prevalence under control has a more drastic effect on the number of
variables (and thus, on the overall computation time) than altering the prevalence under
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Figure 13: (Left) Optimization time and outcome prevalence under treatment; and (right) number
of variables and outcome prevalence under treatment.

treatment, as the matched sets used in our simulation study each have one treated unit and
one or more (up to 20) control units. In turn, heterogeneity among control units within a
given matched set allows for many more possible contributions to the overall test statistic
(variables), particularly in matched sets with large numbers of control units. When altering
the prevalence for the treated units, since there is only one treated unit per matched set an
event prevalence for treated units closer to 0.5 only increases the number of variables in the
optimization problem by making it less likely that two matched sets with the same observed
table for the control units also have the same observed response for their respective treated
unit.
B.3.6. Assessing Avoidance of Symmetry
At Γ = 1, we compare computation time of our formulation, formulation (P1), for the causal
risk difference with that of an equivalent binary programming formulation. We first present
this alternate formulation. Let vij be the unobserved potential outcome for each individual.
That is, vij = rCij if Zi = 1, and vij = rT ij if Zi = 0. When conducting inference assuming
no unmeasured confounders (Γ = 1), we aim to find the worst-case variance among the
set of unobserved potential outcomes such that the null is satisfied, a problem which can
be expressed as a quadratic form involving the unobserved potential outcomes and other
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Figure 14: (Left) Optimization time and outcome prevalence under control; and (right) number of
variables and outcome prevalence under control.

constants known at the time of the optimization. Using the methods of Glover and Woolsey
(1974) for converting a quadratic binary program into a linear binary program, we can
express the problem as:

maximize

ni
I X
X

pij vij + 2

i=1 j=1

subject to

ni
I X
X

I
X
X

pijk wijk + c

(AP1)

i=1 j<k≤ni

(2Zij − 1)vij = −N δ0 +

i=1 j=1

ni
I X
X

(2Zij − 1)Rij

i=1 j=1

vij ∈ {0, 1} ∀i, j
wijk ≤ vij , vik ∀i, j, k
vij + vik − wijk ≤ 1 ∀i, j, k
We now define pij , pijk and c. Let H(i) be an ni ×ni symmetric matrix with diagonal elements
(n2i − ni )/N 2 and off diagonal elements are −ni /N 2 , and define the following vectors. Let
A(i) be an ni × ni diagonal matrix with diagonal entries 1/(Zi,ni (2 − ni ) + ni − 1), and let
B(i) be an ni × ni diagonal matrix with diagonal entries 1/((1 − Zi,ni )(2 − ni ) + ni − 1). We
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can then write var(T (δ0 )) as a sum of stratum-specific quadratic forms:

var(T (δ0 )) =

=

I 
X
i=1
I 
X


[A(i) Ri + B(i) vi ]T H(i) [A(i) Ri + B(i) vi ]
viT B(i) H(i) B(i) vi + 2viT B(i) H(i) A(i) Ri + RTi A(i) H(i) A(i) Ri



i=1

Let pij = (B(i) H(i) A(i) Ri )j + (B(i) H(i) B(i) )jj , pijk = (B(i) H(i) B(i) )jk , and
PI
T (i) (i) (i)
c =
i=1 Ri A H A Ri , we recover the required constants for finding the maximal
variance of the causal risk difference.
Rather than having decision variables for each possible variance contribution, this formulation has binary decision variables for the missing potential outcome for each individual.

A formulation of this sort yields a highly symmetric problem, as any pair of

individuals in a given stratum with [Zij , Rij ] = [Zik , Rik ] are exchangeable. For example, if individual j and k in stratum i both received the control and had an outcome
of 0, then rT ij = 1, rT ik = 0, uij = 1, uik = 0 results in the same objective value as
rT ik = 1, rT ij = 0, uik = 1, uij = 0. We randomly sample 125 strata from the full match
described in Chapter 2. This full match yielded strata of maximal size 8, representing a substantially easier optimization problem than the one presented in Section 3.5.3. The resulting
data sets had roughly 500 patients on average. Rather than randomly sampling outcomes,
we use the observed outcomes in the randomly sampled matched sets, hence basing this
simulation study entirely on real data. In each iteration, we terminated the simulation if
either program took longer than 5 minutes to solve in a given iteration. Here, we report
total computation time including grouping into unique tables, formulating constants and
constraints, and solving the optimization problem.
For formulation (AP1), we found that 29.6% of simulations exceeded the five minute computation limit. Of those that did not, the average computation time was 34.9 seconds for the
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pure binary program, but was 0.68 seconds for the linear relaxation. The average relative
gap between the optimal binary solution and optimal linear relaxation in the simulations
taking under five minutes was 23.5%, representing a marked discrepancy between the linear
relaxation and the integer hull of formulation (AP1). Under formulation (P1), all simulations terminated in under five minutes. In fact, the average computation time for our integer
program was 0.129 seconds, and the maximal computation time was 0.223 seconds. Among
the simulations where alternate formulation (AP1) exceeded our computation time limit,
the average computation for our formulation was 0.130 seconds, indicating that our formulation avoids the computational issues due to symmetry that cripple formulation (AP1).
The average computation time for the linear relaxation of (P1) was 0.122 seconds. 84.7% of
simulated data sets resulted in the optimal integer objective value being equal to that of the
linear relaxation. In those iterations where there was a difference, the average relative gap
between objective values was a mere 0.003%. Hence, our formulation is markedly stronger
than this alternate formulation, as evidenced by reduced computation time even when using
the same optimization software: our formulation is over 250 times faster than formulation
(AP1) among iterations that solved before computation time ran out, and is thus even faster
overall.
B.3.7. Simulation Using Actual Data
In each of 1000 iterations we sample 1250 matched sets from the strata in our motivating
example from Section 3.1.2. Each iteration thus has strata ranging in size from 2 to 21,
and each data set has an average of roughly 10,000 individuals within it. Large strata affect
computation time, as they result in larger numbers of non-exchangeable potential outcome
allocations within a stratum and fewer duplicated 2 × 2 tables in the data. In our data set,
25% of the matched strata had one acute rehabilitation individual and 20 home with home
health services patients. Rather than randomly sampling outcomes, we use the observed
outcomes in the randomly sampled matched sets, hence basing this simulation study entirely
on real data. This simulation setting thus produces particularly challenging optimization
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problems: each iteration resulted in over 200,000 variables over which to optimize on average.
We conduct two hypothesis tests in each iteration: a null on the causal risk difference,
δ = 0.05, and on the causal risk ratio, ϕ = 1.10. For both of the causal estimands being
assessed, we test the stated nulls with two-sided alternatives at Γ = 1 (no unmeasured
confounders, integer linear program) and Γ = 1.05 (unmeasured confounding exists, integer
quadratic program). We record the required computation time for each data set, which
includes the time for grouping into unique tables, the time taken to define the necessary
constants for the problem and also the time required to solve the optimization problem.
To measure the strength of our formulation, we also recorded whether or not the initial
continuous relaxation had an optimal solution which was itself integral, and if not the
relative difference in optimal objective function values between the integer and continuous
formulations (defined to be the absolute difference of the two, divided by the absolute value
of the relaxed value).
Table 12 shows the results of this simulation study. As one can see, our formulation yields
optimal solutions in well under a minute for both the integer linear and integer quadratic
formulations despite the magnitude of the problem at hand. The strength of our formulation
is further evidenced by the typical discrepancy between the integer optimal solution and that
of the continuous relaxation. For testing the causal risk difference, we found that in nearly
all of the simulations performed the integer program and its linear relaxation had the same
optimal objective value. For testing the causal risk ratio, the objective values tended not
to be identically equal, which has to do with the existence of fractional values in the row
of the constraint matrix enforcing the null hypothesis; nonetheless, the average gap among
those iterations where there was a difference was 0.005% percent for the linear program, and
0.01% for the quadratic program. This suggests not only that we have arrived upon a strong
formulation, but that one could in practice accurately approximate (P1) by its continuous
relaxation.
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Table 12: Computation times for tests of δ = 0.05 and ϕ = 1.10 at Γ = 1 (integer linear
program) and Γ = 1.05 (integer quadratic program), along with percentages of coincidence
of the integer and relaxed objective values, and average gaps between integer solution and
the continuous relaxation if a difference existed between the two.
Null
Hypothesis
δ = 0.05; Γ = 1.00
δ = 0.05; Γ = 1.05
ϕ = 1.10; Γ = 1.00
ϕ = 1.10; Γ = 1.05

Avg. Time (s),
Integer
9.26
12.69
9.74
13.40

Avg. Time (s),
Relaxation
8.81
8.20
8.45
8.38

%(objint = objrel )
99.8%
89.5%
9.0%
8.1%

Avg. Gap
If Diff.
0.001%
0.002%
0.005%
0.011%

B.3.8. Proceeding under Time Constraints
While these simulations suggest that a global integer optimum can be attained in a reasonable amount of time using our formulation, it remains a possibility that for a particular
data set the solver may fail to terminate in suitable amount of time for the user. If the user
has a maximum allowable period of time for the solver, Tmax , we would recommend solving
the required integer program while terminating the optimization after Tmax seconds. If the
solver terminates before Tmax then a global integer optimum has been found. Otherwise,
integer programming solvers provide bounds on the objective value at any time point t,
which can be used to conduct conservative inference and are tighter than those attained
by simply solving the continuous relaxation at the outset. Furthermore, one can compare
the lower bound to the best integer solution that the solver has found to that point as an
indication of how conservative the performed inference truly is.

B.4. Point Estimates for θ Through M -Estimation
While our focus in this work is on inference both assuming and not assuming unmeasured
confounding, we briefly describe point estimation for θ. Under the null at Γ = 1, T (θ0 ) has
expectation 0. We propose an m-estimator (also referred to as a z-estimator) for θ by using
T (θ0 ) as an estimating function; see Van der Vaart (2000) for more on m- and z- estimators
and their corresponding properties. Explicitly, θ̂ := SOLVE{θ : T (θ) = 0}. This is in
keeping with the estimator suggested by Baiocchi et al. (2010) for the effect ratio. For our
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three causal estimands of interest, these estimators are:
I ni
1 XX
ni (Zij Rij /mi − (1 − Zij )Rij /(ni − mi ))
N
i=1 j=1
PI Pni
Rij
i=1
j=1 ni Zij mi
ϕ̂ = PI Pn
Rij
i
i=1
j=1 ni (1 − Zij ) ni −mi


PI Pni
Rij
Rij
n
Z
−
(1
−
Z
)
ij mi
i ni −mi
i=1
j=1 i

.
λ̂ = P P
Dij
Dij
ni
I
n
Z
−
(1
−
Z
)
i
ij
i
i=1
j=1
mi
ni −mi

δ̂ =

While useful as indications of effect magnitude size, these estimators do not play a direct role
in conducting inference or performing sensitivity analyses; rather, our focus lies in understanding the randomization distribution of T (θ0 ) at any particular value of θ0 . Confidence
intervals under no unmeasured confounding are then constructed by inverting tests for a
sequence of null hypotheses. Constructing intervals in this manner avoids certain issues
associated with intervals directly based on m-estimators, such as small sample bias and
heavy dependence of the estimator’s variance on the estimand of interest; see Chapter 2 for
a discussion of the latter point as it pertains to constructing confidence intervals for the risk
difference within a matched observational study.

B.5. Assuming a Known Direction of Effect Impacts Reported Sensitivity
In both examples in Section 3.6, we perform inference under a host of assumptions on the
potential outcomes. As is demonstrated therein, the assumption of a known direction of
effect has a particularly strong impact on the corresponding sensitivity analysis. Note that
when testing the null of δ = 0 ⇔ ϕ = 1 ⇔ λ = 0 under the assumption of a direction of effect,
the only allocation of rT , rC that satisfies the null hypothesis is the allocation of Fisher’s
sharp null: rT ij = rCij ∀i, j. This results in testing a simple, rather than composite, null
hypothesis. At Γ = 1, the necessary hypothesis test can be performed using the permutation
distribution (or a normal approximation thereof) of the test statistic under Fisher’s sharp
null. For Γ > 1 the potential outcomes are still fixed at those of Fisher’s sharp null, but
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we must consider the possible vectors of unmeasured confounders. Without the assumption
of a direction of effect, there are many possible allocations of potential outcomes satisfying
this null. This additional flexibility in the optimization problem results in more extreme
worst-case allocations for the inference being conducted.
As a simple illustration of why this is the case, consider testing this null with two pairs of
individuals. In stratum 1, suppose R11 = R12 = 1, while in stratum 2 suppose R21 = R22 =
0, where without loss of generality the first individual in each matched set received the
treatment. If we assume a nonnegative treatment effect, rT 12 = 1, since rC12 = 1. Similarly,
rC21 = 0 since rT 21 = 0. Finally, the constraint that the null is true forces rC11 = 1
and rT 22 = 0. For any Γ, these strata contribute expectation and variance 0. Without
the assumption of a direction of effect, we can also satisfy the null hypothesis by setting
rC11 = 1, rT 12 = 0, rC21 = 0, rT 22 = 1. Not only would we then have positive variance
contribution from each of these strata at any Γ, but also setting u1 = [1, 0] and u2 = [0, 1]
results in an aggregate expected value of (Γ − 1)/(1 + Γ) ≥ 0. These choices allow one to
find a less significant deviate under no constraints on the direction of effect than is possible
under a model with a known direction of effect.

B.6. Sensitivity Analysis for a Simple Null
While the methodology presented herein was motivated by conducting sensitivity analyses
for composite null hypotheses with binary outcomes, we note that a simplified version can
be used to conduct a sensitivity analysis for a simple null hypothesis for general types of
outcome variables without invoking asymptotic separability (Gastwirth et al., 2000). With
a simple null hypothesis, qij are fixed for each individual i and each stratum j. In the
notation of Section 3.4, S represents the number of strata with unique sets of values for the
vector qi . With continuous outcomes S will often equal I, but for other types of outcomes
there may be repeated strata. For each s, Ps (the number of possible allocations of potential
outcomes within unique set s) equals 1 as both sets of potential outcomes are fixed under a
simple null. Hence, the subscript [sp] in our original formulation can be replaced by a single
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subscript s, Define µsa and νsa by replacing [sp] with s in the notation of Section 3.4.1, and
make the analogous substitution of xsa for x[sp]a . Let Ms again represent the number of
times unique stratum s occurred, and let ñs be the number of observations within unique
stratum s. Define µ = [µ11 , .., µS,ñS −1 ] and let the analogous definitions hold for ν and
x. Finally, note that the constraint that the null must be true in formulation (P1) can be
removed entirely as qij are defined under this assumption. A sensitivity analysis at a given
Γ > 1 can be conducted by solving the following optimization problem:

minimize (t − (µT x))2 − κ(ν T x)
x

subject to

ñX
s −1

(P2)

xsa = Ms ∀s

a=1

xsa ∈ Z ∀s, a
xsa ≥ 0 ∀s, a

As described in Section 3.5.2, we can conduct a sensitivity analysis for a given Γ > 1 by
minimizing (P2) with κ = χ21,1−α . To find the actual minimal deviate, we can follow the
iterative procedure outlined in Section 3.5.2 until converging to a stationary κ∗ .
The constraint matrix corresponding to the above optimization program is totally unimodular. As a consequence, the polyhedron of the continuous relaxation equals the integer hull
(Bertsimas and Tsitsiklis, 1997). Hence, if one were solving an integer linear program, the
solution of the continuous relaxation would be guaranteed to be integral. When finding the
worst-case deviate we are minimizing a constrained convex quadratic function; as such, the
solution need not be at the vertex. Nonetheless, strong formulations of integer quadratic
programs are essential for efficiently finding optimal solutions.

B.6.1. Example: Dropping Out of High School and Cognitive Achievement
As an exposition of their methodology, Gastwirth et al. (2000) consider conducting a sensitivity analysis for comparing cognitive achievement of US high-school drop-outs with that
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of non-dropouts; see Rosenbaum (1986) for more details on the study. They conducted
inference on 12 drop-outs in the study, where each drop-out was matched to two students
who did not drop out, yet were similar on the basis of all other observed covariates. Using
an aligned rank test, the test statistic for these 12 matched sets was t = 296, with expectation and variance at Γ = 1 of 222 and 1271, yielding a standardized deviate of 2.07 and
approximate one sided p-value of 0.019.
Table 3 of Gastwirth et al. (2000) shows the results of the asymptotically separable algorithm on this data set for Γ = 2. At this strength of unmeasured confounding, the separable
algorithm yields a bounding normal deviate with a mean of 257.40 and a variance of 1177.23,
resulting in an approximation to the worst-case deviate of 1.125 and a one sided p-value of
0.129. We also explicitly minimized the deviate by solving (P2). This yields a bounding random variable with a mean of 256.60 and a variance of 1228.145, yielding a worst-case deviate
of 1.124 and a worst-case p-value of 0.130. Investigating further, the worst-case allocations
of u for each stratum were in agreement for all of the matched sets except for matched set
11. There, the asymptotically separable algorithm chooses u11 = [0, 1, 1], contributing a
mean of 24.80 and a variance of 139.76. The correct value for u11 for minimizing the deviate
is u11 = [0, 0, 1], which has slightly lower expectation (24.24) but larger variance (173.19).
This demonstrates that for I even moderately large, the asymptotically separable algorithm
can produce a bounding random variable that very closely approximates the true upper
bound on the p-value. That being said, given our formulation the worst-case deviate can be
explicitly found. Furthermore, one need not worry about computation time: for conducting
the sensitivity analysis on this problem, an optimal solution was found in 0.15 seconds.
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APPENDIX C
C.1. Additional Details for the Smoking and Naphthalene Example
Following Weitzman et al. (2005) and Suwan-ampai et al. (2009), individuals were classified
as active smokers if they stated that they smoke “every day” or “some days” in response to
the question “Do you now smoke cigarettes?,” or if their serum cotinine (a metabolite of
nicotine) levels were above 0.05 ng/mL. Using this definition, there were 453 smokers and
1253 nonsmokers. The nonsmokers include former smokers and never smokers, as urinary
naphthol is an indicator of recent naphthalene exposure.
We used full matching to control for observed covariates in this study (Rosenbaum, 1991;
Hansen, 2004). In this match, we allowed for strata of maximal size 10, meaning that a
matched set could have, at most, either 1 current smoker and 9 nonsmokers; or 1 nonsmoker and 9 current smokers. We identified 22 pre-treatment covariates deemed predictive
of smoking and naphthalene levels based on those used in Suwan-ampai et al. (2009); these
covariates are listed in Figure 15. Ten covariates contained missing values, with a maximal
percentage of values missing of 10%. To account for this, we included 10 missingness indicators as additional covariates upon which to match. As discussed in Rosenbaum and Rubin
(1984) and Rosenbaum (2010, Section 9.4), this facilitates balancing the observed covariates and the pattern of missingness. Rank-based Mahalanobis distance with a propensity
score caliper of 0.08 was used, and propensity scores were estimated using logistic regression
(Rosenbaum, 2010, Section 8.3). Figure 15 shows the standardized differences before and
after matching for observed confounders and demonstrates that before matching there were
substantial imbalances between smokers and nonsmokers with respect to many important
variables. It also shows that matching was able to effectively create a well-balanced comparison between smokers and nonsmokers on the basis of these variables. Details for calculating
standardized differences before and after full matching can be found in Stuart and Green
(2008) and Rosenbaum (2010, Section 9.1).
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Standardized Differences Before and After Matching
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Figure 15: Covariate Imbalances Before and After Matching. The dotplot (a Love plot) shows the
absolute standardized differences without matching, and after conducting a matching with a variable
number of controls. The vertical dotted line corresponds to a standardized difference threshold of
0.2, which is often regarded as the maximal allowable absolute standardized difference (for example,
Silber et al., 2001). The largest absolute standardized difference after matching was 0.094.

C.2. A Simple Extension To One-Sided Testing
By taking the square of the deviate in our original formulation, we lose the deviate’s sign.
While this does not make a difference for two-sided testing, it does make a difference when
the test is one-sided. For example, if we stipulated a one-sided, greater than alternative but
observed a test statistic markedly smaller than its expectation under the null we should
fail to reject that null, a fact which is lost when taking the square. To account for this, we
introduce a penalty into the constraints corresponding to one-sided hypotheses that only
allow for a rejection to be registered if the expectation of the test statistic yielded through
the sensitivity analysis maintains the proper relationship with the observed test statistic
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given the nature of the alternative. Let bk be a binary variable for the k th outcome, and let
M be a sufficiently large constant.
Redefine ζk (%) so that

ζk (%) =




(tk − E[tk (Z, Fk ); %])2 − χ2

1,1−α/K Var(tk (Z, Fk ); %)

if two-sided alternative



(tk − E[tk (Z, Fk ); %])2 − χ2
1,1−2α/K Var(tk (Z, Fk ); %) if one-sided alternative

We then modify our optimization problem as follows:

minimize y
y,%ij ,si ,bk

subject to y ≥ ζk (%) − M bk ∀k
ni
X

%ij = 1 ∀i

j=1

si ≤ %ij ≤ Γsi ∀i, j
%ij ≥ 0 ∀i, j
bk ∈ {0, 1} ∀k
bk = 0 if Hk two-sided
−M (1 − bk ) ≤ tk − %T qk ≤ M bk if Hk one-sided , <
−M bk ≤ tk − %T qk ≤ M (1 − bk ) if Hk one-sided , >

The value M bk added to the k constraints on the auxiliary variable y, in conjunction with the
constraints on the value of the test statistic’s numerator, impose a heavy negative penalty if
the relationship between the test statistic and its mean under a given allocation of unmea143

Table 13: Rejection probability for testing true and false nulls through closed testing.
Desired strong familywise error control at 0.05.
True Nulls
False Nulls
Gamma Moments
H1
H2
H1 ∧ H2
H3
H1 ∧ H2 ∧ H3
τ , Σ(1)
0.0260 0.0266
0.0506
0.9884
0.9886
Γ=1
(2)
τ,Σ
0.0267 0.0268
0.0462
0.9881
0.9893
(1)
0.0102 0.0089
0.0189
0.9748
0.9749
τ,Σ
Γ = 1.05
τ , Σ(2)
0.0096 0.0122
0.0197
0.9732
0.9750
(1)
0.0035 0.0043
0.0078
0.9462
0.9463
τ,Σ
Γ = 1.10
τ , Σ(2)
0.0053 0.0032
0.0081
0.9441
0.9462
sured confounders do not adhere to the required direction imposed by the alternative. This
makes it such that we will never reject a null at a given Γ because a given one-sided test
was highly insignificant, which without such a penalty would be construed as being highly
significant.

C.3. Simulation of Type I Error Control
In this simulation study, we demonstrate that, in the presence of true intersection null
hypotheses, our procedure strongly controls the familywise error rate at level α = 0.05. In
each of 6 simulation settings, we simulate 10,000 data sets under no unmeasured confounding
with I = 250 pairs for three outcome variables of interest and using Huber’s M-statistic, as
described in Section 4.6. For each of the 2 combinations of treatment effects and covariances,
closed testing is used, with our minimax procedure being used for each intersection null.
Tests are run at Γ = 1, 1.05, and 1.1. The values for the treatment effect vector and the
covariances were as follows:
1. τ = [0, 0, 0.3]
(2)

(2)

2. Σ(1) = Diag(1); Σij = 1 if i = j, Σij = 0.5 otherwise.
We test Fisher’s sharp null on each outcome. In each iteration, we record whether or not the
true null hypotheses H1 , H2 , and H1 ∧ H2 are rejected. We also record whether or not the
false nulls H3 and H1 ∧ H2 ∧ H3 are rejected. Table 13 shows the results of this simulation
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study. As can be seen, our procedure strongly controls the type I error rate for all values
of Γ tested. The rate of rejection for H1 ∧ H2 reveals that our procedure is conservative
when the test statistics are dependent, while coming very close to attaining the actually
desired level under independence. As Γ increases the Type I error rate decreases for all true
nulls, as many spurious rejections assuming no unmeasured confounding can be explained
by moderate departures from pure randomization.
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APPENDIX D
D.1. Proof of Theorem 2
We begin by restating the optimization problem
PI

i1
i=1 ϕ
q

minimize
{πi ,ϕi2 }

subject to

−

PI

Γ
(1+Γ)2

I
X

i=1 (πi ϕi1 + (1 − πi )ϕi2 )
PI
2
i=1 (ϕi1 − ϕi2 )

(P2)

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X
Γ
(ϕi1 − ϕi2 )2 = v̄¯Γ
(1 + Γ)2
i=1

πi = wi /(1 + Γ) + (1 − wi )Γ/(1 + Γ)
wi = 1{ϕi2 ≥ ϕi1 }

Before proceeding, we prove two useful lemmas:
P
Lemma 3. For Ii=1 wi ∈ {1, ..., I − 2}, any feasible solution to Problem (P2) involving
ϕi2 = ϕi1 for some i has an objective value that is greater than or equal to a feasible solution
with ϕi2 6= ϕi1 ∀i.

Proof. Suppose ϕi1 = ϕi2 and

PI

i=1 wi

∈ {1, ..., I − 2}. Then, there exist two pairs, j and

k, such that ϕj2 − ϕj1 < 0 and ϕk2 − ϕk1 < 0. Define ϕ̃i2 = ϕi2 − c, ϕ̃j2 = ϕj2 + c/2, and
ϕ̃k2 = ϕk2 + c/2.
First, note that the change to the numerator of the objective function is less than or equal
to as changing to ϕ̃i2 decreases by c/(1 + Γ), while changing to ϕ̃j2 and ϕ̃k2 increases it by
(c/2 + c/2)/(1 + Γ) if ϕ̃j2 < ϕ̃j1 and ϕ̃k2 < ϕ̃k1 . If one of these inequalities reverses based
on the value of c, the change in numerator will be negative.
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We now evaluate the impact on the variance. Computing: (ϕ̃i2 − ϕi1 )2 + (ϕ̃j2 − ϕj1 )2 +
(ϕ̃k2 − ϕk1 )2 = (ϕi2 − ϕi1 )2 + (ϕj2 − ϕj1 )2 + (ϕk2 − ϕk1 )2 + 3c2 /2 + c(ϕj2 − ϕj1 + ϕk2 − ϕk1 ).
Setting c = (2/3)(ϕj1 − ϕj2 + ϕk1 − ϕk2 ) > 0 yields the identical
P
Hence we can assume that Ii=1 wi ∈ {1, .., I − 2} ⇒ (wi = 1 ⇒ {ϕi2 < ϕi1 }). That is,
PI
i=1 wi ∈ {1, .., I − 2} ⇒ ϕi1 6= ϕi2 ∀i.
P
Lemma 4. Suppose Ii=1 wi in{1, ..., I − 2}. Then, at the solution to the problem above,
PI
Γ
2
¯
2
i=1 (ϕi1 − ϕi2 ) = v̄Γ
(1+Γ)

Proof. For any feasible set of {ϕi2 }, by Lemma 3 we can find ϕi2 and ϕi0 2 such that ϕi2 > ϕi1
and ϕi0 2 < ϕi0 1 . Define ϕ̃i2 = ϕi2 + c and ϕ̃i0 2 = ϕi0 2 − c with c > 0. Replacing ϕi2 and
ϕi0 2 with ϕ̃i2 and ϕ̃i0 2 , the constraint imposed by the null is still satisfied. Furthermore, the
numerator of the objective function changes by −(Γ − 1)/(1 + Γ)c, while the denominator
increases by Γ/(1 + Γ)2 (2c2 + 2c(ϕi2 − ϕi1 + ϕi0 1 − ϕi0 2 )) > 0. The objective function is thus
further minimized, and c can be chosen such that the variance constraint is still satisfied.

Proof of Theorem 2. Using Lemmas 3-4, we can, for

PI

i=1 wi

∈ {1, ..., I − 2}, reformulate

the optimization problem as one which seeks to maximize the expectation of the average
treatment effect

maximize
{ϕi2 }

subject to

I
X

(πi ϕi1 + (1 − πi )ϕi2 )

i=1
I
X

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X
Γ
(ϕi1 − ϕi2 )2 = v̄¯Γ
(1 + Γ)2
i=1

πi = wi /(1 + Γ) + (1 − wi )Γ/(1 + Γ)
wi = 1{ϕi2 ≥ ϕi1 }
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The Lagrangian of the above problem is :

L=

I
X

(πi ϕi1 + (1 − πi )ϕi2 ) + λ1

i=1

+ λ2

I
X

!
¯0
ϕi1 + ϕi2 − 2I ∆

i=1
I
X
(1 + Γ)2
v̄¯Γ
(ϕi1 − ϕi2 )2 −
Γ

!

i=1

Differentiating with respect to ϕi2 and setting to zero yields:

0 = wi Γ/(1 + Γ) + (1 − wi )/(1 + Γ) + λ1 + 2λ2 (ϕi2 − ϕi1 )

This form then implies

ϕi2 − ϕi1 =




 −Γ/(1+Γ)−λ1

ϕi2 ≥ ϕi1



 −1/(1+Γ)−λ1

ϕi2 < ϕi1

2λ2

2λ2

By Lemma 3, it must be the case that C + :=
C − :=

−1/(1+Γ)−λ1
2λ2

−Γ/(1+Γ)−λ1
2λ2

> 0 and

< 0.

Hence, we can now further simplify the form of the optimization problem:
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I
X

maximize

{C + ,C − ,wi }

subject to

i=1
I
X

I

ϕi1 +

I

ΓC + X
C− X
wi +
(1 − wi )
1+Γ
1+Γ
i=1
I
X

2ϕi1 + C −

(1 − wi ) + C

i=1

i=1

Γ
(1 + Γ)2

I
X

i=1
I
X
+

¯0
wi = 2I ∆

i=1


(C − )2 (1 − wi ) + (C + )2 wi = v̄¯Γ

i=1

C+ ≥ 0
C− ≤ 0
I
X

wi ∈ {1, ..., I − 2}

i=1

For
PI

PI

i=1 wi

i=1 wi

∈ {1, ..., I − 2}, we can express the optimal C + and C − as functions of s =

as:

Cs+

=

¯0 − 2
2I ∆

PI

i=1 ϕi1

s

s
4
Cs−

=

PI

I−s
¯
i=1 (∆0 − ϕi1 ) s − 2

− Cs− (I − s)

I−s
s




P
2 
(1+Γ)2 ¯
I
¯
I Γ v̄Γ − 4
i=1 (∆0 − ϕi1 )

2I

I−s
s



The identity for Cs+ follows trivially from the constraint imposed by the null,
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PI

i=1 ϕi1

+

¯ 0:
ϕi2 = 2I ∆
I
X

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X

¯0
2ϕi1 + wi Cs+ + (1 − wi )Cs− = 2I ∆

i=1

Cs+

I
X
i=1

¯0 − 2
2I ∆

PI

wi +

Cs−

I
X

¯0 − 2
(1 − wi ) = 2I ∆

i=1
PI
−
Cs
i=1 (1

i=1 ϕi1 −
PI
i=1 wi
P
¯ 0 − 2 I ϕi1
2I ∆
i=1

I
X

ϕi1

i=1

− wi )

− Cs− (I − s)

s

= Cs+
= Cs+

To derive the expression for Cs+ , note that the variance equality implies:
(Cs+ )2 s + (Cs− )2 (I − s) = v̄¯

(1 + Γ)2
Γ

Expressing Cs+ in terms of Cs− and using the quadratic formula then yields the expression.
These values of C + then yield the values for µs for s ∈ {1, ..., I − 2} given in the Section
5.4.1., and νs2 = v̄¯Γ for s ∈ {1, ..., I − 2} by Lemma 4.
We now consider the set of solutions for which
(1)

PI

i=1 wi

PI

i=1 wi

∈ {0, I − 1, I}.

¯ 0 as we have assumed, PI wi = I cannot be a solution, as
= I. Given ȳ ≥ ∆
i=1

in this case the constraint imposed by the null cannot be satisfied.
PI

i=1 wi

= 0 At

PI

= 0, the numerator of the objective value will then be fixed,
P
¯ 0 ). Thus, minimizing
due to the constraint imposed by the null, at 2/(1 + Γ) Ii=1 (ϕi1 − ∆

(2)

i=1 wi

the objective function is achieved by maximizing its denominator:
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maximize
{ϕi2 }

I
X
Γ
(ϕi1 − ϕi2 )2
(1 + Γ)2
i=1

subject to

I
X

¯0
ϕi1 + ϕi2 = 2I ∆

i=1
I
X
Γ
(ϕi1 − ϕi2 )2 ≤ v̄¯Γ
(1 + Γ)2
i=1

The KKT conditions, along with

PI

i=1 wi

= 0, require the following to hold:

2(ϕi2 − ϕi1 ) = λ1 + 2λ2 (ϕi2 − ϕi1 )

For all i, given

PI

i=1 wi

= 0 we know ϕi2 < ϕi1 . Based on the KKT condition, it is

clear that ϕi2 = ϕi1 + C − for some constant C − < 0, as rearranging the above yields
(ϕi2 − ϕi1 ) = λ1 /(2 − 2λ2 ) ∀i.
With this in mind, from the constraint imposed by the null we have that
P
¯ 0 − ϕi1 ), yielding an objective value of Γ 2 4I −1 (PI (∆
¯ 0 − ϕi1 ))2 . If
C − = 2I −1 Ii=1 (∆
i=1
(1+Γ)
this satisfies the variance inequality, it is a valid solution; otherwise, there is no potentially
P
optimal solution with Ii=1 wi = 0. This leads to the values for µ0 and ν0 given in the
Section 5.4.1.
(3)

PI

i=1 wi

= I − 1,

In this scenario, it could be the case that ϕi1 = ϕi2 for I − 1 of I pairs, while ϕi0 2 − ϕi0 1 =

2
PI
¯0 − ϕi1 ). If it so happens that Γ 2 PI (2∆¯0 − ϕi1 ) = v̄¯Γ , this is a feasible
(2
∆
i=1
i=1
(1+Γ)
solution; however, it cannot be optimal, as is now shown.
Take j, k 6= i0 . such that ϕj2 − ϕj1 = 0 and ϕk2 − ϕk1 = 0. Define ϕ̃i0 2 = ϕi0 2 + c,
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ϕ̃j2 = ϕj2 − c/2, and ϕ̃k2 = ϕk2 − c/2.
Evaluating further, (ϕ̃i2 − ϕi1 )2 + (ϕ̃j2 − ϕj1 )2 + (ϕ̃k2 − ϕk1 )2 = (ϕi2 − ϕi1 )2 + 3c2 /2 +
2c((ϕi0 2 − ϕi0 1 ). Setting c = (4/3)(ϕi0 1 − ϕj2 ) > 0 yields an objective value that is improved
P
by (1/3)Γ/(1 + Γ)(ϕi0 1 − ϕj2 ) and now has Ii=1 wi = I − 2, thus putting us in the regime
previously considered.
If the variance constraint is not binding, the objective value can be improved by changing
the values of ϕi2 such that none of them exactly ϕi1 . If this is the case, the solution when
PI
PI
i=1 wi = I − 1 can be attained as it was when
i=1 wi ∈ {1, ..., I − 2}, thus recovering
2
the values for µI−1 and νI−1
given in Section 5.4.1.
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J. Hájek and Z. Sĭdák. Theory of Rank Tests. 1967.
E. C. Hammond. Smoking in relation to mortality and morbidity. findings in first thirtyfour months of follow-up in a prospective study started in 1959. Journal of the National
Cancer Institute, 32(5):1161–1188, 1964.
B. B. Hansen. Full matching in an observational study of coaching for the SAT. Journal of
the American Statistical Association, 99(467):609–618, 2004.
B. B. Hansen and S. O. Klopfer. Optimal full matching and related designs via network
flows. Journal of Computational and Graphical Statistics, 2012.
S. S. Hecht. Human urinary carcinogen metabolites: biomarkers for investigating tobacco
and cancer. Carcinogenesis, 23(6):907–922, 2002.
J. J. Heckman, S. Urzua, and E. Vytlacil. Understanding instrumental variables in models
with essential heterogeneity. The Review of Economics and Statistics, 88(3):389–432, 2006.
M. A. Hernán and J. M. Robins. Causal Inference. Chapman & Hall/CRC, Boca Raton,
2016.

155

J. Hill and Y. Su. Assessing lack of common support in causal inference using Bayesian nonparametrics: Implications for evaluating the effect of breastfeeding on children’s cognitive
outcomes. The Annals of Applied Statistics, 7(3):1386–1420, 2013.
J. Hill, C. Weiss, and F. Zhai. Challenges with propensity score strategies in a highdimensional setting and a potential alternative. Multivariate Behavioral Research, 46
(3):477–513, 2011.
J. Hodges and E. L. Lehmann. Rank methods for combination of independent experiments
in analysis of variance. The Annals of Mathematical Statistics, 33(2):482–497, 1962.
J. L. Hodges and E. L. Lehmann. Estimates of location based on rank tests. The Annals of
Mathematical Statistics, 34(2):598–611, 1963.
P. W. Holland. Causal inference, path analysis and recursive structural equations models.
Sociological Methodology, 18:449–484, 1988.
S. Holm. A simple sequentially rejective multiple test procedure. Scandinavian Journal of
Statistics, 6(2):65–70, 1979.
C. A. Hosman, B. B. Hansen, and P. W. Holland. The sensitivity of linear regression
coefficients’ confidence limits to the omission of a confounder. The Annals of Applied
Statistics, 4(2):849–870, 2010.
J. Y. Hsu, D. S. Small, and P. R. Rosenbaum. Effect modification and design sensitivity in
observational studies. Journal of the American Statistical Association, 108(501):135–148,
2013.
J. Y. Hsu, J. R. Zubizarreta, D. S. Small, and P. R. Rosenbaum. Strong control of the familywise error rate in observational studies that discover effect modification by exploratory
methods. Biometrika, 102(4):767–782, 2015.
P. J. Huber. Robust Statistics. Springer, New York, 1981.
IARC. Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene,
volume 82. World Health Organization, IARC Press, Lyon, France, 2002.
G. W. Imbens. Sensitivity to exogeneity assumptions in program evaluation. American
Economic Review, 93(2):126–132, 2003.
G. W. Imbens. Nonparametric estimation of average treatment effects under exogeneity: A
review. Review of Economics and Statistics, 86(1):4–29, 2004.
R. Jaeschke, G. Guyatt, H. Shannon, S. Walter, D. Cook, and N. Heddle. Basic statistics
for clinicians: 3. assessing the effects of treatment: measures of association. Canadian
Medical Association Journal, 152(3):351–357, 1995.

156

S. F. Jencks, M. V. Williams, and E. A. Coleman. Rehospitalizations among patients in the
Medicare fee-for-service program. New England Journal of Medicine, 360(14):1418–1428,
2009.
A. E. Jones. Point: Should Lactate Clearance Be Substituted for Central Venous Oxygen
Saturation as Goals of Early Severe Sepsis and Septic Shock Therapy? Yes. CHEST
Journal, 140(6):1406–1408, 2011.
T. K. Jones, B. D. Fuchs, D. S. Small, S. D. Halpern, A. Hanish, C. A. Umscheid, C. A.
Baillie, M. P. Kerlin, D. F. Gaieski, and M. E. Mikkelsen. Post-acute care use and hospital
readmission after sepsis. Annals of the American Thoracic Society, 12(6):904–913, 2015.
M. Jünger, T. M. Liebling, D. Naddef, G. L. Nemhauser, W. R. Pulleyblank, G. Reinelt,
G. Rinaldi, and L. A. Wolsey. 50 Years of Integer Programming 1958-2008. Springer
Science & Business Media, New York, 2009.
S. Karlin. Mathematical Methods and Theory in Games, Programming, and Economics,
volume II. Dover, New York, 1992.
L. Keele, D. Small, and R. Grieve. Randomization based instrumental variables methods for
binary outcomes with an application to the IMPROVE trial. available on lead author’s
website, 2014.
G. King and L. Zeng. The dangers of extreme counterfactuals. Political Analysis, 14(2):
131–159, 2006.
W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman. APACHE II: a severity
of disease classification system. Critical Care Medicine, 13(10):818–829, 1985.
E. Lehmann. Nonparametric confidence intervals for a shift parameter. The Annals of
Mathematical Statistics, 34(2):1507–1512, 1963.
E. Lehmann. Elements of Large-Sample Theory. Springer, New York, 2004.
M. Levy, J. Rapoport, S. Lemeshow, D. B. Chalfin, G. Phillips, and M. Danis. Association
between critical care physician management and patient mortality in the intensive care
unit. Annals of Internal Medicine, 148(11):801–809, 2008.
V. Liu, G. J. Escobar, J. D. Greene, J. Soule, A. Whippy, D. C. Angus, and T. J. Iwashyna.
Hospital deaths in patients with sepsis from two independent cohorts. Journal of the
American Medical Association, 312(1):90–92, 2014.
W. Liu, M. A. Brookhart, S. Schneeweiss, X. Mi, and S. Setoguchi. Implications of M bias
in epidemiologic studies: a simulation study. American Journal of Epidemiology, 176(10):
938–948, 2012.
W. Liu, S. J. Kuramoto, and E. A. Stuart. An introduction to sensitivity analysis for

157

unobserved confounding in nonexperimental prevention research. Prevention Science, 14
(6):570–580, 2013.
N. Mantel and W. Haenszel. Statistical aspects of the analysis of data from retrospective
studies of disease. Journal of the National Cancer Institute, 22(4):719–748, 1959.
R. Marcus, P. Eric, and K. R. Gabriel. On closed testing procedures with special reference
to ordered analysis of variance. Biometrika, 63(3):655–660, 1976.
S. M. Marcus. Using omitted variable bias to assess uncertainty in the estimation of an
aids education treatment effect. Journal of Educational and Behavioral Statistics, 22(2):
193–201, 1997.
F. Margot. Symmetry in integer linear programming. In 50 Years of Integer Programming
1958-2008, pages 647–686. Springer, New York, 2010.
J. Maritz. A note on exact robust confidence intervals for location. Biometrika, 66(1):
163–170, 1979.
R. Mechanic. Post-acute care: the next frontier for controlling Medicare spending. New
England Journal of Medicine, 370(8):692–694, 2014.
N. Meinshausen. Hierarchical testing of variable importance. Biometrika, 95(2):265–278,
2008.
M. E. Mikkelsen, A. N. Miltiades, D. F. Gaieski, M. Goyal, B. D. Fuchs, C. V. Shah, S. L.
Bellamy, and J. D. Christie. Serum lactate is associated with mortality in severe sepsis
independent of organ failure and shock. Critical Care Medicine, 37(5):1670–1677, 2009.
K. Ming and P. R. Rosenbaum. Substantial gains in bias reduction from matching with a
variable number of controls. Biometrics, 56(1):118–124, 2000.
D. Misselbrook and D. Armstrong. Patients’ responses to risk information about the benefits
of treating hypertension. British Journal of General Practice, 51(465):276–279, 2001.
J. E. Mitchell. Branch-and-cut algorithms for combinatorial optimization problems. Handbook of Applied Optimization, pages 65–77, 2002.
H.-M. Nan, H. Kim, H.-S. Lim, J. K. Choi, T. Kawamoto, J.-W. Kang, C.-H. Lee, Y.D. Kim, and E. H. Kwon. Effects of occupation, lifestyle and genetic polymorphisms
of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol
concentrations. Carcinogenesis, 22(5):787–793, 2001.
J. Neyman. On the application of probability theory to agricultural experiments. Essay on
principles. Section 9 (in Polish). Roczniki Nauk Roiniczych, X:1–51, 1923. Reprinted in
Statistical Science, 1990, 5(4):463-480.

158

Z. Obermeyer, M. Makar, S. Abujaber, F. Dominici, S. Block, and D. M. Cutler. Association
between the medicare hospice benefit and health care utilization and costs for patients
with poor-prognosis cancer. Journal of the American Medical Association, 312(18):1888–
1896, 2014.
K. J. Ottenbacher, A. Karmarkar, J. E. Graham, Y.-F. Kuo, A. Deutsch, T. A. Reistetter,
S. Al Snih, and C. V. Granger. Thirty-day hospital readmission following discharge from
postacute rehabilitation in fee-for-service Medicare patients. Journal of the American
Medical Association, 311(6):604–614, 2014.
C. Poole. On the origin of risk relativism. Epidemiology, 21(1):3–9, 2010.
R. Preuss, H. M. Koch, M. Wilhelm, M. Pischetsrieder, and J. Angerer. Pilot study on the
naphthalene exposure of German adults and children by means of urinary 1-and 2-naphthol
levels. International Journal of Hygiene and Environmental Health, 207(5):441–445, 2004.
M. A. Puskarich, S. Trzeciak, N. I. Shapiro, A. C. Heffner, J. A. Kline, and A. E. Jones.
Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared
with overt shock. Resuscitation, 82(10):1289–1293, 2011.
R Development Core Team. R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing, Vienna, Austria, 2014.
J. Rigdon and M. G. Hudgens. Randomization inference for treatment effects on a binary
outcome. Statistics in Medicine, (6):924 –935, 2014.
J. Rigdon and M. G. Hudgens. Randomization inference for treatment effects on a binary
outcome. Statistics in Medicine, 34(6):924 –935, 2015.
E. P. Rivers, R. Elkin, and C. M. Cannon. Counterpoint: should lactate clearance be
substituted for central venous oxygen saturation as goals of early severe sepsis and septic
shock therapy? No. CHEST Journal, 140(6):1408–1413, 2011.
J. M. Robins. Confidence intervals for causal parameters. Statistics in Medicine, 7(7):
773–785, 1988.
J. M. Rohde, A. J. Odden, C. Bonham, L. Kuhn, P. N. Malani, L. M. Chen, S. A. Flanders,
and T. J. Iwashyna. The epidemiology of acute organ system dysfunction from severe
sepsis outside of the intensive care unit. Journal of Hospital Medicine, 8(5):243–247,
2013.
J. P. Romano and M. Wolf. Exact and approximate stepdown methods for multiple hypothesis testing. Journal of the American Statistical Association, 100(469):94–108, 2005.
P. R. Rosenbaum. Dropping out of high school in the United States: An observational study.
Journal of Educational and Behavioral Statistics, 11(3):207–224, 1986.

159

P. R. Rosenbaum. Sensitivity analysis for certain permutation inferences in matched observational studies. Biometrika, 74(1):13–26, 1987.
P. R. Rosenbaum. A characterization of optimal designs for observational studies. Journal
of the Royal Statistical Society. Series B (Methodological), 53(3):597–610, 1991.
P. R. Rosenbaum. Detecting bias with confidence in observational studies. Biometrika, 79
(2):367–374, 1992.
P. R. Rosenbaum. Effects attributable to treatment: Inference in experiments and observational studies with a discrete pivot. Biometrika, 88(1):219–231, 2001.
P. R. Rosenbaum. Observational Studies. Springer, New York, 2002a.
P. R. Rosenbaum. Attributing effects to treatment in matched observational studies. Journal
of the American Statistical Association, 97(457):183–192, 2002b.
P. R. Rosenbaum. Covariance adjustment in randomized experiments and observational
studies. Statistical Science, 17(3):286–327, 2002c.
P. R. Rosenbaum. Design sensitivity in observational studies. Biometrika, 91(1):153–164,
2004.
P. R. Rosenbaum. Heterogeneity and causality. The American Statistician, 59(1):147–152,
2005.
P. R. Rosenbaum. Sensitivity analysis for M-estimates, tests, and confidence intervals in
matched observational studies. Biometrics, 63(2):456–464, 2007.
P. R. Rosenbaum. Design of Observational Studies. Springer, New York, 2010.
P. R. Rosenbaum. Optimal matching of an optimally chosen subset in observational studies.
Journal of Computational and Graphical Statistics, 21(1):57–71, 2012.
P. R. Rosenbaum. Impact of multiple matched controls on design sensitivity in observational
studies. Biometrics, 69(1):118–127, 2013.
P. R. Rosenbaum. Weighted M-statistics with superior design sensitivity in matched observational studies with multiple controls. Journal of the American Statistical Association,
109(507):1145–1158, 2014.
P. R. Rosenbaum and A. M. Krieger. Sensitivity of two-sample permutation inferences in
observational studies. Journal of the American Statistical Association, 85(410):493–498,
1990.
P. R. Rosenbaum and D. B. Rubin. The central role of the propensity score in observational
studies for causal effects. Biometrika, 70(1):41–55, 1983.

160

P. R. Rosenbaum and D. B. Rubin. Reducing bias in observational studies using subclassification on the propensity score. Journal of the American Statistical Association, 79(387):
516–524, 1984.
P. R. Rosenbaum and J. H. Silber. Sensitivity analysis for equivalence and difference in an
observational study of neonatal intensive care units. Journal of the American Statistical
Association, 104(486):501–511, 2009.
D. B. Rubin. Estimating causal effects of treatments in randomized and nonrandomized
studies. Journal of Educational Psychology, 66(5):688–701, 1974.
D. B. Rubin. Which ifs have causal answers. Journal of the American Statistical Association,
81(396):961–962, 1986.
D. B. Rubin. Should observational studies be designed to allow lack of balance in covariate
distributions across treatment groups? Statistics in Medicine, 28(9):1420–1423, 2009.
D. B. Rubin and R. P. Waterman. Estimating the causal effects of marketing interventions
using propensity score methodology. Statistical Science, 21(2):206–222, 2006.
J. J. Sabia. Does sex education affect adolescent sexual behaviors and health? Journal of
Policy Analysis and Management, 25(4):783–802, 2006.
K. Sanctucci and B. Shah. Association of naphthalene with acute hemolytic anemia. Academic Emergency Medicine, 7(1):42–47, 2000.
T. Sato, S. Greenland, and J. M. Robins. On the variance estimator for the Mantel-Haenszel
risk difference. Biometrics, 45(4):1323 – 1324, 1989.
E. Schechtman. Odds ratio, relative risk, absolute risk reduction, and the number needed
to treat: which of these should we use? Value in Health, 5(5):431–436, 2002.
A. Schrijver. Combinatorial Optimization: Polyhedra and Efficiency. Springer, New York,
2003.
J. H. Silber, P. R. Rosenbaum, M. E. Trudeau, O. Even-Shoshan, W. Chen, X. Zhang, and
R. E. Mosher. Multivariate matching and bias reduction in the surgical outcomes study.
Medical Care, 39(10):1048–1064, 2001.
J. C. Sinclair and M. B. Bracken. Clinically useful measures of effect in binary analyses of
randomized trials. Journal of Clinical Epidemiology, 47(8):881–889, 1994.
E. A. Stuart. Matching methods for causal inference: A review and a look forward. Statistical
Science, 25(1):1–21, 2010.
E. A. Stuart and K. M. Green. Using full matching to estimate causal effects in nonexperimental studies: examining the relationship between adolescent marijuana use and adult
outcomes. Developmental Psychology, 44(2):395–406, 2008.
161

V. Sundararajan, C. M. MacIsaac, J. J. Presneill, J. F. Cade, and K. Visvanathan. Epidemiology of sepsis in Victoria, Australia. Critical Care Medicine, 33(1):71–80, 2005.
P. Suwan-ampai, A. Navas-Acien, P. T. Strickland, and J. Agnew. Involuntary tobacco smoke
exposure and urinary levels of polycyclic aromatic hydrocarbons in the united states, 1999
to 2002. Cancer Epidemiology Biomarkers & Prevention, 18(3):884–893, 2009.
V. Todisco, J. Lamour, and L. Finberg. Hemolysis from exposure to naphthalene mothballs.
New England Journal of Medicine, 325(23):1660–1661, 1991.
M. Traskin and D. S. Small. Defining the study population for an observational study to
ensure sufficient overlap: a tree approach. Statistics in Biosciences, 3(1):94–118, 2011.
A. W. Van der Vaart. Asymptotic Statistics, volume 3. Cambridge University Press, Cambridge, 2000.
T. J. VanderWeele and O. A. Arah. Unmeasured confounding for general outcomes, treatments, and confounders: Bias formulas for sensitivity analysis. Epidemiology, 22(1):42–52,
2011.
T. J. VanderWeele and I. Shpitser. A new criterion for confounder selection. Biometrics, 67
(4):1406–1413, 2011.
T. J. VanderWeele and I. Shpitser. On the definition of a confounder. Annals of Statistics,
41(1):196–220, 2013.
N. Voigtländer and H.-J. Voth. Persecution perpetuated: the medieval origins of anti-semitic
violence in nazi germany. Quarterly Journal of Economics, 127(3):1339–1392, 2012.
L. Wang and A. M. Krieger. Causal conclusions are most sensitive to unobserved binary
covariates. Statistics in Medicine, 25(13):2257–2271, 2006.
M. Weitzman, S. Cook, P. Auinger, T. A. Florin, S. Daniels, M. Nguyen, and J. P. Winickoff. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents.
Circulation, 112(6):862–869, 2005.
P. H. Westfall and S. S. Young. Resampling-Based Multiple Testing: Examples and Methods
for P-value Adjustment, volume 279. John Wiley & Sons, 1993.
S. A. Whittaker, B. D. Fuchs, D. F. Gaieski, J. D. Christie, M. Goyal, N. J. Meyer, C. Kean,
D. S. Small, S. L. Bellamy, and M. E. Mikkelsen. Epidemiology and outcomes in patients
with severe sepsis admitted to the hospital wards. Journal of Critical Care, 30(1):78–84,
2015.
F. Yang, J. R. Zubizarreta, D. S. Small, S. Lorch, and P. R. Rosenbaum. Dissonant conclusions when testing the validity of an instrumental variable. The American Statistician, 68
(4):253–263, 2014.

162

M. Yang, M. Koga, T. Katoh, and T. Kawamoto. A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons. Archives
of Environmental Contamination and Toxicology, 36(1):99–108, 1999.
B. Yu and J. L. Gastwirth. Sensitivity analysis for trend tests: application to the risk of
radiation exposure. Biostatistics, 6(2):201–209, 2005.
J. R. Zubizarreta. Using mixed integer programming for matching in an observational study
of kidney failure after surgery. Journal of the American Statistical Association, 107(500):
1360–1371, 2012.
J. R. Zubizarreta, M. Cerdá, and P. R. Rosenbaum. Effect of the 2010 Chilean earthquake
on posttraumatic stress reducing sensitivity to unmeasured bias through study design.
Epidemiology, 24(1):79–87, 2013.
J. R. Zubizarreta, R. D. Paredes, and P. R. Rosenbaum. Matching for balance, pairing for
heterogeneity in an observational study of the effectiveness of for-profit and not-for-profit
high schools in Chile. The Annals of Applied Statistics, 8(1):204–231, 2014.

163

